{"Title": ["Biotech Stocks Facing FDA Decision In July 2020", "BUZZ-U.S. STOCKS ON THE MOVE-Wynn Resorts, Thermogenesis, U.S. Cruise Lines", "BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Uber, Moderna, Reata Pharma", "BUZZ-U.S. STOCKS ON THE MOVE-Regeneron Pharmaceuticals, Onconova Therapeutics, Nio Inc", "New York charges Endo with insurance fraud over opioid claims", "New York charges Endo with insurance fraud over opioid claims", "3 Drug Stocks That Could Soar in 2020", "Why a Famed Investor Says This Is the Fifth Great Buying Opportunity", "Biotech Stocks Facing FDA Decision In July 2020", "Endo International Fires on All Cylinders in Q1 Thanks to COVID-19 Impact", "BUZZ-U.S. STOCKS ON THE MOVE-Oil stocks, airlines, Peloton, PayPal", "BUZZ-U.S. STOCKS ON THE MOVE-PayPal, GM, Lyft, airlines", "BUZZ-U.S. STOCKS ON THE MOVE-CVS, PayPal, Lyft, GM", "BUZZ-U.S. STOCKS ON THE MOVE-Lyft, Livongo Health, Tonix Pharma", "BUZZ-U.S. STOCKS ON THE MOVE-Lyft, GM, Bristol Myers, Nvidia", "Endo International Q1 20 Earnings Conference Call At 8:00 AM ET", "Endo International (ENDP) Q1 2020 Earnings Call Transcript", "Endo International Fires on All Cylinders in Q1 Thanks to COVID-19 Impact", "BUZZ-U.S. STOCKS ON THE MOVE-Oil stocks, airlines, Peloton, PayPal", "BUZZ-U.S. STOCKS ON THE MOVE-PayPal, GM, Lyft, airlines", "BUZZ-U.S. STOCKS ON THE MOVE-CVS, PayPal, Lyft, GM", "BUZZ-U.S. STOCKS ON THE MOVE-Lyft, Livongo Health, Tonix Pharma", "BUZZ-U.S. STOCKS ON THE MOVE-Lyft, GM, Bristol Myers, Nvidia", "Endo International Q1 20 Earnings Conference Call At 8:00 AM ET", "Endo International (ENDP) Q1 2020 Earnings Call Transcript", "Endo International Fires on All Cylinders in Q1 Thanks to COVID-19 Impact", "BUZZ-U.S. STOCKS ON THE MOVE-Oil stocks, airlines, Peloton, PayPal", "BUZZ-U.S. STOCKS ON THE MOVE-PayPal, GM, Lyft, airlines", "BUZZ-U.S. STOCKS ON THE MOVE-CVS, PayPal, Lyft, GM", "First Week of April 9th Options Trading For Endo International plc (ENDP)", "Endo International (ENDP) Q4 2019 Earnings Call Transcript", "Endo International Q4 19 Earnings Conference Call At 8:00 AM ET", "Endo International Withdraws 2020 Guidance - Quick Facts", "Will an Opioid Manufacturer Stage a Comeback With This New Venture?", "Endo International Breaks Above 200-Day Moving Average - Bullish for ENDP", "Should You Buy This Biotech That Makes A Lower Risk Painkiller?", "FDA Asks for Recalls of Sanofi's Zantac and All Generic Versions", "First Week of April 9th Options Trading For Endo International plc (ENDP)", "Endo International (ENDP) Q4 2019 Earnings Call Transcript", "Endo International Q4 19 Earnings Conference Call At 8:00 AM ET", "Endo International Withdraws 2020 Guidance - Quick Facts", "Endo International plc Q4 adjusted earnings of $0.74 per share", "Interesting ENDP Put And Call Options For April 3rd", "Stock To Watch: Endo International (ENDP)", "ENDP March 6th Options Begin Trading", "3 Big Winners From the \"Super Bowl of Healthcare\"", "Scandal-Ridden Teva Pharmaceutical Is Fishing for a Bottom", "Interesting ENDP Put And Call Options For March 20th", "Endo International Guides FY20 In Line With Estimates - Quick Facts", "Validea's Top Five Healthcare Stocks Based On Kenneth Fisher - 12/15/2019", "January 2020 Options Now Available For Endo International (ENDP)", "Why Sorrento Therapeutics Was Right to Reject Takeover Bids With A 245% Premium", "Endo International Breaks Above 200-Day Moving Average - Bullish for ENDP", "ENDP January 2020 Options Begin Trading", "FTXH's Holdings Could Mean 15% Gain Potential", "3 Recovering Healthcare Stocks to Buy That Already Escaped Flu Season", "How The Parts Add Up: XPH Headed For $54", "Validea's Top Five Healthcare Stocks Based On Kenneth Fisher - 12/15/2019", "January 2020 Options Now Available For Endo International (ENDP)", "Why Sorrento Therapeutics Was Right to Reject Takeover Bids With A 245% Premium", "Endo International Breaks Above 200-Day Moving Average - Bullish for ENDP", "ENDP January 2020 Options Begin Trading", "5 Top Gainers In Healthcare Sector (MNK, ENDP, MLNT...)", "First Week of ENDP July 2020 Options Trading", "Why DocuSign, Endo International, and Guidewire Software Jumped Today", "5 Top Losers In Healthcare Sector (ENDP, AVGR, LPTX...)", "Endo International (ENDP) Q2 2019 Earnings Call Transcript", "Here's Why Endo International Is Falling Today", "13 Stocks to Sell Before They Dive Even More", "3 Drug Stocks With Unimaginably Low P/E Ratios", "Endo International (ENDP) Q1 2019 Earnings Call Transcript", "Why Endo International Stock Is Jumping Today", "Endo International Affirms FY19 Outlook - Quick Facts", "Endo International plc Q1 adjusted earnings Beat Estimates", "First Week of June 21st Options Trading For Endo International (ENDP)", "Interesting ENDP Put And Call Options For May 31st", "Endo Unit Begins Shipping Generic Version Of Merck's PROVENTIL - Quick Facts", "Catalyst (CPRX) Reports Wider Q4 Loss, Focuses on Firdapse", "BioDelivery (BDSI) Q4 Earnings In Line, Sales Beat, Stock Up", "Health Care Sector Update for 05/09/2019: ABIO, AGEN, ENDP, JNJ, PFE, ABT, MRK, AMGN", "After Hours Most Active for Mar 13, 2019 : MSFT, LLY, F, CMCSA, PFE, FOX, CTL, HPQ, PCG, AMD, AAPL, ENDP", "Is Endo International (ENDP) a Great Stock for Value Investors?", "Endo (ENDP) Soars: Stock Adds 6% in Session", "What Scott Gottlieb's FDA Departure Means for Investors", "What's in Store for BioSpecifics (BSTC) This Earnings Season?", "Endo (ENDP) Q4 Earnings & Revenues Beat Estimates, Shares Up", "Endo International plc (ENDP) Q4 2018 Earnings Conference Call Transcript", "Insys Plunges on Auditor's Concern About Insufficient Funds", "Earnings Preview: Endo International (ENDP) Q4 Earnings Expected to Decline", "Endo International To Not Oppose Additional Stay Of FDA Litigation - Quick Facts", "Endo International To Present At J.P. Morgan Conference; Webcast At 2:30 PM ET", "Heron Gains on Priority Review Designation for Pain Drug", "Options Traders Expect Huge Moves in Endo (ENDP) Stock", "Endo: FDA Requests Further Stay Of Compounding Litigation - Quick Facts", "Generic Drugmakers Down on Allegations of Price Fixing", "Interesting ENDP Put And Call Options For April 12th", "Earnings Preview: Endo International (ENDP) Q4 Earnings Expected to Decline", "Endo International To Not Oppose Additional Stay Of FDA Litigation - Quick Facts", "Endo International To Present At J.P. Morgan Conference; Webcast At 2:30 PM ET", "Heron Gains on Priority Review Designation for Pain Drug", "Endo (ENDP) Stock Declines Despite Q3 Earnings & Revenue Beat", "Here's Why Endo International Fell as Much as 18.9% Today", "Endo International Enters Oversold Territory (ENDP)", "Why Is Endo (ENDP) Down 12.3% Since Last Earnings Report?", "ENDP December 28th Options Begin Trading", "Endo International (ENDP) Q3 Earnings and Revenues Surpass Estimates", "Earnings Reaction History: Endo International plc, 50.0% Follow-Through Indicator, 13.0% Sensitive", "Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?", "Noteworthy Thursday Option Activity: LNG, RETA, ENDP", "What's in the Cards for BioSpecifics (BSTC) in Q3 Earnings?", "Endo (ENDP) to Report Q3 Earnings: What's in the Cards?", "Endo International plc (ENDP) Q3 2018 Earnings Conference Call Transcript", "Notable Wednesday Option Activity: POST, SBUX, ENDP", "IJS, SR, WWW, ENDP: ETF Outflow Alert", "Endo Recalls 2 Lots of Robaxin Tablets Due to Labeling Error", "Forget Mylan, Invest in These 3 Generic/Drug Stocks Instead", "Has Endo International plc (ENDP) Outpaced Other Medical Stocks This Year?", "First Week of November 16th Options Trading For Endo International (ENDP)", "Is Endo International (ENDP) a Great Stock for Value Investors?", "Rigel (RIGL) Gets EMA Acceptance for Thrombocytopenia Drug", "Notable Wednesday Option Activity: POST, SBUX, ENDP", "IJS, SR, WWW, ENDP: ETF Outflow Alert", "Endo Recalls 2 Lots of Robaxin Tablets Due to Labeling Error", "Forget Mylan, Invest in These 3 Generic/Drug Stocks Instead", "Has Endo International plc (ENDP) Outpaced Other Medical Stocks This Year?", "Biogen Begins Phase III Study on Ischemic Stroke Candidate", "Esperion (ESPR) Combination Regimen Lowers Bad Cholesterol", "Irish Economy Rebounds in Q2: 4 Great Picks", "Endo International Reaches Analyst Target Price", "Jazz's (JAZZ) Leukemia Drug Vyxeos Gets Approval in Europe", "Lannett Set to Lose Distribution Agreement With Key Supplier", "Zacks.com highlights: Medifast, Endo International, HCA Healthcare, Five9 and FTI Consulting", "Buy These 5 Low-Beta Stocks to Brave Market Volatility", "Buy These 5 Low-Beta Stocks to Brave Market Volatility", "Amneal Pharmaceuticals (AMRX) Jumps: Stock Rises 5.6%", "Ionis Pharmaceuticals (IONS) Looks Good: Stock Adds 7.8% in Session", "Pre-Market Most Active for Aug 13, 2018 : TUR, TKC, QQQ, NLSN, SQQQ, TVIX, BBVA, ENDP, DB, SAN, USLV, BABA", "Monday's ETF with Unusual Volume: FYC", "3 Biotech Stocks That Soared This Week: Are They Buys?", "BioDelivery (BDSI) Q2 Loss Narrows, Sales Miss, Shares Down", "ENDP September 28th Options Begin Trading", "Company News For Aug 9, 2018", "Endo (ENDP) Beats on Q2 Earnings & Sales, Raises Guidance", "ENDP December 21st Options Begin Trading", "Pre-Market Most Active for Aug 13, 2018 : TUR, TKC, QQQ, NLSN, SQQQ, TVIX, BBVA, ENDP, DB, SAN, USLV, BABA", "Monday's ETF with Unusual Volume: FYC", "3 Biotech Stocks That Soared This Week: Are They Buys?", "Notable Wednesday Option Activity: CELG, NVDA, ENDP", "Endo International plc (ENDP) Q2 2018 Earnings Conference Call Transcript", "Mid-Afternoon Market Update: Crude Oil Down 3.5%; Endo International Shares Surge After Strong Q2 Results", "Mid-Day Market Update: 3D Systems Climbs On Earnings Beat; Core Molding Technologies Shares Drop", "What's in Store for Catalyst (CPRX) This Earnings Season?", "Zoetis (ZTS) Gears Up for Q2 Earnings: What's in Store?", "What's in Store for Intrexon (XON) This Earnings Season?", "What's in Store for Epizyme (EPZM) This Earnings Season?", "What's in Store for Immune Design (IMDZ) in Q2 Earnings?", "Will Agenus (AGEN) Disappoint Investors This Earnings Season?", "Is a Beat in Store for Endocyte (ECYT) This Earnings Season?", "Is a Beat in Store for Horizon Pharma (HZNP) in Q2 Earnings?", "Is the Options Market Predicting a Spike in Endo International (ENDP) Stock?", "Pain, Durect Plunge as FDA Committee Votes Against Remoxy ER", "After Hours Most Active for Jun 27, 2018 : GGP, TEGP, ESV, SWN, QQQ, ORCL, CSCO, AZN, MSFT, ENDP, FEYE, FB", "After Hours Most Active for Jun 22, 2018 : RAD, SWN, CMCSA, VZ, BAC, TAHO, P, CZR, OPK, ENDP, UMPQ, MDRX", "BioMarin Begins Pediatric Study on Achondroplasia Candidate", "Teva Pharmaceutical Industries Limited Stock Still Is a Deep Value Play", "After Hours Most Active for Jun 15, 2018 : ENDP, RRC, HFC, BR, GERN, QQQ, AAPL, BAC, CSCO, OPK, GE, WFC", "Is Endo International a Great Stock for Value Investors?", "Is the Options Market Predicting a Spike in Endo International (ENDP) Stock?", "Pain, Durect Plunge as FDA Committee Votes Against Remoxy ER", "After Hours Most Active for Jun 27, 2018 : GGP, TEGP, ESV, SWN, QQQ, ORCL, CSCO, AZN, MSFT, ENDP, FEYE, FB", "After Hours Most Active for May 14, 2018 : F, ENDP, SNCR, INTC, ABEV, MSFT, CMCSA, PFE, CSCO, GE, DHI, CNP", "BioDelivery (BDSI) Q1 Earnings and Sales Beat Estimates", "Xiaflex & Sterile Injectables Drive Endo's (ENDP) Q1 Earnings", "Endo International (ENDP) Up 12.4% Since Earnings Report: Can It Continue?", "Earnings Reaction History: Endo International plc, 54.5% Follow-Through Indicator, 12.9% Sensitive", "Factors Likely to Impact Zillow (ZG) This Earnings Season", "Health Care Sector Update for 05/07/2018: LCI,ENDP,EARS,VRX,VRX.TO,NVAX", "Health Care Sector Update for 04/18/2018: ABT, FCSC, ENDP, SLDB", "Health Care Sector Update for 04/18/2018: SLDB,FCSC,ABT,ENDP,EGRX", "Health Care Sector Update for 04/18/2018: FCSC,ABT,ENDP,EGRX", "Are Options Traders Betting on a Big Move in Endo International (ENDP) Stock?", "Is the Options Market Predicting a Spike in Endo International (ENDP) Stock?", "What Falling Estimates & Price Mean for Endo International (ENDP)", "Why Is Endo International (ENDP) Down 15% Since its Last Earnings Report?", "BioMarin's MAA for Phenylketonuria Candidate Gains EU Nod", "After Hours Most Active for Mar 28, 2018 : BKD, ENDP, TWTR, QQQ, HPQ, FDC, GE, NCLH, SLM, EBAY, NWSA, PEP", "Implied VTI Analyst Target Price: $155", "Close Update: Wall Street Dives as Facebook's Selloff Dents Sentiment Before Fed Meeting", "BioDelivery (BDSI) Q4 Loss Wider-Than-Expected, Sales Up Y/Y", "After Hours Most Active for Apr 13, 2018 : AAPL, QQQ, CMCSA, QCOM, ENDP, MSFT", "After Hours Most Active for Mar 13, 2018 : ENDP, DWDP, NWL, INTC, PFE, HPQ, ZNGA, FOLD, SWN, QQQ, CBS, STLD", "Kohl???s, Endo International and Costco as Zacks Bull and Bear of the Day", "Bear of the Day: Endo International (ENDP)", "What's in the Cards for BioDelivery (BDSI) in Q4 Earnings?", "Endo (ENDP) Surpasses Earnings, Revenue Estimates in Q4", "Valeant Earnings: A 12-Month Journey to Nowhere", "New Strong Sell Stocks for February 28th", "Commit To Purchase Endo International At $5, Earn 12.9% Annualized Using Options", "After Hours Most Active for Mar 13, 2018 : ENDP, DWDP, NWL, INTC, PFE, HPQ, ZNGA, FOLD, SWN, QQQ, CBS, STLD", "Kohl???s, Endo International and Costco as Zacks Bull and Bear of the Day", "After Hours Most Active for Feb 7, 2018 : BAC, QQQ, LHO, TSM, PEB, T, VICI, USMC, AAPL, ENDP, MSFT, CSCO", "Endo International is Now Oversold (ENDP)", "Thursday's ETF with Unusual Volume: MDYV", "Endo (ENDP) Loses 35% in a Year: Can It Turn Around in 2018?", "Is the Options Market Predicting a Spike in Endo International (ENDP) Stock?", "Interesting ENDP Put And Call Options For March 2nd", "Health Care Sector Update for 01/11/2018: MDXG, ENDP, MEIP, BSX, CRL", "Health Care Sector Update for 01/11/2018: ENDP,MEIP,BSX,CRL", "Interesting ENDP Put And Call Options For January 2018", "Endo (ENDP) Earnings & Revenues Beat in Q3, Generics Weak", "BioDelivery (BDSI) Q3 Earnings, Sales Beat Estimates", "Implied Volatility Surging for Endo (ENDP) Stock Options", "Endo (ENDP) Gets Subpoena From Florida for Opioid Misuse", "Why Endo International plc Jumped and Then Faded -- Twice", "Endo's Upbeat Earnings: Don't Get Too Excited", "Morning Movers: Mergers, Earnings and Downgrades, Oh My!", "Here's Why Endo International Stock Dropped as Much as 13.8% Today", "How The Pieces Add Up: PPH Targets $64", "Should Value Investors Consider Endo International (ENDP) Stock?", "Are Options Traders Betting on a Big Move in Endo International (ENDP) Stock?", "Earnings Reaction History: Endo International plc, 50.0% Follow-Through Indicator, 13.0% Sensitive", "New Strong Sell Stocks for August 31st", "Will Endo (ENDP) Continue to Disappoint Investors in 2017?", "BioDelivery (BDSI) CEO Mark Sirgo to Retire by 2017 End", "Endo International (ENDP) Jumps: Stock Rises 6.9%", "BioDelivery (BDSI) Q2 Loss Wider than Expected, Stock Falls", "Thursday's ETF with Unusual Volume: MDYV", "January 2020 Options Now Available For Endo International (ENDP)", "New Strong Sell Stocks for September 11th", "New Strong Sell Stocks for August 31st", "Will Endo (ENDP) Continue to Disappoint Investors in 2017?", "What's in Store for BioDelivery (BDSI) This Earnings Season?", "Drug Stocks Q2 Earnings Roster for Aug 8: ACAD, JAZZ & More", "RSI Alert: Endo International (ENDP) Now Oversold", "Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Catch a Break?", "Pre-Market Most Active for Aug 8, 2017 : VRX, ENDP, TEVA, ABB, FGEN, QQQ, INVA, CAR, KORS, NVDA, HTZ, PAGP", "Endo (ENDP) Q2 Earnings Beat Estimates, 2017 Guidance Cut", "Earnings Reaction History: Endo International plc, 50.0% Follow-Through Indicator, 12.0% Sensitive", "Endo (ENDP) Beats Q2 Earnings & Sales, 2017 Guidance Lowered", "What's in Store for BioDelivery (BDSI) This Earnings Season?", "Drug Stocks Q2 Earnings Roster for Aug 8: ACAD, JAZZ & More", "RSI Alert: Endo International (ENDP) Now Oversold", "BioDelivery Inks New Contract with CVS/Caremark, Shares Up", "What's in the Cards for Endo (ENDP) this Earnings Season?", "Options Traders Expect Huge Moves in Endo International (ENDP) Stock", "Nektar's NKTR-181 Positive in Human Abuse Potential Study", "BioDelivery-Purdue Pharma Ink Marketing Deal for Pain Drug", "Mallinckrodt to Pay $35M for Controlled Substances Probe", "These 2 Marijuana Stocks Plunged Last Week: Should You Be Buying?", "Why Is Endo (ENDP) Down 4.7% Since the Last Earnings Report?", "Company News for June 12, 2017", "7 Healthcare Stocks to Buy Now", "Noteworthy ETF Outflows: XPH, AKRX, ENDP, PRGO", "Should Investors Steer Clear of Opioid Drug Stocks?", "3 Biotech Stocks That Could Become M&A Targets", "Is Endo International (ENDP) a Great Stock for Value Investors?", "Like Snap Inc. (SNAP) Stock? Buy This Instead.", "Endo Asked to Withdraw Pain Drug-Opana ER by FDA, Stock Down", "Pre-Market Most Active for Jun 9, 2017 : SMFG, P, BABA, CAA, RDS/B, NVDA, LYG, ERIC, ENDP, LXRX, XIV, MLCO", "Is Cannabis The Solution to America's Terrifying Opioid Crisis?", "Is the FDA a Big Risk to This Company's Marijuana Plans?", "Mid-Day Market Update: Dow Surges 100 Points; Endo International Shares Plummet", "Intellipharmaceutics Announces Launch of Generic Seroquel XR", "Why Endo International plc Rose 12.9% in May", "Implied PPH Analyst Target Price: $64", "BioDelivery (BDSI) Q1 Earnings Beat Estimates, Stock Gains", "US Futures Cautiously Higher After Theresa May's Conservative Party Loses Outright Majority in UK Election", "Mid-Afternoon Market Update: NASDAQ Down 2.5%; DuPont Fabros Shares Spike Higher", "Why Endo's Bad News Sent Collegium Pharmaceutical Shares Soaring 10%", "Here's Why Endo International plc Stock Surged Today", "Intellipharmaceutics Announces Launch of Generic Seroquel XR", "Commit To Buy Endo International At $7.50, Earn 18% Using Options", "What's in Store for BioDelivery (BDSI) this Earnings Season?", "4 Drug Stocks Poised to Beat this Earnings Season", "Francis Chou Buys Endo International PLC, Teva Pharmaceutical Industries, Valeant ...", "Generic Drugmakers Tumble as Perrigo Discloses DoJ Search", "Is Endo (ENDP) Poised for a Beat This Earnings Season?", "Noteworthy Wednesday Option Activity: SHLD, ENDP, FOXA", "Weitz Value Fund Comments on Endo International", "IntelliPharmaCeutics (IPCI) Q1 Loss Narrower Than Expected", "Are Options Traders Betting on a Big Move in Endo International (ENDP) Stock?", "Endo (ENDP) Reports Preliminary Results for First Quarter", "BioMarin (BMRN) Posts Earnings in Q1, Sales Top, Stock Up", "Generic Drugmakers Tumble as Perrigo Discloses DoJ Search", "Is Endo (ENDP) Poised for a Beat This Earnings Season?", "Noteworthy Wednesday Option Activity: SHLD, ENDP, FOXA", "Weitz Value Fund Comments on Endo International", "IntelliPharmaCeutics (IPCI) Q1 Loss Narrower Than Expected", "Are Options Traders Betting on a Big Move in Endo International (ENDP) Stock?", "Endo (ENDP) Reports Preliminary Results for First Quarter", "BioMarin (BMRN) Posts Earnings in Q1, Sales Top, Stock Up", "SPDR S&P Pharmaceuticals ETF Experiences Big Outflow", "Implied IYH Analyst Target Price: $171", "Why Is Endo (ENDP) Down 10.6% Since the Last Earnings Report?", "VIVUS to Regain Commercial Rights for Stendra from Sanofi", "Valeant Pharmaceuticals Intl Inc (VRX) Stock May Be Healthy for Long-Term Investors", "Will Endo's Troubles Continue to Dent Performance in 2017?", "Monday Sector Laggards: Materials, Healthcare", "BioDelivery (BDSI) Q4 Loss Wider Than Expected; Sales Meet", "Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Expanded", "Endo's (ENDP) Opana ER's Risk Benefit Evaluated by FDA", "Pre-Market Most Active for Feb 28, 2017 : VIAV, TGT, VRX, CNHI, SBY, O, BAC, ENDP, FTR, TVIX, LIFE, CEMP", "Endo (ENDP) Q4 Earnings & Revenues Beat Estimates", "Earnings Reaction History: Endo International plc, 40.0% Follow-Through Indicator, 10.6% Sensitive", "After Hours Most Active for Feb 28, 2017 : PBI, CBOE, GE, ENDP, CLNS, XRX, FTR, CONE, F, BAC, INTC, QCOM", "Start the Week with the Best Earnings Charts", "3 Stocks to Watch on Wednesday: Endo International Plc (ENDP), Etsy Inc (ETSY) and Palo Alto Networks Inc (PANW)", "Trinet Group Larger Than S&P 500 Component Endo International", "Thursday's ETF with Unusual Volume: PPH", "Endo (ENDP) to Post Q4 Earnings: Will the Stock Disappoint?", "Wednesday's ETF with Unusual Volume: PPH", "Wednesday Sector Leaders: Healthcare, Technology & Communications", "Tuesday Sector Leaders: Healthcare, Financial", "Endo's (ENDP) Ephedrine Sulfate Injection Gets FDA Approval", "Implied Volatility Surging for Endo International (ENDP) Stock Options", "Endo (ENDP) Restructures its Branded Pharmaceutical Unit", "New Strong Sell Stocks for January 27th", "Is BioMarin (BMRN) Well Poised for Growth in 2017?", "Weitz Funds Comments on Endo International", "Endo (ENDP) Settles Disputes with Federal Trade Commission", "The 10 Worst Stocks During the Obama Administration", "The Worst Performing Stock of 2016", "Endo (ENDP) Restructures Branded Pharmaceutical Unit (revised)", "Wednesday Sector Laggards: Drugs, Biotechnology Stocks", "S&P 500 Movers: WMB, ILMN", "Noteworthy ETF Inflows: RSP, ENDP, MYL, MDLZ", "The 10 Worst Stocks in the S&P 500 in 2016", "S&P 500 Movers: REGN, AMGN", "Implied Volatility Surging for Endo International (ENDP) Stock Options", "Endo International (ENDP): Can the Stock Rebound in 2017?", "Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again", "Wednesday Sector Laggards: Drugs, Biotechnology Stocks", "S&P 500 Movers: WMB, ILMN", "Why Iconix Brand Group, American Midstream Partners, and Endo International Jumped Today", "20 States Sue Teva, Mylan & Other Drug Companies for Price Fixing", "After Hours Most Active for Dec 16, 2016 : FTR, WFT, ETE, BX, EPD, CPN, OPK, FCX, CSCO, ENDP, HBAN, INTC", "Friday Sector Leaders: Utilities, Healthcare", "Generic Stocks Feel Pricing Heat, 1st Charges Filed in DoJ Antitrust Probe", "Depomed Inc (DEPO) Stock Soars on Takeover Talk", "3 Beaten-Up Cheap Stocks: Are They Bargains?", "Endo (ENDP) Inks Deal to Return Belbuca Rights to BioDelivery", "Mylan (MYL) Stock Falls on Restructuring Plans, Layoffs", "Wednesday Sector Laggards: Healthcare, Energy", "Here's Why Teva Pharmaceutical's (TEVA) Stock Is Down Today", "BioDelivery Sciences: Can Bunvail and Belbuca's Sales Improve?", "3 Stocks That Have Been Cut in Half in the Last 12 Months", "Health Care Sector Update for 12/14/2016: LCI,ENDP,MYL,VCEL,TROV", "S&P 500 Movers: ENDP, AAP", "S&P 500 Movers: KORS, NVDA", "BioDelivery (BDSI) Reports Wider-than-Expected Loss in Q3", "S&P 500 Movers: CNC, ENDP", "Commit To Buy Endo International At $10, Earn 14% Using Options", "S&P 500 Movers: CVS, PCLN", "Endo (ENDP) Q3 Earnings & Revenues Beat; View Intact", "Endo Reports Positive Cellulite Treatment Data on Xiaflex", "Endo (ENDP) Beats Earnings & Revenue Estimates in Q3", "Earnings Reaction History: Endo International plc, 33.3% Follow-Through Indicator, 10.4% Sensitive", "Pre-Market Earnings Report for November 8, 2016 : CVS, JCI, DHI, AER, FANG, VRX, WLK, GLPI, CNK, OA, MOMO, ENDP", "Endo (ENDP) Q3 Earnings: Will the Stock Pull a Surprise?", "DOJ Probe Whacks 19.5% Off Endo International Stock", "Oversold Conditions For Endo International (ENDP)", "Add Up The Pieces: SCIU Could Be Worth $28", "Pre-Market Most Active for Nov 8, 2016 : MT, VRX, CVS, HTZ, STO, BUD, XIV, DEPO, MOMO, TVIX, ENDP, WBA", "Endo (ENDP) Beats Earnings & Revenue Estimates in Q3", "Thursday Sector Laggards: Healthcare, Technology & Communications", "VIVUS Licenses Stendra Rights to Metuchen Pharmaceuticals", "Endo International Reports Positive Phase II Data on Xiaflex", "Better Buy: Valeant Pharmaceuticals International, Inc. vs. Endo International plc", "Notable Thursday Option Activity: MHK, ENDP, LGF", "After Hours Most Active for Oct 12, 2016 : MCHI, NVDA, ARE^D, BAC, AEG, SCTY, GE, PAA, C, SEDG, ENDP, QVCA", "Endo Appoints New CEO, Keeps Q3 & '16 View, Stock Jumps", "S&P 500 Movers: MNK, RIG", "Monday's ETF Movers: OIH, XPH", "S&P 500 Movers: CRM, ENDP", "3 Stocks to Watch on Friday: Alphabet Inc (GOOGL), Glu Mobile, Inc. (GLUU) and Endo International plc \u2013 Ordinary Shares (ENDP)", "Why Twitter, Endo International, and Hyster-Yale Materials Handling Jumped Today", "Endo Internat Soars on New CEO Announcement", "Thursday Sector Laggards: Healthcare, Financial", "Friday's ETF Movers: XPH, GDXJ", "Why Endo International plc Stock Gained 19.2% in August", "Mylan's EpiPen Misclassified, Rebates Underpaid; Stock Down", "S&P 500 Movers: AVGO, VRSN", "S&P 500 Movers: HOG, KLAC", "Stock Market News for August 26, 2016", "Forget Mylan, Buy These 3 Drug Stocks Instead", "Why Endo International plc Jumped Higher Today", "S&P 500 Movers: INTU, MNK", "Endo (ENDP) Withdraws Label Expansion Filing for Opana ER", "Why AngloGold Ashanti, Mid-America Apartment Communities, and Endo International Slumped Today", "Why Salesforce.com, Inc. (CRM), Endo International plc \u2013 Ordinary Shares (ENDP) and Mid-America Apartment Communities Inc (MAA) Are 3 of Today\u2019s Worst Stocks", "Healthcare Growth Stocks in the S&P 500: Part 2", "Pre-Market Most Active for Aug 12, 2016 : SGI, JCP, BABA, NVDA, CXRX, MT, FCX, TLK, ENDP, NVO, XIV, QQQ", "Why Nordstrom, Inc. (JWN), J C Penney Company Inc (JCP) and Endo International plc (ENDP) Are 3 of Today\u2019s Best Stocks", "Stock Market News for August 25, 2016", "7 Intriguing Healthcare Growth Stocks In The S&P 500: Part 2", "Commit To Purchase Endo International At $10, Earn 8.5% Using Options", "Stock Market News for August 10, 2016", "Not Too Late to Board the Endo (ENDP) Train", "S&P 500 Movers: GPS, ENDP", "Endo (ENDP) Tops Q2 Earnings Estimates, Keeps 2016 View", "Pre-Market Most Active for Aug 9, 2016 : MWW, VRX, NVO, CHL, AZN, HIIQ, SM, ARRY, YHOO, ENDP, AAPL, XIV", "BioDelivery (BDSI) Q2 Loss Meets Estimates, Revenues Up", "7 Intriguing Healthcare Growth Stocks In The S&P 500: Part 2", "Commit To Purchase Endo International At $10, Earn 8.5% Using Options", "Stock Market News for August 10, 2016", "Not Too Late to Board the Endo (ENDP) Train", "Why Endo International plc's Shares Made a U-Turn Today", "Earnings Reaction History: Endo International plc, 33.3% Follow-Through Indicator, 11.0% Sensitive", "After-Hours Earnings Report for August 8, 2016 : DVA, BAP, FNV, MCHP, IFF, CSC, OPK, EGN, NWSA, NUAN, ENDP, SINA", "Why Chemours Co (CC), Endo International plc (ENDP) and Valeant Pharmaceuticals Intl Inc (VRX) Are 3 of Today\u2019s Best Stocks", "BioDelivery (BDSI) Q2 Earnings: Will the Stock Disappoint?", "Will Endo (ENDP) Surprise This Earnings Season Again?", "3 Cheap Healthcare Stocks You Can Buy Right Now", "Weitz Funds Comments on Endo International", "S&P 500 Movers: HAS, COH", "After Hours Most Active for Jul 15, 2016 : ENDP, MCHP, CBG, PTEN, QQQ, MS, CONN, PWR, EJ, IXUS, BLL, MPC", "Nasdaq 100 Movers: JD, ENDP", "5 Drug Stocks Reporting Q2 Earnings on Aug 8: AGN & More", "BioDelivery (BDSI) Q2 Earnings: Will the Stock Disappoint?", "Nasdaq 100 Movers: MU, ENDP", "S&P 500 Movers: MU, NFLX", "A Simple Biotech Story That Reveals Huge Potential Of This Cheap Stock", "Nasdaq 100 Movers: TSCO, NTES", "Endo's Stock Gains on Vasostrict's New Patent Approval", "S&P 500 Movers: HST, ENDP", "S&P 500 Movers: SWN, STX", "Why Southwestern Energy, Endo International, and LendingClub Jumped Today", "Why Endo International plc Patented a Higher Stock Price", "Health Care Sector Update for 06/28/2016: ENDP,XNCR,NVS,RGLS", "S&P 500 Movers: BWA, MU", "Nasdaq 100 Movers: ENDP, JD", "Endo's (ENDP) Pain Drug Opana ER to Face FDA Panel in Fall", "Nasdaq 100 Movers: ENDP, STX", "Nasdaq 100 Movers: JD, ENDP", "S&P 500 Movers: SYF, ENDP", "S&P 500 Movers: URBN, HRB", "Nasdaq 100 Movers: ENDP, WBA", "Nasdaq 100 Movers: BBBY, AAL", "Biggest Stock Losers of 2016", "The Illusion of Falling Official 'Unemployment' Fades", "3 Beaten-Up Healthcare Stocks: Are They Bargains?", "Nasdaq 100 Movers: JD, ENDP", "Nasdaq 100 Movers: COST, ENDP", "S&P 500 Movers: SIG, LB", "Wednesday's ETF Movers: XPH, GDXJ", "Wally Weitz Drops Falling Drug Stock Endo but Sees 'Upside Potential'", "Nasdaq 100 Movers: ENDP, WDC", "Valeant Pharmaceuticals Intl Inc: This Trade Could DOUBLE Your Money (VRX)", "George Soros Sells Dow Chemical, Delta Air Lines", "BioDelivery (BDSI) Posts In-Line Loss in Q1, Revenues Miss", "Friday's ETF Movers: GDXJ, IHE", "Friday Sector Laggards: Drugs, Music & Electronics Stores", "Mid-Day Market Update: Yelp Surges On Upbeat Results; Square Shares Decline", "Endo International is Now Oversold (ENDP)", "Endo (ENDP) Lags Q1 Earnings Estimates, Cuts 2016 Outlook", "Is This the End(o) of the Carnage in Endo International Plc (ENDP)?", "S&P 500 Movers: ENDP, TDC", "Mid-Morning Market Update: Markets Edge Lower; Cognizant Issues Weak Q2 Outlook", "Pre-Market Most Active for May 6, 2016 : SO, ENDP, BAC, SNE, QQQ, TVIX, JCP, SQ, GPRO, MT, XIV, SYNC", "Why is Endo International (ENDP) Stock Plunging Today?", "Health Care Sector Update for 05/06/2016: KMPH,CRME,AGN,ENDP", "Friday Sector Laggards: Healthcare, Utilities", "Mid-Afternoon Market Update: U.S. Stocks Turn Higher; Endo International Shares Plunge", "Nasdaq 100 Movers: ENDP, ATVI", "Will BioDelivery (BDSI) Disappoint Estimates in Q1 Earnings?", "After Hours Most Active for May 5, 2016 : INTC, QCOM, CSCO, ENDP, GE, GPRO, DAL, MSFT, BXLT, YELP, SQ, XRX", "The Zacks Analyst Blog Highlights: Zoetis, McKesson, Merck, Endo International and AmerisourceBergen", "3 Dirt-Cheap Biotech Stocks To Buy", "Drug Stocks Reporting Mid-Week: MRK, ABC, ENDP & More", "Endo (ENDP) Q1 Earnings: What's in Store for the Stock?", "Monday's ETF Movers: RWX, XPH", "Health Care Sector Update for 05/06/2016: SYN,CRME,AGN,ENDP", "Why Endo Int'l Shares Shot 12% Higher", "Noteworthy Thursday Option Activity: ENDP, SHW, ASGN", "Thursday Sector Leaders: Healthcare, Services", "Nasdaq 100 Movers: ILMN, ENDP", "Stock Market News for April 12, 2016", "VIVUS (VVUS) Upgraded to Hold on Strong Fundamentals", "Nasdaq 100 Movers: ENDP, STX", "Nasdaq 100 Movers: MSFT, ENDP", "Why Avis Budget Group, Endo International, and PHH Corp. Slumped Today", "Nasdaq 100 Movers: EBAY, BBBY", "How The Pieces Add Up: SPXE Targets $47", "Thursday's ETF with Unusual Volume: IHE", "Nasdaq 100 Movers: ENDP, EBAY", "Nasdaq 100 Movers: ENDP, INCY", "S&P 500 Movers: ENDP, SWN", "S&P 500 Movers: NOV, CHK", "S&P 500 Movers: SHW, MNK", "Nasdaq 100 Movers: BMRN, ENDP", "What is Driving Shares of Endo (ENDP) Sharply Lower?", "Nasdaq 100 Movers: ENDP, VIAB", "S&P 500 Movers: ENDP, FDX", "Close Update: Stocks End Stronger, With Dow Positive for 2016", "Thursday Sector Laggards: Healthcare, Technology & Communications", "Interesting ENDP Put And Call Options For May 20th", "S&P 500 Movers: MNK, ENDP", "Nasdaq 100 Movers: ENDP, AAPL", "Tuesday Sector Laggards: Healthcare, Materials", "BioDelivery (BDSI) Misses on Earnings and Revenue in Q4", "Will BioDelivery (BDSI) Surprise Estimates in Q4 Earnings?", "Nasdaq 100 Movers: FAST, AVGO", "Stock Market News for March 01, 2016", "Nasdaq 100 Movers: EXPE, ENDP", "Are Recession Worries Here to Stay?", "Why Valeant Pharmaceuticals Intl Inc (VRX), Endo International plc (ENDP) and Southwestern Energy Company (SWN) Are 3 of Today\u2019s Worst Stocks", "Nasdaq 100 Movers: ENDP, BMRN", "S&P 500 Movers: ENDP, SIG", "Endo's (ENDP) Q4 Earnings Beat Estimates, Revenues in Line", "Earnings Reaction History: Endo International plc, 25.0% Follow-Through Indicator, 5.7% Sensitive", "QLT (QLTI) Reports Narrower-than-Expected Loss in Q4", "Steve Mandel Sells Allergan, DaVita During 4th Quarter", "Monday's ETF Movers: ILF, XPH", "Monday Sector Laggards: Drugs, Trucking Stocks", "'Outsmarting the Crowd': A Book for Beginning Investors", "Why Earnings Season Could Be Great for Endo International (ENDP)", "Pre-Market Earnings Report for February 29, 2016 : VRX, ENDP, IEP, NRG, HZNP, TRCO, VGR, ACAD, GRFS, BCPC, FI, SJI", "Can Endo (ENDP) Keep the Earnings Streak Alive in Q4?", "Endo (ENDP) Tops Q4 Earnings Estimates, Gives 2016 Outlook", "Why Endo International plc Earned a Lower Price Today", "Monday's ETF Movers: ILF, XPH", "What's in Store for Exelixis (EXEL) this Earnings Season?", "Will Atmel's (ATML) Q4 Earnings Disappoint Investors?", "What's in Store for Agenus (AGEN) This Earnings Season?", "Will Radius Health (RDUS) Disappoint Earnings Estimates in Q4?", "BioMarin (BMRN) to Report Q4 Earnings: What's in Store?", "Juno (JUNO) to Report 4Q Earnings: What's in Store?", "Kite (KITE) to Report 4Q Earnings: What's in Store?", "Will Arena (ARNA) Post a Narrower-than-Expected 4Q Loss?", "What's in Store for Exelixis (EXEL) this Earnings Season?", "Can ARIAD (ARIA) Surprise Estimates This Earnings Season?", "Endo (ENDP) Initiates Phase IIb Study on Xiaflex for Cellulite", "The Zacks Analyst Blog Highlights: Prospect Capital, Xerox, Endo International, Boardwalk Pipeline Partners LP and Time Warner", "5 Momentum Stocks to Buy Right Now", "What's in Store for Celldex (CLDX) This Earnings Season?", "What's in Store for Merrimack (MACK) this Earnings Season?", "What's in Store for Aegerion (AEGR) this Earnings Season?", "Can Keryx (KERX) Surprise Investors this Earnings Season?", "The Zacks Analyst Blog Highlights: Harman International Industries, QUALCOMM, United Continental Holdings, Endo International and Discover Financial Services", "5 S&P 500 Stocks Likely to Turn Around in 2016", "KemPharm Expands Pipeline to Include Pain Candidate KP746", "VIVUS to Regain U.S. and Canada Stendra Rights from Endo", "Endo International Enters Oversold Territory (ENDP)", "Nasdaq 100 Movers: CTRP, GOOGL", "Market Close Report: NASDAQ Composite Index closes above 5000; up 32.19 points at 5,001.11", "Wally Weitz Gives Rare Early Look at 4th Quarter Portfolio", "S&P 500 Analyst Moves: ENDP", "Zogenix Zoomed Higher in November -- Here's Why", "Interesting ENDP Put And Call Options For July 2016", "Health Care Investor Larry Robbins Sells Drug Manufacturers, Buys Providers", "Health Care Sector Update for 12/31/2015: VVUS,ENDP,TLOG,GBSN", "BioDelivery (BDSI) Down on Wider-than-Expected Q3 Loss", "Endo (ENDP) Beats on Q3 Earnings, Retains 2015 Guidance", "Endo Beats on Q3 Earnings and Revenues, Reiterates View", "Will BioDelivery (BDSI) Disappoint Estimates in Q3 Earnings?", "Thursday Sector Laggards: Utilities, Healthcare", "Why Endo International plc Shares Are Crashing Today", "Pre-Market Earnings Report for November 5, 2015 : CELG, DUK, ENB, CNQ, MGA, APA, TAP, SYMC, AGU, ENDP, MPEL, IEP", "S&P 500 Movers: FOSL, MYL", "Repros Hits 52-Week Low, FDA Delays Enclomiphene Meeting", "BioDelivery Sciences (BDSI) in Focus: Stock Moves Up 8.3%", "BioDelivery/Endo Up on FDA Approval of Pain Drug Belbuca", "BioDelivery Sciences International's Stock Jumps on FDA Approval", "Health Care Sector Update for 10/26/2015: SKBI,BSDI,ENDP,ATHN", "Health Care Sector Update for 10/26/2015: MMSI,BSDI,ENDP,ATHN", "First Week of December 18th Options Trading For Endo International (ENDP)", "Can Endo International's (ENDP) Q3 Earnings Surprise?", "Supernus Inks Trokendi XR Settlement Agreement with Endo", "Radius Health (RDUS) Looks Good: Stock Rises 8.7%", "Dipexium Pharmaceuticals (DPRX) Jumps: Stock Up 11.3%", "How Valeant is changing the Pharmaceutical Industry?", "BioDelivery's Bunavail Supply Hit by Specification Issues", "Portola's Betrixaban Gets Fast Track Designation in the U.S.", "Alnylam Offers Data on ALN-TTRsc02 & Platform Technology", "Wednesday's ETF Movers: XLI, XPH", "Ironwood/Allergan to File for Lower Dose of Linzess in 1H16", "BioMarin Presents Data on Vosoritide at Medical Meeting", "Collegium's (COLL) Xtampza Review Date Postponed by FDA", "AcelRx Updates on Zalviso for Pain Management Treatment", "Vertex's Kalydeco Gets Priority Review for Expanded Use", "The Medicines Co. Ties Up with SymBio for Ionsys in Japan", "Osiris (OSIR) Begins Chronic Diabetic Foot Ulcer Study", "Sarepta Down, Eteplirsen Likely to Face FDA Panel in Jan", "Merck KGaA's Pipeline on Track, Updates Key R&D Projects", "Sarepta Unveils New Phase IIb Eteplirsen Data, Shares Soar", "Jazz's Defibrotide under FDA Priority Review, Shares Up", "Endo International Slumps: ENDP Tanks 10.2% in Session", "Endo Completes $8.05B Par Pharma Acquisition, Updates View", "Par Pharmaceuticals officially withdraws IPO after $8 billion acquisition by Endo", "Interesting ENDP Put And Call Options For November 20th", "Pharma Deals in Latin America Continue, Teva to Buy Rimsa", "S&P 500 Movers: WRK, TAP", "BioDelivery Up on Striking Deal with TennCare for Bunavail", "RSI Alert: Endo International (ENDP) Now Oversold", "Endo Gets Favorable Ruling Related to Opana ER in U.S.", "BioDelivery's New Onsolis Formulation Gains FDA Approval", "Company News for August 11, 2015 - Corporate Summary", "BioDelivery Incurs Wider Loss in Q2, Revenues Fall Y/Y - Analyst Blog", "Funds Added To Endo International Positions", "S&P 500 Movers: WRK, TAP", "BioDelivery Up on Striking Deal with TennCare for Bunavail", "RSI Alert: Endo International (ENDP) Now Oversold", "Endo Gets Favorable Ruling Related to Opana ER in U.S.", "BioDelivery's New Onsolis Formulation Gains FDA Approval", "Company News for August 11, 2015 - Corporate Summary", "BioDelivery Incurs Wider Loss in Q2, Revenues Fall Y/Y - Analyst Blog", "Funds Added To Endo International Positions", "Endo (ENDP) Beats on Q2 Earnings, Guidance Reiterated - Tale of the Tape", "Health Care Sector Update for 08/10/2015: PMC, MYL, ESPR", "Notable Two Hundred Day Moving Average Cross - ENDP", "Repros' Enclomiphene to Face FDA Advisory Panel in November - Analyst Blog", "Pre-Market Most Active for Jun 5, 2015 : FTR, ABB, BAC, SAN, GSK, NOK, QQQ, ENDP, FCAU, JASO, AAPL, MRKT", "After Hours Most Active for Jun 5, 2015 : FTR, SUNE, BABA, BAC, MDT, T, BBD, ERIC, ENDP, ROSE, SIRI, QUNR", "First Week of September 18th Options Trading For Endo International (ENDP)", "Egalet Reports Encouraging Results on Pain Drug Egalet-002 - Analyst Blog", "John Griffin Takes Stake in Trendy Fitbit Inc.", "Endo International Breaks Below 200-Day Moving Average - Notable for ENDP", "Dodge & Cox Buys 2 New Stocks", "Repros' Enclomiphene to Face FDA Advisory Panel in November - Analyst Blog", "Pre-Market Most Active for Jun 5, 2015 : FTR, ABB, BAC, SAN, GSK, NOK, QQQ, ENDP, FCAU, JASO, AAPL, MRKT", "BioDelivery (BDSI) Q1 Loss Narrower-Than-Expected - Analyst Blog", "Billionaire-Tracking ETF Just Bulked Up On Health Care", "Company News for May 19, 2015 - Corporate Summary", "Endo to Acquire Par Pharma for $8.05B, Shares Down - Analyst Blog", "Stock Futures Retreat Off Record Levels, Cautious Before Housing Data", "Endo International (ENDP) Expands Generics with $8 Billion Par Pharma Buy - Stocks in the News", "Endo/BioDelivery Reveal Encouraging Data on Pain Drug - Analyst Blog", "Company News for May 12, 2015 - Corporate Summary", "BioDelivery (BDSI) Q1 Loss Narrower-Than-Expected - Analyst Blog", "Billionaire-Tracking ETF Just Bulked Up On Health Care", "Endo (ENDP) Beats on Q1 Earnings, 2015 Guidance Upped - Analyst Blog", "Will Endo International's (ENDP) Q1 Earnings Disappoint? - Analyst Blog", "Pre-Market Earnings Report for May 11, 2015 : ACT, ENDP, AER, AES, CNP, ICPT, RBC, BID, GWPH, SSYS, LGND, OCIP", "S&P 500 Analyst Moves: ENDP", "First Week of ENDP June 19th Options Trading", "BioDelivery Slumps, Diabetic Pain Gel Fails Phase III Study - Analyst Blog", "The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Salix Pharmaceuticals, Endo International and Allergan - Press Releases", "Endo (ENDP) Beats on Q1 Earnings, 2015 Guidance Updated - Tale of the Tape", "Valeant (VRX) Raises Salix Offer, Endo Withdraws Proposal - Analyst Blog", "Valeant Pharma (VRX) Increases Bid for Salix (SLXP) to $173/share - Stocks in the News", "Will BioDelivery Sciences (BDSI) Impress this Earnings? - Analyst Blog", "Salix Up on Endo Proposal Outstripping Valeant Offer - Analyst Blog", "Company News for March 03, 2015 - Corporate Summary", "Boston Scientific to Buy Endo International's Urology Business - Analyst Blog", "Endo (ENDP) Beats on both Q4 Earnings and Revenues - Tale of the Tape", "Intercept Pharmaceuticals (ICPT): Will It Miss Q4 Earnings? - Analyst Blog", "Will Stratasys (SSYS) Disappoint this Earnings Season? - Analyst Blog", "Veeva (VEEV): Will it Beat Earnings Estimates This Season? - Analyst Blog", "Should You Buy Endo International (ENDP) Ahead of Earnings? - Tale of the Tape", "Will Endo Internationa's (ENDP) Beat on Earnings in Q4? - Analyst Blog", "Pre-Market Earnings Report for March 2, 2015 : ENDP, ICPT, SSYS, BID, PEGI, PTLA, STNG, CORE, VNR, XLRN, EMES, FSS", "What Awaits Keryx Biopharmaceuticals (KERX) this Earnings? - Analyst Blog", "Endo (ENDP) Beats on both Q4 Earnings and Revenues - Tale of the Tape", "Health Care Sector Update for 02/03/2015: ISIS, BCLI, ENDP", "NPS Pharmaceuticals' Natpara Approved with Boxed Warning - Analyst Blog", "After Hours Most Active for Jan 26, 2015 : HCA, BAC, ENDP, SWY, FDO, MDT, COV, AAPL, MSFT, SBSI, DLTR, QQQ", "Endo Prices $1.2B Senior Notes Offering for Auxilium Deal - Analyst Blog", "ARIAD's Iclusig Endorsed by EC for All Approved Indications - Analyst Blog", "Evotec Signs New Deal for Addictive Disorder Therapies - Analyst Blog", "Novo Nordisk's Xultophy to Launch First in Switzerland - Analyst Blog", "BioSpecifics Announces Label Expansion for Xiaflex in EU - Analyst Blog", "Health Care Sector Update for 02/03/2015: ISIS, BCLI, ENDP", "NPS Pharmaceuticals' Natpara Approved with Boxed Warning - Analyst Blog", "After Hours Most Active for Jan 26, 2015 : HCA, BAC, ENDP, SWY, FDO, MDT, COV, AAPL, MSFT, SBSI, DLTR, QQQ", "Endo Prices $1.2B Senior Notes Offering for Auxilium Deal - Analyst Blog", "ARIAD's Iclusig Endorsed by EC for All Approved Indications - Analyst Blog", "Evotec Signs New Deal for Addictive Disorder Therapies - Analyst Blog", "Novo Nordisk's Xultophy to Launch First in Switzerland - Analyst Blog", "BioSpecifics Announces Label Expansion for Xiaflex in EU - Analyst Blog", "OncoGenex's AFFINITY on Track, Passes Futility Analysis - Analyst Blog", "UCB-Neuropore Collaborate for Parkinson's Disease Therapy - Analyst Blog", "BioCryst's BCX4161 Recommended for Orphan Drug in EU - Analyst Blog", "ARIAD Reveals 2015 Strategic Objectives, Updates on Pipeline - Analyst Blog", "IJH, SLG, HSIC, ENDP: Large Outflows Detected at ETF", "Hospira's Dyloject Cleared in the U.S. for Pain Management - Analyst Blog", "4 Biotech Stocks that Doubled in 2014 - Analyst Blog", "Get Ready To Be Surprised This Earnings Season - Screen of the Week", "Endo/BioDelivery File Regulatory Application for Pain Drug - Analyst Blog", "Auxilium's Xiapex Gets CHMP Nod for Peyronie's Disease - Analyst Blog", "CR Bard (BCR) Faces Series of Lawuits - Analyst Blog", "Endo to Acquire Rights to Testosterone Nasal Gel Natesto - Analyst Blog", "Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook", "Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews", "The 3 Best ETFs for Mid-Cap Growth", "Health Care Sector Update for 12/24/2014: HALO, BDSI, ENDP", "Sector Update: Health Stocks Generally Higher Pre-Bell", "Sector Update: Health Care", "Endo International Beats on Q3 Earnings & Sales, View Up - Analyst Blog", "Zoetis Q3 Earnings Beat Driven by Higher Livestock Sales - Analyst Blog", "ENDP Crosses Above Key Moving Average Level", "3 Health Care Picks To Beat Earnings - Earnings ESP", "Noteworthy ETF Outflows: IJH, SWKS, ENDP, HSIC", "La Jolla Pharmaceutical (LJPC) in Focus: Stock Surges 10.2% - Tale of the Tape", "Endocyte's TARGET Interim Data Positive for Lung Cancer - Analyst Blog", "Gilead's HCV Combo Drug Harvoni Secures CHMP Backing - Analyst Blog", "Pacira Down on Receipt of FDA Warning Letter for Exparel - Analyst Blog", "IGI, Laboratories (IG) Jumps: Stock Up 18.1% in Session - Tale of the Tape", "Alnylam Starts New Study on Cardiac Amyloidosis Patients - Analyst Blog", "Esperion Therapeutics (ESPR) in Focus: Stock Up 13.4% - Tale of the Tape", "Valeant Pharmaceuticals (VRX) in Focus: Stock Adds 6.9% - Tale of the Tape", "Cempra (CEMP) Jumps: Stock Up 8.9% in Session - Tale of the Tape", "Endocyte's TARGET Interim Data Positive for Lung Cancer - Analyst Blog", "Gilead's HCV Combo Drug Harvoni Secures CHMP Backing - Analyst Blog", "ZS Pharma (ZSPH) in Focus: Stock Moves 10.7% Higher - Tale of the Tape", "Radius Health (RDUS) in Focus: Stock Surges 17.3% - Tale of the Tape", "Galmed's Aramchol Gets Fast-Track Designation in the U.S. - Analyst Blog", "Emergent BioSolutions Initiates Pivotal Study on BioThrax - Analyst Blog", "ZS Pharma Gains on Positive Phase III Hyperkalemia Results - Analyst Blog", "BioMarin (BMRN) Faces Threat of Genericization for Kuvan - Analyst Blog", "Auxilium Pharmaceuticals Favors QLT Deal Over Endo Bid - Analyst Blog", "Zacks Rank #1 Additions for Friday - Tale of the Tape", "Weakness Seen in Avanir Pharmaceuticals (AVNR): Stock Falls 6.5% - Tale of the Tape", "Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog", "Spectrum Pharmaceuticals Out-Licenses Products in China - Analyst Blog", "Bayer to Shed MaterialScience Business, Shares Rise - Analyst Blog", "Alcobra (ADHD) Worth Watching: Stock Moves 5.1% Higher - Tale of the Tape", "Supernus Confirms 2014 Outlook, Epilepsy Products in Focus - Analyst Blog", "Auxilium Pharmaceuticals Favors QLT Deal Over Endo Bid - Analyst Blog", "Zacks Rank #1 Additions for Friday - Tale of the Tape", "Weakness Seen in Avanir Pharmaceuticals (AVNR): Stock Falls 6.5% - Tale of the Tape", "Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog", "Spectrum Pharmaceuticals Out-Licenses Products in China - Analyst Blog", "Bayer to Shed MaterialScience Business, Shares Rise - Analyst Blog", "Alcobra (ADHD) Worth Watching: Stock Moves 5.1% Higher - Tale of the Tape", "Supernus Confirms 2014 Outlook, Epilepsy Products in Focus - Analyst Blog", "Auxilium Pharmaceuticals Favors QLT Deal Over Endo Bid - Analyst Blog", "Zacks Rank #1 Additions for Friday - Tale of the Tape", "Weakness Seen in Avanir Pharmaceuticals (AVNR): Stock Falls 6.5% - Tale of the Tape", "Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog", "Spectrum Pharmaceuticals Out-Licenses Products in China - Analyst Blog", "Bayer to Shed MaterialScience Business, Shares Rise - Analyst Blog", "Alcobra (ADHD) Worth Watching: Stock Moves 5.1% Higher - Tale of the Tape", "Supernus Confirms 2014 Outlook, Epilepsy Products in Focus - Analyst Blog", "Midday Update: Stocks Mixed, Subdued by Upcoming FOMC Outcome", "Lennar Gains On Upbeat Earnings; Adobe Shares Slide", "Endo International (ENDP) Shares Cross Above 200 DMA", "Markets Gain; FedEx Profit Beats Street View", "Futures Move Sideways Ahead of Pivotal FOMC Outcome", "Endo Looking to Acquire Auxilium Pharmaceuticals for $2.2B - Analyst Blog", "Closing Update: Stocks Positive Though Gains Compromised as Fed Keeps Dovish Language But Formulates Exit Strategy", "OncoGenex's Phase III Prostate Cancer Study Fully Enrolled - Analyst Blog", "Catalyst Pharmaceutical (CPRX) Jumps: Stock Up 9% - Tale of the Tape", "Merck KGaA's Kuvan Effective in Under-4 Year Olds - Analyst Blog", "Tetraphase Pharmaceuticals (TTPH) in Focus: Stock Gains 14.8% - Tale of the Tape", "Teva Wins Patent Litigation vs. AstraZeneca in UK - Analyst Blog", "RXi Pharmaceuticals (RXII) Jumps: Stock Moves 11.4% Higher - Tale of the Tape", "Merck KGaA in Deal with S-TARget, Allergy Pipeline in Focus - Analyst Blog", "Novo Nordisk Drops Anti-Inflammatory R&D Activities - Analyst Blog", "Flexion Therapeutics (FLXN) Jumps: Stock Rises 9.4% - Tale of the Tape", "Novo Nordisk's Ryzodeg Now in Mexico for Type II Diabetes - Analyst Blog", "Glaxo Up on Accelerated Ebola Vaccine Development Process - Analyst Blog", "IGI, Laboratories, Inc. (IG) in Focus: Stock Rises 5.8% - Tale of the Tape", "Intellipharmaceutics' Oxycodone Program to Prevent Overdose - Analyst Blog", "Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog", "Flamel Technologies SA (FLML) in Focus: Stock Rises 8% - Tale of the Tape", "OncoGenex's Custirsen Passes First Interim Futility Analysis - Analyst Blog", "UCB's Epilepsy Drug Vimpat's Label Expanded in the U.S. - Analyst Blog", "AstraZeneca Updates on PLATO Study Investigation on Brilinta - Analyst Blog", "Supernus' Trokendi XR Faces Generic Threat from Actavis - Analyst Blog", "Lannett Updates on Digoxin Safety Issues, Expands Portfolio - Analyst Blog", "Gilead (GILD) Hits 52-Week High Thanks to Sovaldi - Analyst Blog", "Astellas-Basilea's Isavuconazole Accepted for EU Review - Analyst Blog", "Salix Pharmaceuticals (SLXP) Jumps: Stock Moves 15.5% Higher - Tale of the Tape", "Falling Earnings Estimates Signal Weakness Ahead for Egalet (EGLT) - Tale of the Tape", "Auxilium Pharmaceuticals Up on Mid-Stage Data on Xiaflex - Analyst Blog", "Salix Pharmaceuticals Jumps on Takeover Rumours by Allergan - Analyst Blog", "Apricus Biosciences' ED Treatment Vitaros Now in Germany - Analyst Blog", "AstraZeneca's Asthma Drug in Focus, Phase III Study Initiated - Analyst Blog", "Merck KGaA Q2 Earnings Slip Y/Y, 2014 Sales View Confirmed - Analyst Blog", "AstraZeneca's Gout Drug in Focus with Phase III Data Readout - Analyst Blog", "Biodel Q3 Loss Narrower than Expected, Gives Pipeline Update - Analyst Blog", "Jazz Pharmaceuticals (JAZZ) in Focus: Stock Surges 8.8% - Tale of the Tape", "Alcobra Starts Patient Enrollment for Mid-Stage Study on MDX - Analyst Blog", "Salix Pharmaceuticals Jumps on Takeover Rumours by Allergan - Analyst Blog", "Apricus Biosciences' ED Treatment Vitaros Now in Germany - Analyst Blog", "What Makes Durata Therapeutics (DRTX) a Strong Sell? - Tale of the Tape", "BioDelivery Sciences Q2 Loss Narrows, Up on Solid Revenues - Analyst Blog", "Spectrum Pharmaceuticals (SPPI) Posts Strong Earnings in Q2 - Analyst Blog", "Repros Therapeutics Q2 Loss a Penny Wider than Expected - Analyst Blog", "Anacor's Q2 Loss Narrower than Expected, Kerydin in Focus - Analyst Blog", "Rigel's R348 Fails in Phase II Study, Shares Down 13.6% - Analyst Blog", "Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance - Analyst Blog", "Tekmira Shares Continue to Rise in the Search for Ebola Cure - Analyst Blog", "ARIAD Falls on Wider-than-Expected Loss, Revenues Miss - Analyst Blog", "Osiris Falls despite Narrower Q2 Loss and Higher Revenues - Analyst Blog", "OncoGenex Pharmaceuticals (OGXI) Soars: Stock Up 8.2% - Tale of the Tape", "Jazz Pharmaceuticals (JAZZ) Jumps: Stock Moves 5.2% Higher - Tale of the Tape", "QLT Q2 Loss Widens, Focus on Impending Merger with Auxilium - Analyst Blog", "Cardiome Pharma Corp. (CRME) Jumps: Stock Rises 6.9% - Tale of the Tape", "Valeant Pharmaceuticals Slumps: VRX Falls 5.3% in Session - Tale of the Tape", "Avanir's Q3 Loss in Line, Revenues Up on High Nuedexta Demand - Analyst Blog", "Ironwood Pharmaceuticals Narrows Q2 Loss, Revenues Down - Analyst Blog", "Durata Therapeutics (DRTX) Worth Watching: Stock Gains 18.5% - Tale of the Tape", "BioCryst Pharmaceuticals (BCRX) Jumps: Stock Adds 5.4% in Session - Tale of the Tape", "Flamel Technologies SA (FLML) Soars: Stock Rises 10.9% - Tale of the Tape", "Vertex Pharmaceuticals' Kalydeco Label Expanded in EU - Analyst Blog", "Earnings Up at Jazz Pharmaceuticals, Revenue Guidance Raised - Analyst Blog", "Notable Two Hundred Day Moving Average Cross - ENDP", "AcelRx Pharmaceuticals (ACRX) Soars: Stock Adds 6.8% in Session - Tale of the Tape", "Endo International Beats on Q2 Earnings & Sales, Guidance Up - Analyst Blog", "Pharmacyclics (PCYC) Jumps: Stock Rises 15% - Tale of the Tape", "QLT Inc. (QLTI) Soars: Stock Adds 7.9% in Session - Tale of the Tape", "Why Neptune Technologies (NEPT) Could Be Positioned for a Slump - Tale of the Tape", "Zoetis Misses Marginally on Q2 Earnings, Up Y/Y, View Adjusted - Analyst Blog", "TESARO (TSRO) Slips on Wider-than-Expected Q2 Loss - Analyst Blog", "Will Merck & Co. (MRK) Surprise This Earnings Season? - Analyst Blog", "Is Pfizer Inc. (PFE) Poised to Beat Earnings Estimates? - Analyst Blog", "Will Amgen (AMGN) Disappoint This Earnings Season? - Analyst Blog", "Will Express Scripts Miss Earnings Estimates this Season? - Analyst Blog", "Will Vertex Pharmaceuticals (VRTX) Loss be Below Estimates? - Analyst Blog", "Can Hospira (HSP) Keep the Earnings Streak Alive? - Analyst Blog", "Will Teva Pharmaceutical (TEVA) Beat Q2 Earnings Estimates? - Analyst Blog", "Will AbbVie (ABBV) Surprise This Earnings Season? - Analyst Blog", "Will Alexion Pharmaceuticals (ALXN) Miss This Earnings Season? - Analyst Blog", "Will Generics Eat Into Eli Lilly's (LLY) Q2 Earnings? - Analyst Blog", "Will Bristol-Myers Squibb (BMY) Disappoint This Earnings Season? - Analyst Blog", "Celgene (CELG) Set to Beat Earnings Estimates on Strong Revs - Analyst Blog", "Will Biogen Idec Inc. (BIIB) Surprise this Earnings Season? - Analyst Blog", "AcelRx Pharmaceuticals (ACRX) Jumps: Stock Adds 11.7% in Session - Tale of the Tape", "Bayer/Amgen's Nexavar Does Not Show Resilience in Study - Analyst Blog", "Zafgen's Beloranib Gets Orphan Drug Status in the EU - Analyst Blog", "MediWound (MDWD) Falls: Stock Goes Down 6.1% - Tale of the Tape", "Astellas Seeks FDA Nod for Fungal Infection Treatment - Analyst Blog", "BioDelivery Jumps after Pain Drug Performs Well in Study - Analyst Blog", "U.S. Futures Follow European, Asian Markets Down From Record Highs Amid Lack of Catalysts", "US Futures Edge Down From Thursday's Record Highs", "Karyopharm Therapeutics (KPTI) in Focus: Stock Goes Down 5.2% - Tale of the Tape", "ImmunoGen (IMGN) Soars: Stock Up 8.8% - Tale of the Tape", "Endo International to Expand Generics Business with DAVA Buy - Analyst Blog", "Pipeline Update from BioDelivery Sciences - Analyst Blog", "Earnings Beat at Endo, Shares Up on Improved Outlook - Analyst Blog", "Endo International plc (ENDP) Jumps: Stock Rises 5.4% - Tale of the Tape", "Will Mylan (MYL) Miss Q1 Earnings? - Analyst Blog", "Can Hospira (HSP) Keep the Earnings Streak Alive? - Analyst Blog", "Tuesday's ETF with Unusual Volume: PPH", "Pacira's Exparel Positive in Phase IV Studies - Analyst Blog", "Mylan to Settle with Endo on Frova - Analyst Blog", "BioDelivery Sciences' Clonidine in Phase III Study - Analyst Blog", "BioDelivery Sciences and Quintiles Sign Deal for Bunavail - Analyst Blog", "Endo International Moves Up In Market Cap Rank, Passing L-3 Communications Holdings", "IJH, HFC, ENDP, AMG: ETF Inflow Alert", "Pipeline Update from BioDelivery Sciences - Analyst Blog", "Update on Endo's Product Portfolio - Analyst Blog", "Pullback brings bulls back to Endo", "Mylan to Settle with Endo on Frova - Analyst Blog", "BioDelivery Sciences' Clonidine in Phase III Study - Analyst Blog", "BioDelivery Sciences and Quintiles Sign Deal for Bunavail - Analyst Blog", "Endo International Moves Up In Market Cap Rank, Passing L-3 Communications Holdings", "IJH, HFC, ENDP, AMG: ETF Inflow Alert", "Pipeline Update from BioDelivery Sciences - Analyst Blog", "Update on Endo's Product Portfolio - Analyst Blog", "Q4 Earnings Decline Y/Y at Endo, Weak Outlook - Analyst Blog", "Earnings Reaction History: Endo Health Solutions, Inc., 25.0% Follow-Through Indicator, 5.4% Sensitive", "Pre-Market Earnings Report for February 28, 2014 : LMCA, NRG, ENDP, DDD, ISIS, IRM, POM, KBR, XLS, ERIE, RHP, PNM", "First Week of October 18th Options Trading For Endo Health Solutions (ENDP)", "Will Mylan (MYL) Miss this Earnings Season? - Analyst Blog", "Interesting ENDP Put And Call Options For January 2016", "Legal Settlement at Endo on Lidoderm - Analyst Blog", "Pre-Market Most Active for Mar 5, 2014 : FCEL, BLMN, BLDP, VZ, RATE, VNTV, ENDP, CPST, BAC, FB, NOK, NLSN", "Endo Closes Boca Pharmacal Acquisition - Analyst Blog", "Endo Health Scores Legal Victory - Analyst Blog", "Closing Update: Blue-Chips Pull Stocks Under Following Fed Minutes; S&P 500 Ends Little Changed", "Update on Endo's Acquisition Strategy - Analyst Blog", "Endo to Acquire NuPathe - Analyst Blog", "Update on Endo's AMS Unit - Analyst Blog", "Teva to Acquire NuPathe - Analyst Blog", "Sector Update: Healthcare", "Healthcare Stocks Building on Smaller Gains Earlier; Endo Health Up on Deal to Acquire NuPathe", "Sector Update: Healthcare", "Back to Neutral on Endo Health - Analyst Blog", "New Magic Formula Stocks From Joel Greenblatt: URS, Nabors Industries, Pilgrims Pride, NeuStar, ...", "Blue Ridge Capital Buys Charter Communications, American Homes 4 Rent, Tesla Motors, Sells ...", "Endo Health Beats on Earnings, Eyes Paladin - Analyst Blog", "Sector Update: Healthcare Shares Higher Pre-Market; Endo to Acquire NuPathe", "Mid-Afternoon Market Update: Marvell Rises on KKR Stake While Orbitz Gives Up Last Week's Gains", "Mylan Beats on Earnings, Revs Down - Analyst Blog", "Will AmerisourceBergen (ABC) Disappoint on Earnings? - Analyst Blog", "Is Mylan (MYL) Poised to Beat Earnings Estimates? - Analyst Blog", "Will Pfizer (PFE) Disappoint this Earnings? - Analyst Blog", "Will Gilead (GILD) Disappoint in Q3? - Analyst Blog", "Will Merck's (MRK) Earnings Streak End? - Analyst Blog", "Pre-Market Most Active for Nov 5, 2013 : GTAT, KORS, ENDP, EPD, ALU, FB, NMR, BBRY, WFT, TSLA, VALE, QQQ", "Will Celgene's (CELG) Earnings Streak End? - Analyst Blog", "Endo Health Upped to Outperform - Analyst Blog", "FDA Not in Favor of Amarin's Vascepa - Analyst Blog", "NPS Pharma's Gattex Looks Promising - Analyst Blog", "Pipeline Progress at Alnylam - Analyst Blog", "Update on Portola's Pipeline - Analyst Blog", "Update on BioDelivery Sciences' Bunavail - Analyst Blog", "Will Alexion's (ALXN) Earnings Streak End? - Analyst Blog", "Good News for BioLineRx - Analyst Blog", "Generic Product Launches at Actavis - Analyst Blog", "Drug Firm Actavis Eyes Growth From A Buyout, Lidoderm", "Target Date for Endo Health's Aveed - Analyst Blog", "Update on BEMA Buprenorphine - Analyst Blog", "Endo Health Eyeing Generic Company, Shares up - Analyst Blog", "BioDelivery Sciences Posts Loss Y/Y - Analyst Blog", "Pipeline Update at Alnylam - Analyst Blog", "Endo Health Beats on Earnings & Revs. in Q2 - Analyst Blog", "Sector Update: Healthcare Shares Flat Pre-Market; Endo Health'S Q2 Earnings Top Street Consensus", "Sector Update: Healthcare", "BioDelivery Announces $20M Debt Financing - Analyst Blog", "Endo Health to Shell Out $54.5 million - Analyst Blog", "Endo to Trim Workforce - Analyst Blog", "CRL for Endo Health's Aveed - Analyst Blog", "ENDP to Offload Anatomical Pathology Unit - Analyst Blog", "Merck Enters into Strategic Deal - Analyst Blog", "Setback for Endo Health on Opana ER - Analyst Blog", "Company News for May 8, 2013 - Corporate Summary", "Earnings Beat at Endo Health, Sales Slip - Analyst Blog", "Back to Neutral on Endo Health - Analyst Blog", "Actavis Files ANDA for Endo Product - Analyst Blog", "Earnings Beat at Endo Health - Analyst Blog", "Two Top Endo Executives Depart - Analyst Blog", "Merck Enters into Strategic Deal - Analyst Blog", "Setback for Endo Health on Opana ER - Analyst Blog", "Company News for May 8, 2013 - Corporate Summary", "Earnings Beat at Endo Health, Sales Slip - Analyst Blog", "Back to Neutral on Endo Health - Analyst Blog", "Endo Inks Deal with Indian Company - Analyst Blog", "Bearish MACD for Endo Health Solutions Inc. - Tale of the Tape", "Endo Health draws big call spread", "Tough Times Ahead for Endo Health - Analyst Blog", "Patent Challenge for Auxilium Pharma - Analyst Blog", "Setback for Endo Health - Analyst Blog", "Endo Cuts EPS View, CEO to Retire - Analyst Blog", "AUXL Downgraded to Underperform - Analyst Blog", "Stock Market News for November 13, 2012 - Market News", "ENDP Beats on Earnings, View Lowered - Analyst Blog", "Impax Launches Opana ER Generic - Analyst Blog", "Watson A Step Closer to Actavis - Analyst Blog", "After Hours Most Active for Oct 15, 2012 : CIM, C, KMI, GOV, GEN, S, SIRI, CELL, MSFT, QQQ, ENDP, QCOM", "Endo Highlights Growth Strategy - Analyst Blog", "Update on Repros' Androxal - Analyst Blog", "Watson's Generic Lidoderm Approved - Analyst Blog", "After Hours Most Active for Aug 27, 2012 : BAC, T, BSX, PBR/A, GFA, PSSI, SCS, QQQ, CSGS, VRSN, ENDP, DELL", "Pipeline Progress at BioDelivery - Analyst Blog", "Watson Pharma Starts New Era As Generic Drug Titan", "Endo Health Walks the Neutral Path - Analyst Blog", "Weekly Top Insider Buys: MDT, KMI, WIN, ENDP, OC", "Weekly CEO Buys Highlight: UTHR, TAT, PMC, BRCD, ENDP", "Good News for Endo's Pain Portfolio - Analyst Blog", "Endo, Watson Settle Patent Dispute - Analyst Blog", "Auxilium Pharma Sues Watson - Analyst Blog", "Auxilium-Glaxo to Drive Testim Sales - Analyst Blog", "Endo Health Beats on All Fronts - Analyst Blog", "Patent Challenge for Auxilium Pharma - Analyst Blog", "Endo Pharma to Shell Out $15M - Analyst Blog", "Endo pullback doesn't scare off the bulls", "Management Change at Endo Pharma - Analyst Blog", "Endo Pharma Treads the Neutral Path - Analyst Blog", "Earnings Beat at Endo Pharma - Analyst Blog", "What's driving big run in the Nasdaq", "Endo Pharma Misses, Backs View - Analyst Blog", "Patent Challenge for Auxilium Pharma - Analyst Blog", "Endo Pharma to Shell Out $15M - Analyst Blog", "Endo pullback doesn't scare off the bulls", "Risk-Reward Balances for Endo Pharma - Analyst Blog", "Increasing Volume to Uncover Institutional Buying - Screen of the Week", "Zacks.com featured expert Kevin Matras highlights: Akorn, Inc., Diana Shipping Inc., Endo Pharmaceuticals Holdings Inc., Southwest Airlines Co. and UnitedHealth Group Inc. - Press Releases", "Pharma & Biotech Stock Review & Outlook - Zacks Analyst Interviews", "Upside position is extended in Endo", "Mid-Day Update: Stocks Lower as Europe Concern Weighs; Moody's Evaluate Europe Ratings in 2012", "Largest option buying in equities so far", "Mid-Day Update: Stocks Firm as Greece Referendum Proceeds; Jobs Gain More Than Expected", "Takeover Target? BioSante Attracts Deal Talks With Female Sex Drug", "Stocks Off Early Lows; Upbeat Service Sector Report Tempers Anemic Job Growth", "Mid-Day Update: Weak Jobs Data Saps Stocks, Signal Economic Slowdown", "Giving health care a positive prognosis", "Company News for December 13, 2011 - Corporate Summary", "Bear bets that upside is limited for Endo", "14 Rallying Stocks With Excellent Management Teams", "10 Healthcare Stocks With Excellent Growth Prospects", "25 Undervalued Stocks With Great Management Teams", "Stocks Slide Despite Positive Employment, Manufacturing Data; Crude Stockpiles Fall Less Than Expected", "Mid-Day Update: Stocks Moderately Lower as Investors Shrug Off Positive Employment Data", "Squeezing pennies from Penwest", "Opening View: Stocks Could Retest Resistance Ahead of Earnings Kick-Off; AA, NYX, ENDP, LVLT in Focus", "Endo Pharmaceuticals Has Some Upside", "High Conviction: This Stock Pick Won Cara Goldenberg Dinner With Warren Buffett", "Put seller sees Penwest holding"], "Elapsed Time": ["2 DAYS AGO", "JUN 11, 2020", "JUN 11, 2020", "JUN 11, 2020", "JUN 10, 2020", "JUN 10, 2020", "JUN 10, 2020", "MAY 22, 2020", "2 DAYS AGO", "MAY 7, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 8, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 8, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 7, 2020", "MAY 7, 2020", "FEB 28, 2020", "FEB 26, 2020", "FEB 26, 2020", "MAY 7, 2020", "MAY 1, 2020", "APR 27, 2020", "APR 21, 2020", "APR 1, 2020", "FEB 28, 2020", "FEB 26, 2020", "FEB 26, 2020", "MAY 7, 2020", "FEB 26, 2020", "FEB 13, 2020", "FEB 12, 2020", "JAN 23, 2020", "JAN 19, 2020", "JAN 8, 2020", "JAN 7, 2020", "FEB 26, 2020", "DEC 15, 2019", "DEC 12, 2019", "DEC 5, 2019", "DEC 4, 2019", "NOV 21, 2019", "NOV 21, 2019", "NOV 20, 2019", "DEC 30, 2019", "DEC 15, 2019", "DEC 12, 2019", "DEC 5, 2019", "DEC 4, 2019", "NOV 21, 2019", "SEP 10, 2019", "NOV 19, 2019", "SEP 6, 2019", "AUG 7, 2019", "AUG 6, 2019", "AUG 6, 2019", "JUL 22, 2019", "JUL 17, 2019", "MAY 10, 2019", "JUL 1, 2019", "MAY 9, 2019", "MAY 9, 2019", "APR 29, 2019", "APR 17, 2019", "APR 5, 2019", "MAR 19, 2019", "MAR 15, 2019", "MAY 9, 2019", "MAR 13, 2019", "MAR 12, 2019", "MAR 8, 2019", "MAR 7, 2019", "MAR 5, 2019", "MAR 1, 2019", "FEB 28, 2019", "MAR 14, 2019", "FEB 21, 2019", "FEB 7, 2019", "JAN 7, 2019", "JAN 2, 2019", "DEC 31, 2018", "DEC 31, 2018", "DEC 11, 2018", "FEB 28, 2019", "FEB 21, 2019", "FEB 7, 2019", "JAN 7, 2019", "NOV 12, 2018", "NOV 9, 2018", "NOV 8, 2018", "NOV 8, 2018", "DEC 8, 2018", "NOV 8, 2018", "NOV 8, 2018", "NOV 8, 2018", "NOV 8, 2018", "NOV 8, 2018", "NOV 6, 2018", "NOV 5, 2018", "NOV 8, 2018", "OCT 3, 2018", "OCT 2, 2018", "OCT 1, 2018", "SEP 28, 2018", "SEP 28, 2018", "SEP 26, 2018", "SEP 18, 2018", "OCT 12, 2018", "OCT 3, 2018", "OCT 2, 2018", "OCT 1, 2018", "SEP 28, 2018", "SEP 5, 2018", "SEP 5, 2018", "AUG 28, 2018", "SEP 14, 2018", "AUG 28, 2018", "AUG 27, 2018", "AUG 21, 2018", "AUG 21, 2018", "AUG 20, 2018", "AUG 20, 2018", "AUG 14, 2018", "AUG 28, 2018", "AUG 13, 2018", "AUG 13, 2018", "AUG 11, 2018", "AUG 10, 2018", "AUG 9, 2018", "AUG 9, 2018", "AUG 9, 2018", "AUG 13, 2018", "AUG 13, 2018", "AUG 13, 2018", "AUG 11, 2018", "AUG 8, 2018", "AUG 8, 2018", "AUG 8, 2018", "AUG 8, 2018", "AUG 1, 2018", "JUL 31, 2018", "JUL 31, 2018", "JUL 31, 2018", "JUL 30, 2018", "JUL 30, 2018", "JUL 27, 2018", "AUG 6, 2018", "JUN 29, 2018", "JUN 28, 2018", "JUN 27, 2018", "JUN 22, 2018", "JUN 15, 2018", "JUN 15, 2018", "JUN 15, 2018", "JUL 3, 2018", "JUN 29, 2018", "JUN 28, 2018", "JUN 27, 2018", "MAY 14, 2018", "MAY 11, 2018", "MAY 10, 2018", "JUN 7, 2018", "MAY 8, 2018", "MAY 7, 2018", "MAY 7, 2018", "APR 18, 2018", "APR 18, 2018", "APR 18, 2018", "APR 13, 2018", "MAY 8, 2018", "APR 3, 2018", "MAR 29, 2018", "MAR 29, 2018", "MAR 28, 2018", "MAR 22, 2018", "MAR 19, 2018", "MAR 16, 2018", "APR 13, 2018", "MAR 13, 2018", "MAR 8, 2018", "MAR 8, 2018", "MAR 1, 2018", "FEB 28, 2018", "FEB 28, 2018", "FEB 28, 2018", "MAR 14, 2018", "MAR 13, 2018", "MAR 8, 2018", "FEB 7, 2018", "FEB 2, 2018", "JAN 18, 2018", "JAN 16, 2018", "FEB 27, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 11, 2018", "NOV 22, 2017", "NOV 10, 2017", "NOV 10, 2017", "NOV 9, 2017", "JAN 12, 2018", "OCT 31, 2017", "OCT 30, 2017", "OCT 30, 2017", "OCT 27, 2017", "OCT 9, 2017", "SEP 25, 2017", "SEP 19, 2017", "NOV 9, 2017", "AUG 31, 2017", "AUG 25, 2017", "AUG 24, 2017", "AUG 17, 2017", "AUG 10, 2017", "AUG 10, 2017", "SEP 11, 2017", "SEP 11, 2017", "AUG 31, 2017", "AUG 25, 2017", "AUG 7, 2017", "AUG 7, 2017", "AUG 3, 2017", "AUG 2, 2017", "AUG 8, 2017", "AUG 8, 2017", "AUG 8, 2017", "AUG 8, 2017", "AUG 7, 2017", "AUG 7, 2017", "JUL 6, 2017", "JUN 22, 2017", "AUG 1, 2017", "AUG 1, 2017", "JUL 19, 2017", "JUL 13, 2017", "JUN 16, 2017", "JUN 14, 2017", "JUN 13, 2017", "JUN 12, 2017", "JUN 21, 2017", "JUN 20, 2017", "JUN 20, 2017", "JUN 17, 2017", "JUN 9, 2017", "JUN 9, 2017", "JUN 9, 2017", "JUN 9, 2017", "JUN 12, 2017", "JUN 10, 2017", "JUN 9, 2017", "JUN 7, 2017", "JUN 6, 2017", "JUN 5, 2017", "MAY 16, 2017", "JUN 9, 2017", "JUN 9, 2017", "JUN 9, 2017", "JUN 8, 2017", "JUN 7, 2017", "MAY 8, 2017", "MAY 8, 2017", "MAY 8, 2017", "MAY 12, 2017", "MAY 4, 2017", "MAY 4, 2017", "MAY 3, 2017", "APR 27, 2017", "APR 13, 2017", "APR 13, 2017", "APR 11, 2017", "MAY 5, 2017", "MAY 4, 2017", "MAY 4, 2017", "MAY 3, 2017", "APR 27, 2017", "APR 13, 2017", "APR 13, 2017", "APR 11, 2017", "MAY 5, 2017", "APR 10, 2017", "APR 3, 2017", "MAR 31, 2017", "MAR 28, 2017", "MAR 28, 2017", "MAR 28, 2017", "MAR 6, 2017", "MAR 20, 2017", "MAR 17, 2017", "FEB 28, 2017", "FEB 28, 2017", "FEB 28, 2017", "FEB 28, 2017", "FEB 28, 2017", "FEB 27, 2017", "MAR 1, 2017", "FEB 24, 2017", "FEB 23, 2017", "FEB 22, 2017", "FEB 15, 2017", "FEB 15, 2017", "FEB 14, 2017", "JAN 31, 2017", "FEB 24, 2017", "JAN 27, 2017", "JAN 27, 2017", "JAN 26, 2017", "JAN 26, 2017", "JAN 24, 2017", "JAN 20, 2017", "JAN 17, 2017", "JAN 30, 2017", "JAN 11, 2017", "JAN 10, 2017", "JAN 9, 2017", "JAN 8, 2017", "JAN 6, 2017", "JAN 4, 2017", "JAN 4, 2017", "JAN 12, 2017", "JAN 11, 2017", "JAN 10, 2017", "DEC 30, 2016", "DEC 16, 2016", "DEC 16, 2016", "DEC 16, 2016", "DEC 15, 2016", "JAN 3, 2017", "DEC 13, 2016", "DEC 9, 2016", "DEC 8, 2016", "DEC 7, 2016", "DEC 6, 2016", "NOV 28, 2016", "NOV 25, 2016", "DEC 14, 2016", "NOV 15, 2016", "NOV 11, 2016", "NOV 10, 2016", "NOV 9, 2016", "NOV 8, 2016", "NOV 8, 2016", "NOV 8, 2016", "NOV 18, 2016", "NOV 8, 2016", "NOV 8, 2016", "NOV 7, 2016", "NOV 3, 2016", "NOV 3, 2016", "NOV 3, 2016", "OCT 17, 2016", "NOV 8, 2016", "NOV 8, 2016", "OCT 6, 2016", "OCT 4, 2016", "OCT 3, 2016", "SEP 30, 2016", "SEP 29, 2016", "OCT 12, 2016", "SEP 26, 2016", "SEP 26, 2016", "SEP 26, 2016", "SEP 23, 2016", "SEP 23, 2016", "SEP 23, 2016", "SEP 23, 2016", "SEP 29, 2016", "SEP 23, 2016", "SEP 9, 2016", "SEP 5, 2016", "SEP 2, 2016", "AUG 29, 2016", "AUG 26, 2016", "AUG 26, 2016", "SEP 23, 2016", "AUG 24, 2016", "AUG 16, 2016", "AUG 15, 2016", "AUG 15, 2016", "AUG 12, 2016", "AUG 12, 2016", "AUG 12, 2016", "AUG 25, 2016", "AUG 11, 2016", "AUG 10, 2016", "AUG 10, 2016", "AUG 9, 2016", "AUG 9, 2016", "AUG 9, 2016", "AUG 9, 2016", "AUG 11, 2016", "AUG 11, 2016", "AUG 10, 2016", "AUG 10, 2016", "AUG 9, 2016", "AUG 9, 2016", "AUG 8, 2016", "AUG 8, 2016", "AUG 9, 2016", "AUG 5, 2016", "AUG 4, 2016", "JUL 21, 2016", "JUL 20, 2016", "JUL 18, 2016", "JUL 15, 2016", "JUL 13, 2016", "AUG 5, 2016", "AUG 5, 2016", "JUL 1, 2016", "JUL 1, 2016", "JUN 30, 2016", "JUN 30, 2016", "JUN 29, 2016", "JUL 13, 2016", "JUN 29, 2016", "JUN 28, 2016", "JUN 28, 2016", "JUN 28, 2016", "JUN 21, 2016", "JUN 20, 2016", "JUN 16, 2016", "JUN 29, 2016", "JUN 14, 2016", "JUN 14, 2016", "JUN 10, 2016", "JUN 10, 2016", "JUN 9, 2016", "JUN 8, 2016", "JUN 6, 2016", "JUN 15, 2016", "JUN 14, 2016", "JUN 2, 2016", "JUN 2, 2016", "JUN 1, 2016", "MAY 27, 2016", "MAY 24, 2016", "MAY 18, 2016", "JUN 6, 2016", "MAY 11, 2016", "MAY 6, 2016", "MAY 6, 2016", "MAY 6, 2016", "MAY 6, 2016", "MAY 6, 2016", "MAY 18, 2016", "MAY 6, 2016", "MAY 6, 2016", "MAY 6, 2016", "MAY 6, 2016", "MAY 6, 2016", "MAY 6, 2016", "MAY 6, 2016", "MAY 6, 2016", "MAY 5, 2016", "MAY 5, 2016", "MAY 4, 2016", "MAY 4, 2016", "MAY 3, 2016", "MAY 2, 2016", "APR 25, 2016", "MAY 6, 2016", "APR 21, 2016", "APR 21, 2016", "APR 21, 2016", "APR 19, 2016", "APR 12, 2016", "APR 11, 2016", "APR 11, 2016", "APR 22, 2016", "APR 11, 2016", "APR 7, 2016", "APR 7, 2016", "APR 7, 2016", "APR 5, 2016", "MAR 31, 2016", "MAR 31, 2016", "APR 11, 2016", "MAR 21, 2016", "MAR 21, 2016", "MAR 18, 2016", "MAR 17, 2016", "MAR 17, 2016", "MAR 17, 2016", "MAR 17, 2016", "MAR 22, 2016", "MAR 16, 2016", "MAR 15, 2016", "MAR 15, 2016", "MAR 11, 2016", "MAR 8, 2016", "MAR 4, 2016", "MAR 1, 2016", "MAR 16, 2016", "MAR 1, 2016", "FEB 29, 2016", "FEB 29, 2016", "FEB 29, 2016", "FEB 29, 2016", "FEB 29, 2016", "FEB 29, 2016", "MAR 1, 2016", "FEB 29, 2016", "FEB 29, 2016", "FEB 29, 2016", "FEB 26, 2016", "FEB 26, 2016", "FEB 26, 2016", "FEB 29, 2016", "FEB 29, 2016", "FEB 29, 2016", "FEB 25, 2016", "FEB 24, 2016", "FEB 23, 2016", "FEB 23, 2016", "FEB 23, 2016", "FEB 26, 2016", "FEB 26, 2016", "FEB 26, 2016", "FEB 25, 2016", "FEB 19, 2016", "FEB 18, 2016", "FEB 17, 2016", "FEB 16, 2016", "FEB 22, 2016", "FEB 22, 2016", "FEB 22, 2016", "JAN 15, 2016", "JAN 13, 2016", "JAN 12, 2016", "JAN 4, 2016", "JAN 4, 2016", "FEB 11, 2016", "DEC 28, 2015", "DEC 22, 2015", "DEC 21, 2015", "DEC 7, 2015", "DEC 6, 2015", "NOV 24, 2015", "NOV 20, 2015", "DEC 31, 2015", "NOV 10, 2015", "NOV 5, 2015", "NOV 5, 2015", "NOV 5, 2015", "NOV 5, 2015", "NOV 5, 2015", "NOV 4, 2015", "NOV 13, 2015", "OCT 30, 2015", "OCT 27, 2015", "OCT 27, 2015", "OCT 26, 2015", "OCT 26, 2015", "OCT 26, 2015", "OCT 21, 2015", "NOV 3, 2015", "OCT 20, 2015", "OCT 15, 2015", "OCT 15, 2015", "OCT 15, 2015", "OCT 15, 2015", "OCT 15, 2015", "OCT 15, 2015", "OCT 21, 2015", "OCT 14, 2015", "OCT 13, 2015", "OCT 13, 2015", "OCT 8, 2015", "OCT 8, 2015", "OCT 7, 2015", "OCT 7, 2015", "OCT 15, 2015", "OCT 2, 2015", "OCT 2, 2015", "OCT 1, 2015", "SEP 29, 2015", "SEP 29, 2015", "SEP 28, 2015", "SEP 24, 2015", "OCT 2, 2015", "SEP 16, 2015", "SEP 9, 2015", "AUG 24, 2015", "AUG 17, 2015", "AUG 14, 2015", "AUG 11, 2015", "AUG 11, 2015", "SEP 22, 2015", "SEP 16, 2015", "SEP 9, 2015", "AUG 24, 2015", "AUG 17, 2015", "AUG 14, 2015", "AUG 11, 2015", "AUG 11, 2015", "SEP 22, 2015", "AUG 10, 2015", "AUG 10, 2015", "AUG 7, 2015", "JUN 9, 2015", "JUN 5, 2015", "JUN 5, 2015", "JUL 21, 2015", "JUL 1, 2015", "JUN 30, 2015", "JUN 29, 2015", "JUN 11, 2015", "JUN 9, 2015", "JUN 5, 2015", "MAY 12, 2015", "MAY 24, 2015", "MAY 19, 2015", "MAY 19, 2015", "MAY 18, 2015", "MAY 18, 2015", "MAY 15, 2015", "MAY 12, 2015", "MAY 12, 2015", "MAY 24, 2015", "MAY 11, 2015", "MAY 8, 2015", "MAY 8, 2015", "APR 30, 2015", "APR 22, 2015", "MAR 31, 2015", "MAR 18, 2015", "MAY 11, 2015", "MAR 17, 2015", "MAR 16, 2015", "MAR 13, 2015", "MAR 12, 2015", "MAR 3, 2015", "MAR 3, 2015", "MAR 2, 2015", "FEB 28, 2015", "FEB 27, 2015", "FEB 27, 2015", "FEB 27, 2015", "FEB 27, 2015", "FEB 27, 2015", "FEB 26, 2015", "MAR 2, 2015", "FEB 3, 2015", "JAN 27, 2015", "JAN 26, 2015", "JAN 22, 2015", "JAN 21, 2015", "JAN 20, 2015", "JAN 20, 2015", "FEB 5, 2015", "FEB 3, 2015", "JAN 27, 2015", "JAN 26, 2015", "JAN 22, 2015", "JAN 21, 2015", "JAN 20, 2015", "JAN 20, 2015", "FEB 5, 2015", "JAN 19, 2015", "JAN 19, 2015", "JAN 15, 2015", "JAN 14, 2015", "DEC 31, 2014", "DEC 31, 2014", "DEC 26, 2014", "JAN 20, 2015", "DEC 24, 2014", "DEC 23, 2014", "DEC 16, 2014", "NOV 25, 2014", "NOV 19, 2014", "NOV 19, 2014", "NOV 18, 2014", "DEC 24, 2014", "NOV 7, 2014", "NOV 7, 2014", "NOV 6, 2014", "NOV 4, 2014", "NOV 3, 2014", "OCT 29, 2014", "OCT 14, 2014", "NOV 10, 2014", "SEP 29, 2014", "SEP 29, 2014", "SEP 29, 2014", "SEP 26, 2014", "SEP 26, 2014", "SEP 25, 2014", "SEP 25, 2014", "SEP 29, 2014", "SEP 29, 2014", "SEP 29, 2014", "SEP 24, 2014", "SEP 24, 2014", "SEP 24, 2014", "SEP 24, 2014", "SEP 24, 2014", "SEP 25, 2014", "SEP 23, 2014", "SEP 19, 2014", "SEP 19, 2014", "SEP 19, 2014", "SEP 19, 2014", "SEP 19, 2014", "SEP 18, 2014", "SEP 23, 2014", "SEP 23, 2014", "SEP 19, 2014", "SEP 19, 2014", "SEP 19, 2014", "SEP 19, 2014", "SEP 19, 2014", "SEP 18, 2014", "SEP 23, 2014", "SEP 23, 2014", "SEP 19, 2014", "SEP 19, 2014", "SEP 19, 2014", "SEP 19, 2014", "SEP 19, 2014", "SEP 18, 2014", "SEP 23, 2014", "SEP 17, 2014", "SEP 17, 2014", "SEP 17, 2014", "SEP 17, 2014", "SEP 17, 2014", "SEP 17, 2014", "SEP 17, 2014", "SEP 18, 2014", "SEP 5, 2014", "SEP 5, 2014", "SEP 4, 2014", "SEP 4, 2014", "SEP 3, 2014", "SEP 3, 2014", "SEP 3, 2014", "SEP 5, 2014", "SEP 2, 2014", "SEP 2, 2014", "AUG 29, 2014", "AUG 29, 2014", "AUG 27, 2014", "AUG 22, 2014", "AUG 22, 2014", "SEP 2, 2014", "AUG 22, 2014", "AUG 22, 2014", "AUG 22, 2014", "AUG 21, 2014", "AUG 21, 2014", "AUG 20, 2014", "AUG 20, 2014", "AUG 22, 2014", "AUG 20, 2014", "AUG 19, 2014", "AUG 18, 2014", "AUG 15, 2014", "AUG 15, 2014", "AUG 14, 2014", "AUG 14, 2014", "AUG 20, 2014", "AUG 20, 2014", "AUG 19, 2014", "AUG 13, 2014", "AUG 13, 2014", "AUG 12, 2014", "AUG 12, 2014", "AUG 12, 2014", "AUG 14, 2014", "AUG 12, 2014", "AUG 12, 2014", "AUG 11, 2014", "AUG 11, 2014", "AUG 8, 2014", "AUG 7, 2014", "AUG 6, 2014", "AUG 12, 2014", "AUG 6, 2014", "AUG 6, 2014", "AUG 5, 2014", "AUG 5, 2014", "AUG 5, 2014", "AUG 5, 2014", "AUG 5, 2014", "AUG 6, 2014", "AUG 4, 2014", "AUG 1, 2014", "AUG 1, 2014", "JUL 30, 2014", "JUL 30, 2014", "JUL 30, 2014", "AUG 5, 2014", "JUL 30, 2014", "JUL 28, 2014", "JUL 28, 2014", "JUL 28, 2014", "JUL 28, 2014", "JUL 28, 2014", "JUL 28, 2014", "JUL 30, 2014", "JUL 24, 2014", "JUL 23, 2014", "JUL 23, 2014", "JUL 23, 2014", "JUL 22, 2014", "JUL 22, 2014", "JUL 21, 2014", "JUL 25, 2014", "JUL 14, 2014", "JUL 14, 2014", "JUL 10, 2014", "JUL 8, 2014", "JUL 7, 2014", "JUL 7, 2014", "JUL 2, 2014", "JUL 21, 2014", "JUN 25, 2014", "MAY 14, 2014", "MAY 2, 2014", "MAY 2, 2014", "APR 30, 2014", "APR 29, 2014", "APR 29, 2014", "JUN 27, 2014", "APR 14, 2014", "APR 4, 2014", "MAR 28, 2014", "MAR 26, 2014", "MAR 19, 2014", "MAR 18, 2014", "MAR 10, 2014", "APR 17, 2014", "APR 14, 2014", "APR 4, 2014", "MAR 28, 2014", "MAR 26, 2014", "MAR 19, 2014", "MAR 18, 2014", "MAR 10, 2014", "MAR 3, 2014", "FEB 28, 2014", "FEB 27, 2014", "FEB 26, 2014", "FEB 26, 2014", "FEB 25, 2014", "FEB 24, 2014", "MAR 5, 2014", "FEB 4, 2014", "JAN 30, 2014", "JAN 8, 2014", "DEC 23, 2013", "DEC 17, 2013", "DEC 16, 2013", "JAN 22, 2014", "DEC 16, 2013", "DEC 16, 2013", "DEC 16, 2013", "NOV 29, 2013", "NOV 18, 2013", "NOV 14, 2013", "NOV 6, 2013", "DEC 16, 2013", "NOV 5, 2013", "OCT 31, 2013", "OCT 30, 2013", "OCT 29, 2013", "OCT 28, 2013", "OCT 28, 2013", "OCT 25, 2013", "NOV 5, 2013", "OCT 21, 2013", "OCT 18, 2013", "OCT 17, 2013", "OCT 16, 2013", "OCT 14, 2013", "OCT 14, 2013", "OCT 11, 2013", "OCT 22, 2013", "OCT 8, 2013", "SEP 20, 2013", "SEP 19, 2013", "SEP 9, 2013", "SEP 5, 2013", "AUG 29, 2013", "AUG 14, 2013", "OCT 8, 2013", "AUG 7, 2013", "AUG 6, 2013", "AUG 6, 2013", "JUL 10, 2013", "JUN 24, 2013", "JUN 6, 2013", "JUN 3, 2013", "AUG 14, 2013", "MAY 22, 2013", "MAY 13, 2013", "MAY 8, 2013", "MAY 8, 2013", "MAR 6, 2013", "MAR 5, 2013", "MAR 4, 2013", "MAY 30, 2013", "MAY 22, 2013", "MAY 13, 2013", "MAY 8, 2013", "MAY 8, 2013", "MAR 6, 2013", "JAN 29, 2013", "JAN 22, 2013", "FEB 28, 2013", "JAN 4, 2013", "JAN 4, 2013", "DEC 21, 2012", "DEC 14, 2012", "NOV 19, 2012", "NOV 13, 2012", "NOV 6, 2012", "JAN 7, 2013", "OCT 19, 2012", "OCT 15, 2012", "OCT 10, 2012", "SEP 14, 2012", "AUG 27, 2012", "AUG 27, 2012", "AUG 24, 2012", "NOV 2, 2012", "JUL 6, 2012", "JUN 25, 2012", "JUN 16, 2012", "JUN 15, 2012", "JUN 4, 2012", "MAY 29, 2012", "MAY 22, 2012", "AUG 9, 2012", "APR 20, 2012", "APR 18, 2012", "APR 11, 2012", "MAR 30, 2012", "MAR 16, 2012", "FEB 28, 2012", "FEB 20, 2012", "MAY 2, 2012", "APR 20, 2012", "APR 18, 2012", "APR 11, 2012", "FEB 1, 2012", "JAN 24, 2012", "JAN 24, 2012", "DEC 28, 2011", "FEB 14, 2012", "DEC 12, 2011", "NOV 22, 2011", "NOV 2, 2011", "JUL 19, 2011", "JUN 3, 2011", "JUN 3, 2011", "APR 20, 2011", "DEC 13, 2011", "MAR 16, 2011", "MAR 1, 2011", "FEB 25, 2011", "JAN 21, 2011", "DEC 30, 2010", "DEC 30, 2010", "AUG 10, 2010", "APR 11, 2011", "APR 22, 2010", "FEB 24, 2010", "JUN 8, 2010"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/biotech-stocks-facing-fda-decision-in-july-2020-2020-06-25", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-wynn-resorts-thermogenesis-u.s.-cruise-lines-2020-06-11", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-amazon-uber-moderna-reata-pharma-2020-06-11", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-regeneron-pharmaceuticals-onconova-therapeutics-nio-inc-2020", "https://www.nasdaq.com/articles/new-york-charges-endo-with-insurance-fraud-over-opioid-claims-2020-06-10-0", "https://www.nasdaq.com/articles/new-york-charges-endo-with-insurance-fraud-over-opioid-claims-2020-06-10", "https://www.nasdaq.com/articles/3-drug-stocks-that-could-soar-in-2020-2020-06-10", "https://www.nasdaq.com/articles/why-a-famed-investor-says-this-is-the-fifth-great-buying-opportunity-2020-05-22", "https://www.nasdaq.com/articles/biotech-stocks-facing-fda-decision-in-july-2020-2020-06-25", "https://www.nasdaq.com/articles/endo-international-fires-on-all-cylinders-in-q1-thanks-to-covid-19-impact-2020-05-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-oil-stocks-airlines-peloton-paypal-2020-05-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-paypal-gm-lyft-airlines-2020-05-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-cvs-paypal-lyft-gm-2020-05-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-lyft-livongo-health-tonix-pharma-2020-05-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-lyft-gm-bristol-myers-nvidia-2020-05-07", "https://www.nasdaq.com/articles/endo-international-q1-20-earnings-conference-call-at-8%3A00-am-et-2020-05-07", "https://www.nasdaq.com/articles/endo-international-endp-q1-2020-earnings-call-transcript-2020-05-08", "https://www.nasdaq.com/articles/endo-international-fires-on-all-cylinders-in-q1-thanks-to-covid-19-impact-2020-05-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-oil-stocks-airlines-peloton-paypal-2020-05-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-paypal-gm-lyft-airlines-2020-05-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-cvs-paypal-lyft-gm-2020-05-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-lyft-livongo-health-tonix-pharma-2020-05-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-lyft-gm-bristol-myers-nvidia-2020-05-07", "https://www.nasdaq.com/articles/endo-international-q1-20-earnings-conference-call-at-8%3A00-am-et-2020-05-07", "https://www.nasdaq.com/articles/endo-international-endp-q1-2020-earnings-call-transcript-2020-05-08", "https://www.nasdaq.com/articles/endo-international-fires-on-all-cylinders-in-q1-thanks-to-covid-19-impact-2020-05-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-oil-stocks-airlines-peloton-paypal-2020-05-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-paypal-gm-lyft-airlines-2020-05-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-cvs-paypal-lyft-gm-2020-05-07", "https://www.nasdaq.com/articles/first-week-of-april-9th-options-trading-for-endo-international-plc-endp-2020-02-28", "https://www.nasdaq.com/articles/endo-international-endp-q4-2019-earnings-call-transcript-2020-02-27", "https://www.nasdaq.com/articles/endo-international-q4-19-earnings-conference-call-at-8%3A00-am-et-2020-02-26", "https://www.nasdaq.com/articles/endo-international-withdraws-2020-guidance-quick-facts-2020-05-07", "https://www.nasdaq.com/articles/will-an-opioid-manufacturer-stage-a-comeback-with-this-new-venture-2020-05-01", "https://www.nasdaq.com/articles/endo-international-breaks-above-200-day-moving-average-bullish-for-endp-2020-04-27", "https://www.nasdaq.com/articles/should-you-buy-this-biotech-that-makes-a-lower-risk-painkiller-2020-04-21", "https://www.nasdaq.com/articles/fda-asks-for-recalls-of-sanofis-zantac-and-all-generic-versions-2020-04-01", "https://www.nasdaq.com/articles/first-week-of-april-9th-options-trading-for-endo-international-plc-endp-2020-02-28", "https://www.nasdaq.com/articles/endo-international-endp-q4-2019-earnings-call-transcript-2020-02-27", "https://www.nasdaq.com/articles/endo-international-q4-19-earnings-conference-call-at-8%3A00-am-et-2020-02-26", "https://www.nasdaq.com/articles/endo-international-withdraws-2020-guidance-quick-facts-2020-05-07", "https://www.nasdaq.com/articles/endo-international-plc-q4-adjusted-earnings-of-%240.74-per-share-2020-02-26", "https://www.nasdaq.com/articles/interesting-endp-put-and-call-options-for-april-3rd-2020-02-13", "https://www.nasdaq.com/articles/stock-to-watch%3A-endo-international-endp-2020-02-12", "https://www.nasdaq.com/articles/endp-march-6th-options-begin-trading-2020-01-23", "https://www.nasdaq.com/articles/3-big-winners-from-the-super-bowl-of-healthcare-2020-01-19", "https://www.nasdaq.com/articles/scandal-ridden-teva-pharmaceutical-is-fishing-for-a-bottom-2020-01-08", "https://www.nasdaq.com/articles/interesting-endp-put-and-call-options-for-march-20th-2020-01-07", "https://www.nasdaq.com/articles/endo-international-guides-fy20-in-line-with-estimates-quick-facts-2020-02-26", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-kenneth-fisher-12-15-2019-2019-12-15", "https://www.nasdaq.com/articles/january-2020-options-now-available-for-endo-international-endp-2019-12-12", "https://www.nasdaq.com/articles/why-sorrento-therapeutics-was-right-to-reject-takeover-bids-with-a-245-premium-2019-12-05", "https://www.nasdaq.com/articles/endo-international-breaks-above-200-day-moving-average-bullish-for-endp-2019-12-04", "https://www.nasdaq.com/articles/endp-january-2020-options-begin-trading-2019-11-21", "https://www.nasdaq.com/articles/ftxhs-holdings-could-mean-15-gain-potential-2019-11-21", "https://www.nasdaq.com/articles/3-recovering-healthcare-stocks-to-buy-that-already-escaped-flu-season-2019-11-20", "https://www.nasdaq.com/articles/how-the-parts-add-up%3A-xph-headed-for-%2454-2019-12-30", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-kenneth-fisher-12-15-2019-2019-12-15", "https://www.nasdaq.com/articles/january-2020-options-now-available-for-endo-international-endp-2019-12-12", "https://www.nasdaq.com/articles/why-sorrento-therapeutics-was-right-to-reject-takeover-bids-with-a-245-premium-2019-12-05", "https://www.nasdaq.com/articles/endo-international-breaks-above-200-day-moving-average-bullish-for-endp-2019-12-04", "https://www.nasdaq.com/articles/endp-january-2020-options-begin-trading-2019-11-21", "https://www.nasdaq.com/articles/5-top-gainers-in-healthcare-sector-mnk-endp-mlnt...-2019-09-10", "https://www.nasdaq.com/articles/first-week-of-endp-july-2020-options-trading-2019-11-19", "https://www.nasdaq.com/articles/why-docusign-endo-international-and-guidewire-software-jumped-today-2019-09-06", "https://www.nasdaq.com/articles/5-top-losers-in-healthcare-sector-endp-avgr-lptx...-2019-08-07", "https://www.nasdaq.com/articles/endo-international-endp-q2-2019-earnings-call-transcript-2019-08-07", "https://www.nasdaq.com/articles/heres-why-endo-international-is-falling-today-2019-08-06", "https://www.nasdaq.com/articles/13-stocks-to-sell-before-they-dive-even-more-2019-07-22", "https://www.nasdaq.com/articles/why-endo-international-shares-are-under-pressure-today-2019-05-13", "https://www.nasdaq.com/articles/endo-international-endp-q1-2019-earnings-call-transcript-2019-05-10", "https://www.nasdaq.com/articles/why-endo-international-stock-is-jumping-today-2019-07-01", "https://www.nasdaq.com/articles/endo-international-affirms-fy19-outlook-quick-facts-2019-05-09", "https://www.nasdaq.com/articles/endo-international-plc-q1-adjusted-earnings-beat-estimates-2019-05-09", "https://www.nasdaq.com/articles/first-week-june-21st-options-trading-endo-international-endp-2019-04-29", "https://www.nasdaq.com/articles/interesting-endp-put-and-call-options-may-31st-2019-04-17", "https://www.nasdaq.com/articles/endo-unit-begins-shipping-generic-version-mercks-proventil-quick-facts-2019-04-05", "https://www.nasdaq.com/articles/catalyst-cprx-reports-wider-q4-loss-focuses-on-firdapse-2019-03-19", "https://www.nasdaq.com/articles/biodelivery-bdsi-q4-earnings-in-line-sales-beat-stock-up-2019-03-15", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-09-2019%3A-abio-agen-endp-jnj-pfe-abt-mrk-amgn-2019-05-09", "https://www.nasdaq.com/articles/after-hours-most-active-mar-13-2019-msft-lly-f-cmcsa-pfe-fox-ctl-hpq-pcg-amd-aapl-endp", "https://www.nasdaq.com/articles/is-endo-international-endp-a-great-stock-for-value-investors-2019-03-12", "https://www.nasdaq.com/articles/endo-endp-soars%3A-stock-adds-6-in-session-2019-03-08", "https://www.nasdaq.com/articles/what-scott-gottliebs-fda-departure-means-investors-2019-03-07", "https://www.nasdaq.com/articles/whats-in-store-for-biospecifics-bstc-this-earnings-season-2019-03-05", "https://www.nasdaq.com/articles/endo-endp-q4-earnings-revenues-beat-estimates-shares-up-2019-03-01", "https://www.nasdaq.com/articles/endo-international-plc-endp-q4-2018-earnings-conference-call-transcript-2019-02-28", "https://www.nasdaq.com/articles/insys-plunges-on-auditors-concern-about-insufficient-funds-2019-03-14", "https://www.nasdaq.com/articles/earnings-preview%3A-endo-international-endp-q4-earnings-expected-to-decline-2019-02-21", "https://www.nasdaq.com/articles/endo-international-not-oppose-additional-stay-fda-litigation-quick-facts-2019-02-07", "https://www.nasdaq.com/articles/endo-international-present-jp-morgan-conference-webcast-230-pm-et-2019-01-07", "https://www.nasdaq.com/articles/heron-gains-on-priority-review-designation-for-pain-drug-2019-01-02", "https://www.nasdaq.com/articles/options-traders-expect-huge-moves-in-endo-endp-stock-2018-12-31", "https://www.nasdaq.com/articles/endo-fda-requests-further-stay-compounding-litigation-quick-facts-2018-12-31", "https://www.nasdaq.com/articles/generic-drugmakers-down-on-allegations-of-price-fixing-2018-12-11", "https://www.nasdaq.com/articles/interesting-endp-put-and-call-options-april-12th-2019-02-28", "https://www.nasdaq.com/articles/earnings-preview%3A-endo-international-endp-q4-earnings-expected-to-decline-2019-02-21", "https://www.nasdaq.com/articles/endo-international-not-oppose-additional-stay-fda-litigation-quick-facts-2019-02-07", "https://www.nasdaq.com/articles/endo-international-present-jp-morgan-conference-webcast-230-pm-et-2019-01-07", "https://www.nasdaq.com/articles/biodelivery-bdsi-q3-earnings-beat-sales-in-line-stock-up-2018-11-12", "https://www.nasdaq.com/articles/endo-endp-stock-declines-despite-q3-earnings-revenue-beat-2018-11-09", "https://www.nasdaq.com/articles/heres-why-endo-international-fell-much-189-today-2018-11-08", "https://www.nasdaq.com/articles/endo-international-enters-oversold-territory-endp-2018-11-08", "https://www.nasdaq.com/articles/why-is-endo-endp-down-12.3-since-last-earnings-report-2018-12-08", "https://www.nasdaq.com/articles/endp-december-28th-options-begin-trading-2018-11-08", "https://www.nasdaq.com/articles/endo-international-endp-q3-earnings-and-revenues-surpass-estimates-2018-11-08", "https://www.nasdaq.com/articles/earnings-reaction-history-endo-international-plc-500-follow-through-indicator-130", "https://www.nasdaq.com/articles/should-first-trust-small-cap-growth-alphadex-fund-fyc-be-on-your-investing-radar-2018-11-0", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-lng-reta-endp-2018-11-08", "https://www.nasdaq.com/articles/whats-in-the-cards-for-biospecifics-bstc-in-q3-earnings-2018-11-06", "https://www.nasdaq.com/articles/endo-endp-to-report-q3-earnings%3A-whats-in-the-cards-2018-11-05", "https://www.nasdaq.com/articles/endo-international-plc-endp-q3-2018-earnings-conference-call-transcript-2018-11-08", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-post-sbux-endp-2018-10-03", "https://www.nasdaq.com/articles/ijs-sr-www-endp-etf-outflow-alert-2018-10-02", "https://www.nasdaq.com/articles/endo-recalls-2-lots-of-robaxin-tablets-due-to-labeling-error-2018-10-01", "https://www.nasdaq.com/articles/forget-mylan-invest-these-3-genericdrug-stocks-instead-2018-09-28", "https://www.nasdaq.com/articles/has-endo-international-plc-endp-outpaced-other-medical-stocks-this-year-2018-09-28", "https://www.nasdaq.com/articles/first-week-november-16th-options-trading-endo-international-endp-2018-09-26", "https://www.nasdaq.com/articles/is-endo-international-endp-a-great-stock-for-value-investors-2018-09-18", "https://www.nasdaq.com/articles/rigel-rigl-gets-ema-acceptance-for-thrombocytopenia-drug-2018-10-12", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-post-sbux-endp-2018-10-03", "https://www.nasdaq.com/articles/ijs-sr-www-endp-etf-outflow-alert-2018-10-02", "https://www.nasdaq.com/articles/endo-recalls-2-lots-of-robaxin-tablets-due-to-labeling-error-2018-10-01", "https://www.nasdaq.com/articles/forget-mylan-invest-these-3-genericdrug-stocks-instead-2018-09-28", "https://www.nasdaq.com/articles/endo-endp-hits-52-week-high-can-the-run-continue-2018-09-05", "https://www.nasdaq.com/articles/biogen-begins-phase-iii-study-on-ischemic-stroke-candidate-2018-09-05", "https://www.nasdaq.com/articles/esperion-espr-combination-regimen-lowers-bad-cholesterol-2018-08-28", "https://www.nasdaq.com/articles/irish-economy-rebounds-q2-4-great-picks-2018-09-14", "https://www.nasdaq.com/articles/endo-international-reaches-analyst-target-price-2018-08-28", "https://www.nasdaq.com/articles/jazzs-jazz-leukemia-drug-vyxeos-gets-approval-in-europe-2018-08-27", "https://www.nasdaq.com/articles/lannett-set-to-lose-distribution-agreement-with-key-supplier-2018-08-21", "https://www.nasdaq.com/articles/zacks.com-highlights%3A-medifast-endo-international-hca-healthcare-five9-and-fti-consulting", "https://www.nasdaq.com/articles/buy-these-5-low-beta-stocks-to-brave-market-volatility-2018-08-20-0", "https://www.nasdaq.com/articles/buy-these-5-low-beta-stocks-to-brave-market-volatility-2018-08-20", "https://www.nasdaq.com/articles/amneal-pharmaceuticals-amrx-jumps%3A-stock-rises-5.6-2018-08-14", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-ions-looks-good%3A-stock-adds-7.8-in-session-2018-08-28", "https://www.nasdaq.com/articles/pre-market-most-active-aug-13-2018-tur-tkc-qqq-nlsn-sqqq-tvix-bbva-endp-db-san-uslv-baba", "https://www.nasdaq.com/articles/mondays-etf-unusual-volume-fyc-2018-08-13", "https://www.nasdaq.com/articles/3-biotech-stocks-soared-week-are-they-buys-2018-08-11", "https://www.nasdaq.com/articles/biodelivery-bdsi-q2-loss-narrows-sales-miss-shares-down-2018-08-10", "https://www.nasdaq.com/articles/endp-september-28th-options-begin-trading-2018-08-09", "https://www.nasdaq.com/articles/company-news-for-aug-9-2018-2018-08-09", "https://www.nasdaq.com/articles/endo-endp-beats-on-q2-earnings-sales-raises-guidance-2018-08-09", "https://www.nasdaq.com/articles/endp-december-21st-options-begin-trading-2018-08-13", "https://www.nasdaq.com/articles/pre-market-most-active-aug-13-2018-tur-tkc-qqq-nlsn-sqqq-tvix-bbva-endp-db-san-uslv-baba", "https://www.nasdaq.com/articles/mondays-etf-unusual-volume-fyc-2018-08-13", "https://www.nasdaq.com/articles/3-biotech-stocks-soared-week-are-they-buys-2018-08-11", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-celg-nvda-endp-2018-08-08", "https://www.nasdaq.com/articles/endo-international-plc-endp-q2-2018-earnings-conference-call-transcript-2018-08-08", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-down-35-endo-international-shares-surge-after-strong", "https://www.nasdaq.com/articles/mid-day-market-update-3d-systems-climbs-earnings-beat-core-molding-technologies-shares", "https://www.nasdaq.com/articles/whats-in-store-for-catalyst-cprx-this-earnings-season-2018-08-01", "https://www.nasdaq.com/articles/zoetis-zts-gears-up-for-q2-earnings%3A-whats-in-store-2018-07-31", "https://www.nasdaq.com/articles/whats-in-store-for-intrexon-xon-this-earnings-season-2018-07-31", "https://www.nasdaq.com/articles/whats-in-store-for-epizyme-epzm-this-earnings-season-2018-07-31", "https://www.nasdaq.com/articles/whats-in-store-for-immune-design-imdz-in-q2-earnings-2018-07-30", "https://www.nasdaq.com/articles/will-agenus-agen-disappoint-investors-this-earnings-season-2018-07-30", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-endocyte-ecyt-this-earnings-season-2018-07-27", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-horizon-pharma-hznp-in-q2-earnings-2018-08-06", "https://www.nasdaq.com/articles/is-the-options-market-predicting-a-spike-in-endo-international-endp-stock-2018-06-29", "https://www.nasdaq.com/articles/pain-durect-plunge-as-fda-committee-votes-against-remoxy-er-2018-06-28", "https://www.nasdaq.com/articles/after-hours-most-active-jun-27-2018-ggp-tegp-esv-swn-qqq-orcl-csco-azn-msft-endp-feye-fb", "https://www.nasdaq.com/articles/after-hours-most-active-jun-22-2018-rad-swn-cmcsa-vz-bac-taho-p-czr-opk-endp-umpq-mdrx", "https://www.nasdaq.com/articles/biomarin-begins-pediatric-study-on-achondroplasia-candidate-2018-06-15", "https://www.nasdaq.com/articles/teva-pharmaceutical-industries-limited-stock-still-deep-value-play-2018-06-15", "https://www.nasdaq.com/articles/after-hours-most-active-jun-15-2018-endp-rrc-hfc-br-gern-qqq-aapl-bac-csco-opk-ge-wfc-2018", "https://www.nasdaq.com/articles/is-endo-international-a-great-stock-for-value-investors-2018-07-03", "https://www.nasdaq.com/articles/is-the-options-market-predicting-a-spike-in-endo-international-endp-stock-2018-06-29", "https://www.nasdaq.com/articles/pain-durect-plunge-as-fda-committee-votes-against-remoxy-er-2018-06-28", "https://www.nasdaq.com/articles/after-hours-most-active-jun-27-2018-ggp-tegp-esv-swn-qqq-orcl-csco-azn-msft-endp-feye-fb", "https://www.nasdaq.com/articles/after-hours-most-active-may-14-2018-f-endp-sncr-intc-abev-msft-cmcsa-pfe-csco-ge-dhi-cnp", "https://www.nasdaq.com/articles/biodelivery-bdsi-q1-earnings-and-sales-beat-estimates-2018-05-11", "https://www.nasdaq.com/articles/xiaflex-sterile-injectables-drive-endos-endp-q1-earnings-2018-05-10", "https://www.nasdaq.com/articles/endo-international-endp-up-12.4-since-earnings-report%3A-can-it-continue-2018-06-07", "https://www.nasdaq.com/articles/earnings-reaction-history-endo-international-plc-545-follow-through-indicator-129", "https://www.nasdaq.com/articles/factors-likely-to-impact-zillow-zg-this-earnings-season-2018-05-07", "https://www.nasdaq.com/articles/health-care-sector-update-05072018-lciendpearsvrxvrxtonvax-2018-05-07", "https://www.nasdaq.com/articles/health-care-sector-update-04182018-abt-fcsc-endp-sldb-2018-04-18", "https://www.nasdaq.com/articles/health-care-sector-update-04182018-sldbfcscabtendpegrx-2018-04-18", "https://www.nasdaq.com/articles/health-care-sector-update-04182018-fcscabtendpegrx-2018-04-18", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-endo-international-endp-stock-2018-04-13", "https://www.nasdaq.com/articles/is-the-options-market-predicting-a-spike-in-endo-international-endp-stock-2018-05-08", "https://www.nasdaq.com/articles/what-falling-estimates-price-mean-for-endo-international-endp-2018-04-03", "https://www.nasdaq.com/articles/why-is-endo-international-endp-down-15-since-its-last-earnings-report-2018-03-29", "https://www.nasdaq.com/articles/biomarins-maa-for-phenylketonuria-candidate-gains-eu-nod-2018-03-29", "https://www.nasdaq.com/articles/after-hours-most-active-mar-28-2018-bkd-endp-twtr-qqq-hpq-fdc-ge-nclh-slm-ebay-nwsa-pep", "https://www.nasdaq.com/articles/implied-vti-analyst-target-price-155-2018-03-22", "https://www.nasdaq.com/articles/close-update-wall-street-dives-facebooks-selloff-dents-sentiment-fed-meeting-2018-03-19", "https://www.nasdaq.com/articles/biodelivery-bdsi-q4-loss-wider-than-expected-sales-up-y-y-2018-03-16", "https://www.nasdaq.com/articles/after-hours-most-active-apr-13-2018-aapl-qqq-cmcsa-qcom-endp-msft-2018-04-13", "https://www.nasdaq.com/articles/after-hours-most-active-mar-13-2018-endp-dwdp-nwl-intc-pfe-hpq-znga-fold-swn-qqq-cbs-stld", "https://www.nasdaq.com/articles/kohls-endo-international-and-costco-as-zacks-bull-and-bear-of-the-day-2018-03-08", "https://www.nasdaq.com/articles/bear-day-endo-international-endp-2018-03-08", "https://www.nasdaq.com/articles/whats-in-the-cards-for-biodelivery-bdsi-in-q4-earnings-2018-03-01", "https://www.nasdaq.com/articles/endo-endp-surpasses-earnings-revenue-estimates-in-q4-2018-02-28", "https://www.nasdaq.com/articles/valeant-earnings-12-month-journey-nowhere-2018-02-28", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-february-28th-2018-02-28", "https://www.nasdaq.com/articles/commit-purchase-endo-international-5-earn-129-annualized-using-options-2018-03-14", "https://www.nasdaq.com/articles/after-hours-most-active-mar-13-2018-endp-dwdp-nwl-intc-pfe-hpq-znga-fold-swn-qqq-cbs-stld", "https://www.nasdaq.com/articles/kohls-endo-international-and-costco-as-zacks-bull-and-bear-of-the-day-2018-03-08", "https://www.nasdaq.com/articles/after-hours-most-active-feb-7-2018-bac-qqq-lho-tsm-peb-t-vici-usmc-aapl-endp-msft-csco", "https://www.nasdaq.com/articles/endo-international-now-oversold-endp-2018-02-02", "https://www.nasdaq.com/articles/thursdays-etf-unusual-volume-mdyv-2018-01-18", "https://www.nasdaq.com/articles/endo-endp-loses-35-in-a-year%3A-can-it-turn-around-in-2018-2018-01-16", "https://www.nasdaq.com/articles/is-the-options-market-predicting-a-spike-in-endo-international-endp-stock-2018-02-27", "https://www.nasdaq.com/articles/interesting-endp-put-and-call-options-march-2nd-2018-01-11", "https://www.nasdaq.com/articles/health-care-sector-update-01112018-mdxg-endp-meip-bsx-crl-2018-01-11", "https://www.nasdaq.com/articles/health-care-sector-update-01112018-endpmeipbsxcrl-2018-01-11", "https://www.nasdaq.com/articles/interesting-endp-put-and-call-options-january-2018-2017-11-22", "https://www.nasdaq.com/articles/endo-endp-earnings-revenues-beat-in-q3-generics-weak-2017-11-10", "https://www.nasdaq.com/articles/biodelivery-bdsi-q3-earnings-sales-beat-estimates-2017-11-10", "https://www.nasdaq.com/articles/implied-volatility-surging-for-endo-endp-stock-options-2017-11-09", "https://www.nasdaq.com/articles/endo-endp-gets-subpoena-from-florida-for-opioid-misuse-2018-01-12", "https://www.nasdaq.com/articles/why-endo-international-plc-jumped-and-then-faded-twice-2017-10-31", "https://www.nasdaq.com/articles/endos-upbeat-earnings-dont-get-too-excited-2017-10-30", "https://www.nasdaq.com/articles/morning-movers-mergers-earnings-and-downgrades-oh-my-2017-10-30", "https://www.nasdaq.com/articles/heres-why-endo-international-stock-dropped-much-138-today-2017-10-27", "https://www.nasdaq.com/articles/how-pieces-add-pph-targets-64-2017-10-09", "https://www.nasdaq.com/articles/should-value-investors-consider-endo-international-endp-stock-2017-09-25", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-endo-international-endp-stock-2017-09-19", "https://www.nasdaq.com/articles/earnings-reaction-history-endo-international-plc-500-follow-through-indicator-130-0", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-august-31st-2017-08-31", "https://www.nasdaq.com/articles/will-endo-endp-continue-to-disappoint-investors-in-2017-2017-08-25", "https://www.nasdaq.com/articles/biodelivery-bdsi-ceo-mark-sirgo-to-retire-by-2017-end-2017-08-24", "https://www.nasdaq.com/articles/endo-international-endp-jumps%3A-stock-rises-6.9-2017-08-17", "https://www.nasdaq.com/articles/biodelivery-bdsi-q2-loss-wider-than-expected-stock-falls-2017-08-10", "https://www.nasdaq.com/articles/thursdays-etf-unusual-volume-mdyv-2017-08-10", "https://www.nasdaq.com/articles/january-2020-options-now-available-endo-international-endp-2017-09-11", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-september-11th-2017-09-11", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-august-31st-2017-08-31", "https://www.nasdaq.com/articles/will-endo-endp-continue-to-disappoint-investors-in-2017-2017-08-25", "https://www.nasdaq.com/articles/whats-in-store-for-biodelivery-bdsi-this-earnings-season-2017-08-07", "https://www.nasdaq.com/articles/drug-stocks-q2-earnings-roster-for-aug-8%3A-acad-jazz-more-2017-08-07", "https://www.nasdaq.com/articles/rsi-alert-endo-international-endp-now-oversold-2017-08-03", "https://www.nasdaq.com/articles/will-teva-pharmaceutical-industries-ltd-adr-teva-stock-catch-a-break-2017-08-02", "https://www.nasdaq.com/articles/pre-market-most-active-aug-8-2017-vrx-endp-teva-abb-fgen-qqq-inva-car-kors-nvda-htz-pagp", "https://www.nasdaq.com/articles/endo-endp-q2-earnings-beat-estimates-2017-guidance-cut-2017-08-08", "https://www.nasdaq.com/articles/earnings-reaction-history-endo-international-plc-500-follow-through-indicator-120", "https://www.nasdaq.com/articles/endo-endp-beats-q2-earnings-sales-2017-guidance-lowered-2017-08-08", "https://www.nasdaq.com/articles/whats-in-store-for-biodelivery-bdsi-this-earnings-season-2017-08-07", "https://www.nasdaq.com/articles/drug-stocks-q2-earnings-roster-for-aug-8%3A-acad-jazz-more-2017-08-07", "https://www.nasdaq.com/articles/why-flexion-therapeutics-rallied-18-june-2017-07-06", "https://www.nasdaq.com/articles/biodelivery-inks-new-contract-with-cvs-caremark-shares-up-2017-06-22", "https://www.nasdaq.com/articles/whats-in-the-cards-for-endo-endp-this-earnings-season-2017-08-01", "https://www.nasdaq.com/articles/options-traders-expect-huge-moves-in-endo-international-endp-stock-2017-08-01", "https://www.nasdaq.com/articles/nektars-nktr-181-positive-in-human-abuse-potential-study-2017-07-19", "https://www.nasdaq.com/articles/biodelivery-purdue-pharma-ink-marketing-deal-for-pain-drug-2017-07-13", "https://www.nasdaq.com/articles/is-endo-international-endp-a-great-stock-for-value-investors-2017-06-16", "https://www.nasdaq.com/articles/these-2-marijuana-stocks-plunged-last-week-should-you-be-buying-2017-06-14", "https://www.nasdaq.com/articles/why-is-endo-endp-down-4.7-since-the-last-earnings-report-2017-06-13", "https://www.nasdaq.com/articles/company-news-for-june-12-2017-2017-06-12", "https://www.nasdaq.com/articles/7-healthcare-stocks-to-buy-now-2017-06-21", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xph-akrx-endp-prgo-2017-06-20", "https://www.nasdaq.com/articles/should-investors-steer-clear-opioid-drug-stocks-2017-06-20", "https://www.nasdaq.com/articles/3-biotech-stocks-could-become-ma-targets-2017-06-17", "https://www.nasdaq.com/articles/wall-street-sees-cautiously-higher-open-after-theresa-mays-conservative-party-loses", "https://www.nasdaq.com/articles/like-snap-inc.-snap-stock-buy-this-instead.-2017-06-09", "https://www.nasdaq.com/articles/endo-asked-to-withdraw-pain-drug-opana-er-by-fda-stock-down-2017-06-09", "https://www.nasdaq.com/articles/pre-market-most-active-jun-9-2017-smfg-p-baba-caa-rdsb-nvda-lyg-eric-endp-lxrx-xiv-mlco", "https://www.nasdaq.com/articles/cannabis-solution-americas-terrifying-opioid-crisis-2017-06-12", "https://www.nasdaq.com/articles/fda-big-risk-companys-marijuana-plans-2017-06-10", "https://www.nasdaq.com/articles/mid-day-market-update-dow-surges-100-points-endo-international-shares-plummet-2017-06-09", "https://www.nasdaq.com/articles/intellipharmaceutics-announces-launch-of-generic-seroquel-xr-2017-06-07", "https://www.nasdaq.com/articles/why-endo-international-plc-rose-129-may-2017-06-06", "https://www.nasdaq.com/articles/implied-pph-analyst-target-price-64-2017-06-05", "https://www.nasdaq.com/articles/biodelivery-bdsi-q1-earnings-beat-estimates-stock-gains-2017-05-16", "https://www.nasdaq.com/articles/us-futures-cautiously-higher-after-theresa-mays-conservative-party-loses-outright-majority", "https://www.nasdaq.com/articles/mid-afternoon-market-update-nasdaq-down-25-dupont-fabros-shares-spike-higher-2017-06-09", "https://www.nasdaq.com/articles/why-endos-bad-news-sent-collegium-pharmaceutical-shares-soaring-10-2017-06-09", "https://www.nasdaq.com/articles/heres-why-endo-international-plc-stock-surged-today-2017-06-08", "https://www.nasdaq.com/articles/heres-whats-behind-endo-international-plcs-rally-today-2017-05-09", "https://www.nasdaq.com/articles/commit-buy-endo-international-750-earn-18-using-options-2017-05-08", "https://www.nasdaq.com/articles/whats-in-store-for-biodelivery-bdsi-this-earnings-season-2017-05-08", "https://www.nasdaq.com/articles/4-drug-stocks-poised-to-beat-this-earnings-season-2017-05-08", "https://www.nasdaq.com/articles/francis-chou-buys-endo-international-plc-teva-pharmaceutical-industries-valeant-2017-05-12", "https://www.nasdaq.com/articles/generic-drugmakers-tumble-perrigo-discloses-doj-search-2017-05-04", "https://www.nasdaq.com/articles/is-endo-endp-poised-for-a-beat-this-earnings-season-2017-05-04", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-shld-endp-foxa-2017-05-03", "https://www.nasdaq.com/articles/weitz-value-fund-comments-endo-international-2017-04-27", "https://www.nasdaq.com/articles/intellipharmaceutics-ipci-q1-loss-narrower-than-expected-2017-04-13", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-endo-international-endp-stock-2017-04-13", "https://www.nasdaq.com/articles/endo-endp-reports-preliminary-results-for-first-quarter-2017-04-11", "https://www.nasdaq.com/articles/biomarin-bmrn-posts-earnings-in-q1-sales-top-stock-up-2017-05-05", "https://www.nasdaq.com/articles/generic-drugmakers-tumble-perrigo-discloses-doj-search-2017-05-04", "https://www.nasdaq.com/articles/is-endo-endp-poised-for-a-beat-this-earnings-season-2017-05-04", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-shld-endp-foxa-2017-05-03", "https://www.nasdaq.com/articles/weitz-value-fund-comments-endo-international-2017-04-27", "https://www.nasdaq.com/articles/intellipharmaceutics-ipci-q1-loss-narrower-than-expected-2017-04-13", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-endo-international-endp-stock-2017-04-13", "https://www.nasdaq.com/articles/endo-endp-reports-preliminary-results-for-first-quarter-2017-04-11", "https://www.nasdaq.com/articles/biomarin-bmrn-posts-earnings-in-q1-sales-top-stock-up-2017-05-05", "https://www.nasdaq.com/articles/spdr-sp-pharmaceuticals-etf-experiences-big-outflow-2017-04-10", "https://www.nasdaq.com/articles/implied-iyh-analyst-target-price-171-2017-04-03", "https://www.nasdaq.com/articles/why-is-endo-endp-down-10.6-since-the-last-earnings-report-2017-03-31", "https://www.nasdaq.com/articles/vivus-to-regain-commercial-rights-for-stendra-from-sanofi-2017-03-28", "https://www.nasdaq.com/articles/valeant-pharmaceuticals-intl-inc-vrx-stock-may-be-healthy-for-long-term-investors-2017-03", "https://www.nasdaq.com/articles/has-biodelivery-sciences-finally-turned-corner-2017-03-06", "https://www.nasdaq.com/articles/monday-sector-laggards-materials-healthcare-2017-03-06", "https://www.nasdaq.com/articles/biodelivery-bdsi-q4-loss-wider-than-expected-sales-meet-2017-03-20", "https://www.nasdaq.com/articles/pharma-stock-roundup-astrazenecas-lynparza-impresses-study-merck-drug-label-expanded-2017", "https://www.nasdaq.com/articles/endo-endp-beats-on-q4-earnings-revenues-guides-low-2017-02-28", "https://www.nasdaq.com/articles/pre-market-most-active-feb-28-2017-viav-tgt-vrx-cnhi-sby-o-bac-endp-ftr-tvix-life-cemp", "https://www.nasdaq.com/articles/endo-endp-q4-earnings-revenues-beat-estimates-2017-02-28", "https://www.nasdaq.com/articles/earnings-reaction-history-endo-international-plc-400-follow-through-indicator-106", "https://www.nasdaq.com/articles/after-hours-most-active-feb-28-2017-pbi-cboe-ge-endp-clns-xrx-ftr-cone-f-bac-intc-qcom", "https://www.nasdaq.com/articles/start-week-best-earnings-charts-2017-02-27", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-wednesday%3A-endo-international-plc-endp-etsy-inc-etsy-and-palo-alto", "https://www.nasdaq.com/articles/trinet-group-larger-sp-500-component-endo-international-2017-02-24", "https://www.nasdaq.com/articles/thursdays-etf-unusual-volume-pph-2017-02-23", "https://www.nasdaq.com/articles/endo-endp-to-post-q4-earnings%3A-will-the-stock-disappoint-2017-02-22", "https://www.nasdaq.com/articles/wednesdays-etf-unusual-volume-pph-2017-02-15", "https://www.nasdaq.com/articles/wednesday-sector-leaders-healthcare-technology-communications-2017-02-15", "https://www.nasdaq.com/articles/tuesday-sector-leaders-healthcare-financial-2017-02-14", "https://www.nasdaq.com/articles/endos-endp-ephedrine-sulfate-injection-gets-fda-approval-2017-01-31", "https://www.nasdaq.com/articles/implied-volatility-surging-for-endo-international-endp-stock-options-2017-02-24", "https://www.nasdaq.com/articles/endo-endp-restructures-its-branded-pharmaceutical-unit-2017-01-27", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-january-27th-2017-01-27", "https://www.nasdaq.com/articles/is-biomarin-bmrn-well-poised-for-growth-in-2017-2017-01-26", "https://www.nasdaq.com/articles/weitz-funds-comments-endo-international-2017-01-26", "https://www.nasdaq.com/articles/endo-endp-settles-disputes-with-federal-trade-commission-2017-01-24", "https://www.nasdaq.com/articles/10-worst-stocks-during-obama-administration-2017-01-20", "https://www.nasdaq.com/articles/worst-performing-stock-2016-2017-01-17", "https://www.nasdaq.com/articles/endo-endp-restructures-branded-pharmaceutical-unit-revised-2017-01-30", "https://www.nasdaq.com/articles/wednesday-sector-laggards-drugs-biotechnology-stocks-2017-01-11", "https://www.nasdaq.com/articles/sp-500-movers-wmb-ilmn-2017-01-10", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-rsp-endp-myl-mdlz-2017-01-09", "https://www.nasdaq.com/articles/10-worst-stocks-sp-500-2016-2017-01-08", "https://www.nasdaq.com/articles/sp-500-movers-regn-amgn-2017-01-06", "https://www.nasdaq.com/articles/implied-volatility-surging-for-endo-international-endp-stock-options-2017-01-04", "https://www.nasdaq.com/articles/endo-international-endp%3A-can-the-stock-rebound-in-2017-2017-01-04", "https://www.nasdaq.com/articles/deja-vu-drug-stocks-trump-slams-drug-pricing-again-2017-01-12", "https://www.nasdaq.com/articles/wednesday-sector-laggards-drugs-biotechnology-stocks-2017-01-11", "https://www.nasdaq.com/articles/sp-500-movers-nvda-endp-2016-12-30", "https://www.nasdaq.com/articles/why-iconix-brand-group-american-midstream-partners-and-endo-international-jumped-today", "https://www.nasdaq.com/articles/20-states-sue-teva-mylan-other-drug-companies-price-fixing-2016-12-16", "https://www.nasdaq.com/articles/after-hours-most-active-dec-16-2016-ftr-wft-ete-bx-epd-cpn-opk-fcx-csco-endp-hban-intc", "https://www.nasdaq.com/articles/friday-sector-leaders-utilities-healthcare-2016-12-16", "https://www.nasdaq.com/articles/generic-stocks-feel-pricing-heat-1st-charges-filed-doj-antitrust-probe-2016-12-15", "https://www.nasdaq.com/articles/depomed-inc-depo-stock-soars-takeover-talk-2017-01-03", "https://www.nasdaq.com/articles/3-beaten-cheap-stocks-are-they-bargains-2016-12-13", "https://www.nasdaq.com/articles/endo-endp-inks-deal-to-return-belbuca-rights-to-biodelivery-2016-12-09", "https://www.nasdaq.com/articles/mylan-myl-stock-falls-on-restructuring-plans-layoffs-2016-12-08", "https://www.nasdaq.com/articles/wednesday-sector-laggards-healthcare-energy-2016-12-07", "https://www.nasdaq.com/articles/heres-why-teva-pharmaceuticals-teva-stock-down-today-2016-12-06", "https://www.nasdaq.com/articles/biodelivery-sciences%3A-can-bunvail-and-belbucas-sales-improve-2016-11-28", "https://www.nasdaq.com/articles/3-stocks-have-been-cut-half-last-12-months-2016-11-25", "https://www.nasdaq.com/articles/health-care-sector-update-12142016-lciendpmylvceltrov-2016-12-14", "https://www.nasdaq.com/articles/sp-500-movers-endp-aap-2016-11-15", "https://www.nasdaq.com/articles/sp-500-movers-kors-nvda-2016-11-11", "https://www.nasdaq.com/articles/biodelivery-bdsi-reports-wider-than-expected-loss-in-q3-2016-11-10", "https://www.nasdaq.com/articles/sp-500-movers-cnc-endp-2016-11-09", "https://www.nasdaq.com/articles/commit-buy-endo-international-10-earn-14-using-options-2016-11-08", "https://www.nasdaq.com/articles/sp-500-movers-cvs-pcln-2016-11-08", "https://www.nasdaq.com/articles/endo-endp-q3-earnings-revenues-beat-view-intact-2016-11-08", "https://www.nasdaq.com/articles/endo-reports-positive-cellulite-treatment-data-on-xiaflex-2016-11-18", "https://www.nasdaq.com/articles/endo-endp-beats-earnings-revenue-estimates-in-q3-2016-11-08", "https://www.nasdaq.com/articles/earnings-reaction-history-endo-international-plc-333-follow-through-indicator-104", "https://www.nasdaq.com/articles/pre-market-earnings-report-november-8-2016-cvs-jci-dhi-aer-fang-vrx-wlk-glpi-cnk-oa-momo", "https://www.nasdaq.com/articles/endo-endp-q3-earnings%3A-will-the-stock-pull-a-surprise-2016-11-03", "https://www.nasdaq.com/articles/doj-probe-whacks-195-endo-international-stock-2016-11-03", "https://www.nasdaq.com/articles/oversold-conditions-endo-international-endp-2016-11-03", "https://www.nasdaq.com/articles/add-pieces-sciu-could-be-worth-28-2016-10-17", "https://www.nasdaq.com/articles/pre-market-most-active-nov-8-2016-mt-vrx-cvs-htz-sto-bud-xiv-depo-momo-tvix-endp-wba-2016", "https://www.nasdaq.com/articles/endo-endp-beats-earnings-revenue-estimates-in-q3-2016-11-08", "https://www.nasdaq.com/articles/thursday-sector-laggards-healthcare-technology-communications-2016-10-06", "https://www.nasdaq.com/articles/vivus-licenses-stendra-rights-to-metuchen-pharmaceuticals-2016-10-04", "https://www.nasdaq.com/articles/endo-international-reports-positive-phase-ii-data-on-xiaflex-2016-10-03", "https://www.nasdaq.com/articles/better-buy-valeant-pharmaceuticals-international-inc-vs-endo-international-plc-2016-09-30", "https://www.nasdaq.com/articles/notable-thursday-option-activity-mhk-endp-lgf-2016-09-29", "https://www.nasdaq.com/articles/after-hours-most-active-oct-12-2016-mchi-nvda-ared-bac-aeg-scty-ge-paa-c-sedg-endp-qvca", "https://www.nasdaq.com/articles/endo-appoints-new-ceo-keeps-q3-16-view-stock-jumps-2016-09-26", "https://www.nasdaq.com/articles/sp-500-movers-mnk-rig-2016-09-26", "https://www.nasdaq.com/articles/mondays-etf-movers-oih-xph-2016-09-26", "https://www.nasdaq.com/articles/sp-500-movers-crm-endp-2016-09-23", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-friday%3A-alphabet-inc-googl-glu-mobile-inc.-gluu-and-endo", "https://www.nasdaq.com/articles/why-twitter-endo-international-and-hyster-yale-materials-handling-jumped-today-2016-09-23", "https://www.nasdaq.com/articles/endo-internat-soars-new-ceo-announcement-2016-09-23", "https://www.nasdaq.com/articles/thursday-sector-laggards-healthcare-financial-2016-09-29", "https://www.nasdaq.com/articles/fridays-etf-movers-xph-gdxj-2016-09-23", "https://www.nasdaq.com/articles/why-endo-international-plc-stock-gained-192-august-2016-09-09", "https://www.nasdaq.com/articles/mylans-epipen-misclassified-rebates-underpaid-stock-down-2016-09-05", "https://www.nasdaq.com/articles/sp-500-movers-avgo-vrsn-2016-09-02", "https://www.nasdaq.com/articles/sp-500-movers-hog-klac-2016-08-29", "https://www.nasdaq.com/articles/stock-market-news-for-august-26-2016-2016-08-26", "https://www.nasdaq.com/articles/forget-mylan-buy-these-3-drug-stocks-instead-2016-08-26", "https://www.nasdaq.com/articles/why-endo-international-plc-jumped-higher-today-2016-09-23", "https://www.nasdaq.com/articles/sp-500-movers-intu-mnk-2016-08-24", "https://www.nasdaq.com/articles/endo-endp-withdraws-label-expansion-filing-for-opana-er-2016-08-16", "https://www.nasdaq.com/articles/why-anglogold-ashanti-mid-america-apartment-communities-and-endo-international-slumped", "https://www.nasdaq.com/articles/why-salesforce.com-inc.-crm-endo-international-plc-ordinary-shares-endp-and-mid-america", "https://www.nasdaq.com/articles/healthcare-growth-stocks-sp-500-part-2-2016-08-12", "https://www.nasdaq.com/articles/pre-market-most-active-aug-12-2016-sgi-jcp-baba-nvda-cxrx-mt-fcx-tlk-endp-nvo-xiv-qqq-2016", "https://www.nasdaq.com/articles/why-nordstrom-inc.-jwn-j-c-penney-company-inc-jcp-and-endo-international-plc-endp-are-3-of", "https://www.nasdaq.com/articles/stock-market-news-for-august-25-2016-2016-08-25", "https://www.nasdaq.com/articles/7-intriguing-healthcare-growth-stocks-sp-500-part-2-2016-08-11", "https://www.nasdaq.com/articles/commit-purchase-endo-international-10-earn-85-using-options-2016-08-10", "https://www.nasdaq.com/articles/stock-market-news-for-august-10-2016-2016-08-10", "https://www.nasdaq.com/articles/not-too-late-board-endo-endp-train-2016-08-09", "https://www.nasdaq.com/articles/sp-500-movers-gps-endp-2016-08-09", "https://www.nasdaq.com/articles/endo-endp-tops-q2-earnings-estimates-keeps-2016-view-2016-08-09", "https://www.nasdaq.com/articles/pre-market-most-active-aug-9-2016-mww-vrx-nvo-chl-azn-hiiq-sm-arry-yhoo-endp-aapl-xiv-2016", "https://www.nasdaq.com/articles/biodelivery-bdsi-q2-loss-meets-estimates-revenues-up-2016-08-11", "https://www.nasdaq.com/articles/7-intriguing-healthcare-growth-stocks-sp-500-part-2-2016-08-11", "https://www.nasdaq.com/articles/commit-purchase-endo-international-10-earn-85-using-options-2016-08-10", "https://www.nasdaq.com/articles/stock-market-news-for-august-10-2016-2016-08-10", "https://www.nasdaq.com/articles/endo-international-plc%3A-endp-stock-gets-a-helping-hand-from-par-pharmaceutical-2016-08-09", "https://www.nasdaq.com/articles/why-endo-international-plcs-shares-made-u-turn-today-2016-08-09", "https://www.nasdaq.com/articles/earnings-reaction-history-endo-international-plc-333-follow-through-indicator-110", "https://www.nasdaq.com/articles/after-hours-earnings-report-august-8-2016-dva-bap-fnv-mchp-iff-csc-opk-egn-nwsa-nuan-endp", "https://www.nasdaq.com/articles/why-chemours-co-cc-endo-international-plc-endp-and-valeant-pharmaceuticals-intl-inc-vrx", "https://www.nasdaq.com/articles/biodelivery-bdsi-q2-earnings-will-stock-disappoint-2016-08-05", "https://www.nasdaq.com/articles/will-endo-endp-surprise-this-earnings-season-again-2016-08-04", "https://www.nasdaq.com/articles/3-cheap-healthcare-stocks-you-can-buy-right-now-2016-07-21", "https://www.nasdaq.com/articles/weitz-funds-comments-endo-international-2016-07-20", "https://www.nasdaq.com/articles/sp-500-movers-has-coh-2016-07-18", "https://www.nasdaq.com/articles/after-hours-most-active-jul-15-2016-endp-mchp-cbg-pten-qqq-ms-conn-pwr-ej-ixus-bll-mpc", "https://www.nasdaq.com/articles/nasdaq-100-movers-jd-endp-2016-07-13", "https://www.nasdaq.com/articles/5-drug-stocks-reporting-q2-earnings-on-aug-8%3A-agn-more-2016-08-05", "https://www.nasdaq.com/articles/biodelivery-bdsi-q2-earnings-will-stock-disappoint-2016-08-05", "https://www.nasdaq.com/articles/nasdaq-100-movers-mu-endp-2016-07-01", "https://www.nasdaq.com/articles/sp-500-movers-mu-nflx-2016-07-01", "https://www.nasdaq.com/articles/simple-biotech-story-reveals-huge-potential-cheap-stock-2016-06-30", "https://www.nasdaq.com/articles/nasdaq-100-movers-tsco-ntes-2016-06-30", "https://www.nasdaq.com/articles/endos-stock-gains-on-vasostricts-new-patent-approval-2016-06-29", "https://www.nasdaq.com/articles/sp-500-movers-hst-endp-2016-07-13", "https://www.nasdaq.com/articles/sp-500-movers-swn-stx-2016-06-29", "https://www.nasdaq.com/articles/why-southwestern-energy-endo-international-and-lendingclub-jumped-today-2016-06-28", "https://www.nasdaq.com/articles/why-endo-international-plc-patented-higher-stock-price-2016-06-28", "https://www.nasdaq.com/articles/health-care-sector-update-06282016-endpxncrnvsrgls-2016-06-28", "https://www.nasdaq.com/articles/sp-500-movers-bwa-mu-2016-06-21", "https://www.nasdaq.com/articles/nasdaq-100-movers-endp-jd-2016-06-20", "https://www.nasdaq.com/articles/endos-endp-pain-drug-opana-er-to-face-fda-panel-in-fall-2016-06-16", "https://www.nasdaq.com/articles/nasdaq-100-movers-endp-stx-2016-06-29", "https://www.nasdaq.com/articles/nasdaq-100-movers-jd-endp-2016-06-14", "https://www.nasdaq.com/articles/sp-500-movers-syf-endp-2016-06-14", "https://www.nasdaq.com/articles/sp-500-movers-urbn-hrb-2016-06-10", "https://www.nasdaq.com/articles/nasdaq-100-movers-endp-wba-2016-06-10", "https://www.nasdaq.com/articles/nasdaq-100-movers-bbby-aal-2016-06-09", "https://www.nasdaq.com/articles/biggest-stock-losers-2016-2016-06-08", "https://www.nasdaq.com/articles/illusion-falling-official-unemployment-fades-2016-06-06", "https://www.nasdaq.com/articles/3-beaten-healthcare-stocks-are-they-bargains-2016-06-15", "https://www.nasdaq.com/articles/nasdaq-100-movers-jd-endp-2016-06-14", "https://www.nasdaq.com/articles/nasdaq-100-movers-cost-endp-2016-06-02", "https://www.nasdaq.com/articles/sp-500-movers-sig-lb-2016-06-02", "https://www.nasdaq.com/articles/wednesdays-etf-movers-xph-gdxj-2016-06-01", "https://www.nasdaq.com/articles/wally-weitz-drops-falling-drug-stock-endo-sees-upside-potential-2016-05-27", "https://www.nasdaq.com/articles/nasdaq-100-movers-endp-wdc-2016-05-24", "https://www.nasdaq.com/articles/valeant-pharmaceuticals-intl-inc%3A-this-trade-could-double-your-money-vrx-2016-05-18", "https://www.nasdaq.com/articles/george-soros-sells-dow-chemical-delta-air-lines-2016-06-06", "https://www.nasdaq.com/articles/biodelivery-bdsi-posts-line-loss-q1-revenues-miss-2016-05-11", "https://www.nasdaq.com/articles/fridays-etf-movers-gdxj-ihe-2016-05-06", "https://www.nasdaq.com/articles/friday-sector-laggards-drugs-music-electronics-stores-2016-05-06", "https://www.nasdaq.com/articles/mid-day-market-update-yelp-surges-upbeat-results-square-shares-decline-2016-05-06", "https://www.nasdaq.com/articles/endo-international-now-oversold-endp-2016-05-06", "https://www.nasdaq.com/articles/endo-endp-lags-q1-earnings-estimates-cuts-2016-outlook-2016-05-06", "https://www.nasdaq.com/articles/is-this-the-endo-of-the-carnage-in-endo-international-plc-endp-2016-05-18", "https://www.nasdaq.com/articles/sp-500-movers-endp-tdc-2016-05-06", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-lower-cognizant-issues-weak-q2-outlook-2016-05-06", "https://www.nasdaq.com/articles/pre-market-most-active-may-6-2016-so-endp-bac-sne-qqq-tvix-jcp-sq-gpro-mt-xiv-sync-2016-05", "https://www.nasdaq.com/articles/why-endo-international-endp-stock-plunging-today-2016-05-06", "https://www.nasdaq.com/articles/health-care-sector-update-05062016-kmphcrmeagnendp-2016-05-06", "https://www.nasdaq.com/articles/friday-sector-laggards-healthcare-utilities-2016-05-06", "https://www.nasdaq.com/articles/mid-afternoon-market-update-us-stocks-turn-higher-endo-international-shares-plunge-2016-05", "https://www.nasdaq.com/articles/nasdaq-100-movers-endp-atvi-2016-05-06", "https://www.nasdaq.com/articles/will-biodelivery-bdsi-disappoint-estimates-in-q1-earnings-2016-05-05", "https://www.nasdaq.com/articles/after-hours-most-active-may-5-2016-intc-qcom-csco-endp-ge-gpro-dal-msft-bxlt-yelp-sq-xrx", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-zoetis-mckesson-merck-endo-international-and", "https://www.nasdaq.com/articles/3-dirt-cheap-biotech-stocks-buy-2016-05-04", "https://www.nasdaq.com/articles/drug-stocks-reporting-mid-week-mrk-abc-endp-more-2016-05-03", "https://www.nasdaq.com/articles/endo-endp-q1-earnings%3A-whats-in-store-for-the-stock-2016-05-02", "https://www.nasdaq.com/articles/mondays-etf-movers-rwx-xph-2016-04-25", "https://www.nasdaq.com/articles/health-care-sector-update-05062016-syncrmeagnendp-2016-05-06", "https://www.nasdaq.com/articles/why-endo-intl-shares-shot-12-higher-2016-04-21", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-endp-shw-asgn-2016-04-21", "https://www.nasdaq.com/articles/thursday-sector-leaders-healthcare-services-2016-04-21", "https://www.nasdaq.com/articles/nasdaq-100-movers-ilmn-endp-2016-04-19", "https://www.nasdaq.com/articles/stock-market-news-for-april-12-2016-2016-04-12", "https://www.nasdaq.com/articles/vivus-vvus-upgraded-to-hold-on-strong-fundamentals-2016-04-11", "https://www.nasdaq.com/articles/nasdaq-100-movers-endp-stx-2016-04-11", "https://www.nasdaq.com/articles/nasdaq-100-movers-msft-endp-2016-04-22", "https://www.nasdaq.com/articles/why-avis-budget-group-endo-international-and-phh-corp-slumped-today-2016-04-11", "https://www.nasdaq.com/articles/nasdaq-100-movers-ebay-bbby-2016-04-07", "https://www.nasdaq.com/articles/how-pieces-add-spxe-targets-47-2016-04-07", "https://www.nasdaq.com/articles/thursdays-etf-unusual-volume-ihe-2016-04-07", "https://www.nasdaq.com/articles/nasdaq-100-movers-endp-ebay-2016-04-05", "https://www.nasdaq.com/articles/nasdaq-100-movers-endp-incy-2016-03-31", "https://www.nasdaq.com/articles/sp-500-movers-endp-swn-2016-03-31", "https://www.nasdaq.com/articles/sp-500-movers-nov-chk-2016-04-11", "https://www.nasdaq.com/articles/sp-500-movers-shw-mnk-2016-03-21", "https://www.nasdaq.com/articles/nasdaq-100-movers-bmrn-endp-2016-03-21", "https://www.nasdaq.com/articles/what-is-driving-shares-of-endo-endp-sharply-lower-2016-03-18", "https://www.nasdaq.com/articles/nasdaq-100-movers-endp-viab-2016-03-17", "https://www.nasdaq.com/articles/sp-500-movers-endp-fdx-2016-03-17", "https://www.nasdaq.com/articles/close-update-stocks-end-stronger-dow-positive-2016-2016-03-17", "https://www.nasdaq.com/articles/thursday-sector-laggards-healthcare-technology-communications-2016-03-17", "https://www.nasdaq.com/articles/interesting-endp-put-and-call-options-may-20th-2016-03-22", "https://www.nasdaq.com/articles/sp-500-movers-mnk-endp-2016-03-16", "https://www.nasdaq.com/articles/nasdaq-100-movers-endp-aapl-2016-03-15", "https://www.nasdaq.com/articles/tuesday-sector-laggards-healthcare-materials-2016-03-15", "https://www.nasdaq.com/articles/biodelivery-bdsi-misses-on-earnings-and-revenue-in-q4-2016-03-11", "https://www.nasdaq.com/articles/will-biodelivery-bdsi-surprise-estimates-in-q4-earnings-2016-03-08", "https://www.nasdaq.com/articles/nasdaq-100-movers-fast-avgo-2016-03-04", "https://www.nasdaq.com/articles/stock-market-news-for-march-01-2016-2016-03-01", "https://www.nasdaq.com/articles/nasdaq-100-movers-expe-endp-2016-03-16", "https://www.nasdaq.com/articles/are-recession-worries-here-stay-2016-03-01", "https://www.nasdaq.com/articles/why-valeant-pharmaceuticals-intl-inc-vrx-endo-international-plc-endp-and-southwestern", "https://www.nasdaq.com/articles/nasdaq-100-movers-endp-bmrn-2016-02-29", "https://www.nasdaq.com/articles/sp-500-movers-endp-sig-2016-02-29", "https://www.nasdaq.com/articles/endos-endp-q4-earnings-beat-estimates-revenues-in-line-2016-02-29", "https://www.nasdaq.com/articles/earnings-reaction-history-endo-international-plc-250-follow-through-indicator-57-sensitive", "https://www.nasdaq.com/articles/qlt-qlti-reports-narrower-than-expected-loss-in-q4-2016-02-29", "https://www.nasdaq.com/articles/steve-mandel-sells-allergan-davita-during-4th-quarter-2016-03-01", "https://www.nasdaq.com/articles/mondays-etf-movers-ilf-xph-2016-02-29", "https://www.nasdaq.com/articles/monday-sector-laggards-drugs-trucking-stocks-2016-02-29", "https://www.nasdaq.com/articles/outsmarting-crowd-book-beginning-investors-2016-02-29", "https://www.nasdaq.com/articles/why-earnings-season-could-be-great-for-endo-international-endp-2016-02-26", "https://www.nasdaq.com/articles/pre-market-earnings-report-february-29-2016-vrx-endp-iep-nrg-hznp-trco-vgr-acad-grfs-bcpc", "https://www.nasdaq.com/articles/can-endo-endp-keep-the-earnings-streak-alive-in-q4-2016-02-26", "https://www.nasdaq.com/articles/endo-endp-tops-q4-earnings-estimates-gives-2016-outlook-2016-02-29", "https://www.nasdaq.com/articles/why-endo-international-plc-earned-lower-price-today-2016-02-29", "https://www.nasdaq.com/articles/will-arena-arna-post-narrower-expected-4q-loss-2016-02-26", "https://www.nasdaq.com/articles/whats-in-store-for-exelixis-exel-this-earnings-season-2016-02-25", "https://www.nasdaq.com/articles/will-atmels-atml-q4-earnings-disappoint-investors-2016-02-24", "https://www.nasdaq.com/articles/whats-in-store-for-agenus-agen-this-earnings-season-2016-02-23", "https://www.nasdaq.com/articles/will-radius-health-rdus-disappoint-earnings-estimates-in-q4-2016-02-23", "https://www.nasdaq.com/articles/biomarin-bmrn-to-report-q4-earnings%3A-whats-in-store-2016-02-23", "https://www.nasdaq.com/articles/juno-juno-report-4q-earnings-whats-store-2016-02-26", "https://www.nasdaq.com/articles/kite-kite-report-4q-earnings-whats-store-2016-02-26", "https://www.nasdaq.com/articles/will-arena-arna-post-narrower-expected-4q-loss-2016-02-26", "https://www.nasdaq.com/articles/whats-in-store-for-exelixis-exel-this-earnings-season-2016-02-25", "https://www.nasdaq.com/articles/can-ariad-aria-surprise-estimates-this-earnings-season-2016-02-19", "https://www.nasdaq.com/articles/endo-endp-initiates-phase-iib-study-on-xiaflex-for-cellulite-2016-02-18", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-prospect-capital-xerox-endo-international-boardwalk", "https://www.nasdaq.com/articles/5-momentum-stocks-buy-right-now-2016-02-16", "https://www.nasdaq.com/articles/whats-in-store-for-celldex-cldx-this-earnings-season-2016-02-22", "https://www.nasdaq.com/articles/whats-in-store-for-merrimack-mack-this-earnings-season-2016-02-22", "https://www.nasdaq.com/articles/whats-in-store-for-aegerion-aegr-this-earnings-season-2016-02-22", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-january-15th-2016-01-15", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-harman-international-industries-qualcomm-united", "https://www.nasdaq.com/articles/5-sp-500-stocks-likely-turn-around-2016-2016-01-12", "https://www.nasdaq.com/articles/kempharm-expands-pipeline-to-include-pain-candidate-kp746-2016-01-04", "https://www.nasdaq.com/articles/vivus-to-regain-u.s.-and-canada-stendra-rights-from-endo-2016-01-04", "https://www.nasdaq.com/articles/endo-international-enters-oversold-territory-endp-2016-02-11", "https://www.nasdaq.com/articles/nasdaq-100-movers-ctrp-googl-2015-12-28", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-above-5000-3219-points-500111-2015-12-22", "https://www.nasdaq.com/articles/wally-weitz-gives-rare-early-look-4th-quarter-portfolio-2015-12-21", "https://www.nasdaq.com/articles/sp-500-analyst-moves-endp-2015-12-07", "https://www.nasdaq.com/articles/zogenix-zoomed-higher-november-heres-why-2015-12-06", "https://www.nasdaq.com/articles/interesting-endp-put-and-call-options-july-2016-2015-11-24", "https://www.nasdaq.com/articles/health-care-investor-larry-robbins-sells-drug-manufacturers-buys-providers-2015-11-20", "https://www.nasdaq.com/articles/health-care-sector-update-12312015-vvusendptloggbsn-2015-12-31", "https://www.nasdaq.com/articles/biodelivery-bdsi-down-on-wider-than-expected-q3-loss-2015-11-10", "https://www.nasdaq.com/articles/endo-endp-beats-q3-earnings-retains-2015-guidance-2015-11-05", "https://www.nasdaq.com/articles/endo-beats-on-q3-earnings-and-revenues-reiterates-view-2015-11-05", "https://www.nasdaq.com/articles/will-biodelivery-bdsi-disappoint-estimates-in-q3-earnings-2015-11-05", "https://www.nasdaq.com/articles/thursday-sector-laggards-utilities-healthcare-2015-11-05", "https://www.nasdaq.com/articles/why-endo-international-plc-shares-are-crashing-today-2015-11-05", "https://www.nasdaq.com/articles/pre-market-earnings-report-november-5-2015-celg-duk-enb-cnq-mga-apa-tap-symc-agu-endp-mpel", "https://www.nasdaq.com/articles/sp-500-movers-fosl-myl-2015-11-13", "https://www.nasdaq.com/articles/repros-hits-52-week-low-fda-delays-enclomiphene-meeting-2015-10-30", "https://www.nasdaq.com/articles/biodelivery-sciences-bdsi-in-focus%3A-stock-moves-up-8.3-2015-10-27", "https://www.nasdaq.com/articles/biodelivery-endo-up-on-fda-approval-of-pain-drug-belbuca-2015-10-27", "https://www.nasdaq.com/articles/biodelivery-sciences-internationals-stock-jumps-fda-approval-2015-10-26", "https://www.nasdaq.com/articles/health-care-sector-update-10262015-skbibsdiendpathn-2015-10-26", "https://www.nasdaq.com/articles/health-care-sector-update-10262015-mmsibsdiendpathn-2015-10-26", "https://www.nasdaq.com/articles/first-week-december-18th-options-trading-endo-international-endp-2015-10-21", "https://www.nasdaq.com/articles/can-endo-internationals-endp-q3-earnings-surprise-2015-11-03", "https://www.nasdaq.com/articles/supernus-inks-trokendi-xr-settlement-agreement-with-endo-2015-10-20", "https://www.nasdaq.com/articles/radius-health-rdus-looks-good%3A-stock-rises-8.7-2015-10-15", "https://www.nasdaq.com/articles/dipexium-pharmaceuticals-dprx-jumps%3A-stock-up-11.3-2015-10-15", "https://www.nasdaq.com/articles/how-valeant-is-changing-the-pharmaceutical-industry-2015-10-15", "https://www.nasdaq.com/articles/biodeliverys-bunavail-supply-hit-by-specification-issues-2015-10-15", "https://www.nasdaq.com/articles/portolas-betrixaban-gets-fast-track-designation-in-the-u.s.-2015-10-15", "https://www.nasdaq.com/articles/alnylam-offers-data-on-aln-ttrsc02-platform-technology-2015-10-15", "https://www.nasdaq.com/articles/wednesdays-etf-movers-xli-xph-2015-10-21", "https://www.nasdaq.com/articles/ironwood-allergan-to-file-for-lower-dose-of-linzess-in-1h16-2015-10-14", "https://www.nasdaq.com/articles/biomarin-presents-data-on-vosoritide-at-medical-meeting-2015-10-13", "https://www.nasdaq.com/articles/collegiums-coll-xtampza-review-date-postponed-by-fda-2015-10-13", "https://www.nasdaq.com/articles/acelrx-updates-on-zalviso-for-pain-management-treatment-2015-10-08", "https://www.nasdaq.com/articles/vertexs-kalydeco-gets-priority-review-for-expanded-use-2015-10-08", "https://www.nasdaq.com/articles/the-medicines-co.-ties-up-with-symbio-for-ionsys-in-japan-2015-10-07", "https://www.nasdaq.com/articles/osiris-osir-begins-chronic-diabetic-foot-ulcer-study-2015-10-07", "https://www.nasdaq.com/articles/sarepta-down-eteplirsen-likely-to-face-fda-panel-in-jan-2015-10-15", "https://www.nasdaq.com/articles/merck-kgaas-pipeline-on-track-updates-key-rd-projects-2015-10-02", "https://www.nasdaq.com/articles/sarepta-unveils-new-phase-iib-eteplirsen-data-shares-soar-2015-10-02", "https://www.nasdaq.com/articles/jazzs-defibrotide-under-fda-priority-review-shares-up-2015-10-01", "https://www.nasdaq.com/articles/endo-international-slumps%3A-endp-tanks-10.2-in-session-2015-09-29", "https://www.nasdaq.com/articles/endo-completes-%248.05b-par-pharma-acquisition-updates-view-2015-09-29", "https://www.nasdaq.com/articles/par-pharmaceuticals-officially-withdraws-ipo-after-8-billion-acquisition-endo-2015-09-28", "https://www.nasdaq.com/articles/interesting-endp-put-and-call-options-november-20th-2015-09-24", "https://www.nasdaq.com/articles/pharma-deals-latin-america-continue-teva-buy-rimsa-2015-10-02", "https://www.nasdaq.com/articles/sp-500-movers-wrk-tap-2015-09-16", "https://www.nasdaq.com/articles/biodelivery-up-on-striking-deal-with-tenncare-for-bunavail-2015-09-09", "https://www.nasdaq.com/articles/rsi-alert-endo-international-endp-now-oversold-2015-08-24", "https://www.nasdaq.com/articles/endo-gets-favorable-ruling-related-to-opana-er-in-u.s.-2015-08-17", "https://www.nasdaq.com/articles/biodeliverys-new-onsolis-formulation-gains-fda-approval-2015-08-14", "https://www.nasdaq.com/articles/company-news-for-august-11-2015-corporate-summary-2015-08-11", "https://www.nasdaq.com/articles/biodelivery-incurs-wider-loss-in-q2-revenues-fall-y-y-analyst-blog-2015-08-11", "https://www.nasdaq.com/articles/funds-added-endo-international-positions-2015-09-22", "https://www.nasdaq.com/articles/sp-500-movers-wrk-tap-2015-09-16", "https://www.nasdaq.com/articles/biodelivery-up-on-striking-deal-with-tenncare-for-bunavail-2015-09-09", "https://www.nasdaq.com/articles/rsi-alert-endo-international-endp-now-oversold-2015-08-24", "https://www.nasdaq.com/articles/endo-gets-favorable-ruling-related-to-opana-er-in-u.s.-2015-08-17", "https://www.nasdaq.com/articles/biodeliverys-new-onsolis-formulation-gains-fda-approval-2015-08-14", "https://www.nasdaq.com/articles/company-news-for-august-11-2015-corporate-summary-2015-08-11", "https://www.nasdaq.com/articles/biodelivery-incurs-wider-loss-in-q2-revenues-fall-y-y-analyst-blog-2015-08-11", "https://www.nasdaq.com/articles/funds-added-endo-international-positions-2015-09-22", "https://www.nasdaq.com/articles/endo-endp-beats-on-q2-earnings-guidance-reiterated-tale-of-the-tape-2015-08-10", "https://www.nasdaq.com/articles/health-care-sector-update-08102015-pmc-myl-espr-2015-08-10", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-endp-2015-08-07", "https://www.nasdaq.com/articles/repros-enclomiphene-to-face-fda-advisory-panel-in-november-analyst-blog-2015-06-09", "https://www.nasdaq.com/articles/pre-market-most-active-jun-5-2015-ftr-abb-bac-san-gsk-nok-qqq-endp-fcau-jaso-aapl-mrkt", "https://www.nasdaq.com/articles/after-hours-most-active-jun-5-2015-ftr-sune-baba-bac-mdt-t-bbd-eric-endp-rose-siri-qunr", "https://www.nasdaq.com/articles/first-week-september-18th-options-trading-endo-international-endp-2015-07-21", "https://www.nasdaq.com/articles/egalet-reports-encouraging-results-on-pain-drug-egalet-002-analyst-blog-2015-07-01", "https://www.nasdaq.com/articles/john-griffin-takes-stake-trendy-fitbit-inc-2015-06-30", "https://www.nasdaq.com/articles/endo-international-breaks-below-200-day-moving-average-notable-endp-2015-06-29", "https://www.nasdaq.com/articles/dodge-cox-buys-2-new-stocks-2015-06-11", "https://www.nasdaq.com/articles/repros-enclomiphene-to-face-fda-advisory-panel-in-november-analyst-blog-2015-06-09", "https://www.nasdaq.com/articles/company-news-for-may-12-2015-corporate-summary-2015-05-12", "https://www.nasdaq.com/articles/biodelivery-bdsi-q1-loss-narrower-than-expected-analyst-blog-2015-05-12", "https://www.nasdaq.com/articles/billionaire-tracking-etf-just-bulked-health-care-2015-05-24", "https://www.nasdaq.com/articles/company-news-for-may-19-2015-corporate-summary-2015-05-19", "https://www.nasdaq.com/articles/endo-to-acquire-par-pharma-for-%248.05b-shares-down-analyst-blog-2015-05-19", "https://www.nasdaq.com/articles/stock-futures-retreat-record-levels-cautious-housing-data-2015-05-18", "https://www.nasdaq.com/articles/endo-international-endp-expands-generics-8-billion-par-pharma-buy-stocks-news-2015-05-18", "https://www.nasdaq.com/articles/endo-biodelivery-reveal-encouraging-data-on-pain-drug-analyst-blog-2015-05-15", "https://www.nasdaq.com/articles/company-news-for-may-12-2015-corporate-summary-2015-05-12", "https://www.nasdaq.com/articles/biodelivery-bdsi-q1-loss-narrower-than-expected-analyst-blog-2015-05-12", "https://www.nasdaq.com/articles/billionaire-tracking-etf-just-bulked-health-care-2015-05-24", "https://www.nasdaq.com/articles/endo-endp-beats-on-q1-earnings-2015-guidance-upped-analyst-blog-2015-05-11", "https://www.nasdaq.com/articles/will-endo-internationals-endp-q1-earnings-disappoint-analyst-blog-2015-05-08", "https://www.nasdaq.com/articles/pre-market-earnings-report-may-11-2015-act-endp-aer-aes-cnp-icpt-rbc-bid-gwph-ssys-lgnd", "https://www.nasdaq.com/articles/sp-500-analyst-moves-endp-2015-04-30", "https://www.nasdaq.com/articles/first-week-endp-june-19th-options-trading-2015-04-22", "https://www.nasdaq.com/articles/biodelivery-slumps-diabetic-pain-gel-fails-phase-iii-study-analyst-blog-2015-03-31", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-valeant-pharmaceuticals-international-salix", "https://www.nasdaq.com/articles/endo-endp-beats-on-q1-earnings-2015-guidance-updated-tale-of-the-tape-2015-05-11", "https://www.nasdaq.com/articles/valeant-vrx-raises-salix-offer-endo-withdraws-proposal-analyst-blog-2015-03-17", "https://www.nasdaq.com/articles/valeant-pharma-vrx-increases-bid-salix-slxp-173share-stocks-news-2015-03-16", "https://www.nasdaq.com/articles/will-biodelivery-sciences-bdsi-impress-this-earnings-analyst-blog-2015-03-13", "https://www.nasdaq.com/articles/salix-up-on-endo-proposal-outstripping-valeant-offer-analyst-blog-2015-03-12", "https://www.nasdaq.com/articles/company-news-for-march-03-2015-corporate-summary-2015-03-03", "https://www.nasdaq.com/articles/boston-scientific-to-buy-endo-internationals-urology-business-analyst-blog-2015-03-03", "https://www.nasdaq.com/articles/endo-endp-beats-on-both-q4-earnings-and-revenues-tale-of-the-tape-2015-03-02", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-will-it-miss-q4-earnings-analyst-blog-2015-02-28", "https://www.nasdaq.com/articles/will-stratasys-ssys-disappoint-this-earnings-season-analyst-blog-2015-02-27", "https://www.nasdaq.com/articles/veeva-veev%3A-will-it-beat-earnings-estimates-this-season-analyst-blog-2015-02-27", "https://www.nasdaq.com/articles/should-you-buy-endo-international-endp-ahead-of-earnings-tale-of-the-tape-2015-02-27", "https://www.nasdaq.com/articles/will-endo-internationas-endp-beat-on-earnings-in-q4-analyst-blog-2015-02-27", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-2-2015-endp-icpt-ssys-bid-pegi-ptla-stng-core-vnr-xlrn", "https://www.nasdaq.com/articles/what-awaits-keryx-biopharmaceuticals-kerx-this-earnings-analyst-blog-2015-02-26", "https://www.nasdaq.com/articles/endo-endp-beats-on-both-q4-earnings-and-revenues-tale-of-the-tape-2015-03-02", "https://www.nasdaq.com/articles/health-care-sector-update-02032015-isis-bcli-endp-2015-02-03", "https://www.nasdaq.com/articles/nps-pharmaceuticals-natpara-approved-with-boxed-warning-analyst-blog-2015-01-27", "https://www.nasdaq.com/articles/after-hours-most-active-jan-26-2015-hca-bac-endp-swy-fdo-mdt-cov-aapl-msft-sbsi-dltr-qqq", "https://www.nasdaq.com/articles/endo-prices-%241.2b-senior-notes-offering-for-auxilium-deal-analyst-blog-2015-01-22", "https://www.nasdaq.com/articles/ariads-iclusig-endorsed-by-ec-for-all-approved-indications-analyst-blog-2015-01-21", "https://www.nasdaq.com/articles/evotec-signs-new-deal-for-addictive-disorder-therapies-analyst-blog-2015-01-20", "https://www.nasdaq.com/articles/novo-nordisks-xultophy-to-launch-first-in-switzerland-analyst-blog-2015-01-20", "https://www.nasdaq.com/articles/biospecifics-announces-label-expansion-for-xiaflex-in-eu-analyst-blog-2015-02-05", "https://www.nasdaq.com/articles/health-care-sector-update-02032015-isis-bcli-endp-2015-02-03", "https://www.nasdaq.com/articles/nps-pharmaceuticals-natpara-approved-with-boxed-warning-analyst-blog-2015-01-27", "https://www.nasdaq.com/articles/after-hours-most-active-jan-26-2015-hca-bac-endp-swy-fdo-mdt-cov-aapl-msft-sbsi-dltr-qqq", "https://www.nasdaq.com/articles/endo-prices-%241.2b-senior-notes-offering-for-auxilium-deal-analyst-blog-2015-01-22", "https://www.nasdaq.com/articles/ariads-iclusig-endorsed-by-ec-for-all-approved-indications-analyst-blog-2015-01-21", "https://www.nasdaq.com/articles/evotec-signs-new-deal-for-addictive-disorder-therapies-analyst-blog-2015-01-20", "https://www.nasdaq.com/articles/novo-nordisks-xultophy-to-launch-first-in-switzerland-analyst-blog-2015-01-20", "https://www.nasdaq.com/articles/biospecifics-announces-label-expansion-for-xiaflex-in-eu-analyst-blog-2015-02-05", "https://www.nasdaq.com/articles/oncogenexs-affinity-on-track-passes-futility-analysis-analyst-blog-2015-01-19", "https://www.nasdaq.com/articles/ucb-neuropore-collaborate-for-parkinsons-disease-therapy-analyst-blog-2015-01-19", "https://www.nasdaq.com/articles/biocrysts-bcx4161-recommended-for-orphan-drug-in-eu-analyst-blog-2015-01-15", "https://www.nasdaq.com/articles/ariad-reveals-2015-strategic-objectives-updates-on-pipeline-analyst-blog-2015-01-14", "https://www.nasdaq.com/articles/ijh-slg-hsic-endp-large-outflows-detected-etf-2014-12-31", "https://www.nasdaq.com/articles/hospiras-dyloject-cleared-in-the-u.s.-for-pain-management-analyst-blog-2014-12-31", "https://www.nasdaq.com/articles/4-biotech-stocks-doubled-2014-analyst-blog-2014-12-26", "https://www.nasdaq.com/articles/get-ready-be-surprised-earnings-season-screen-week-2015-01-20", "https://www.nasdaq.com/articles/endo-biodelivery-file-regulatory-application-for-pain-drug-analyst-blog-2014-12-24", "https://www.nasdaq.com/articles/auxiliums-xiapex-gets-chmp-nod-for-peyronies-disease-analyst-blog-2014-12-23", "https://www.nasdaq.com/articles/cr-bard-bcr-faces-series-of-lawuits-analyst-blog-2014-12-16", "https://www.nasdaq.com/articles/endo-to-acquire-rights-to-testosterone-nasal-gel-natesto-analyst-blog-2014-11-25", "https://www.nasdaq.com/articles/pharma-industry-outlook-ma-licensing-abound-industry-outlook-2014-11-19", "https://www.nasdaq.com/articles/pharma-industry-outlook-ma-licensing-abound-zacks-analyst-interviews-2014-11-19", "https://www.nasdaq.com/articles/3-best-etfs-mid-cap-growth-2014-11-18", "https://www.nasdaq.com/articles/health-care-sector-update-12242014-halo-bdsi-endp-2014-12-24", "https://www.nasdaq.com/articles/sector-update-health-stocks-generally-higher-pre-bell-2014-11-07", "https://www.nasdaq.com/articles/sector-update-health-care-2014-11-07", "https://www.nasdaq.com/articles/endo-international-beats-on-q3-earnings-sales-view-up-analyst-blog-2014-11-06", "https://www.nasdaq.com/articles/zoetis-q3-earnings-beat-driven-by-higher-livestock-sales-analyst-blog-2014-11-04", "https://www.nasdaq.com/articles/endp-crosses-above-key-moving-average-level-2014-11-03", "https://www.nasdaq.com/articles/3-health-care-picks-to-beat-earnings-earnings-esp-2014-10-29", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-ijh-swks-endp-hsic-2014-10-14", "https://www.nasdaq.com/articles/la-jolla-pharmaceutical-ljpc-in-focus%3A-stock-surges-10.2-tale-of-the-tape-2014-11-10", "https://www.nasdaq.com/articles/endocytes-target-interim-data-positive-for-lung-cancer-analyst-blog-2014-09-29", "https://www.nasdaq.com/articles/gileads-hcv-combo-drug-harvoni-secures-chmp-backing-analyst-blog-2014-09-29", "https://www.nasdaq.com/articles/pacira-down-on-receipt-of-fda-warning-letter-for-exparel-analyst-blog-2014-09-29", "https://www.nasdaq.com/articles/igi-laboratories-ig-jumps%3A-stock-up-18.1-in-session-tale-of-the-tape-2014-09-26", "https://www.nasdaq.com/articles/alnylam-starts-new-study-on-cardiac-amyloidosis-patients-analyst-blog-2014-09-26", "https://www.nasdaq.com/articles/esperion-therapeutics-espr-in-focus%3A-stock-up-13.4-tale-of-the-tape-2014-09-25", "https://www.nasdaq.com/articles/valeant-pharmaceuticals-vrx-in-focus%3A-stock-adds-6.9-tale-of-the-tape-2014-09-25", "https://www.nasdaq.com/articles/cempra-cemp-jumps%3A-stock-up-8.9-in-session-tale-of-the-tape-2014-09-29", "https://www.nasdaq.com/articles/endocytes-target-interim-data-positive-for-lung-cancer-analyst-blog-2014-09-29", "https://www.nasdaq.com/articles/gileads-hcv-combo-drug-harvoni-secures-chmp-backing-analyst-blog-2014-09-29", "https://www.nasdaq.com/articles/zs-pharma-zsph-in-focus%3A-stock-moves-10.7-higher-tale-of-the-tape-2014-09-24", "https://www.nasdaq.com/articles/radius-health-rdus-in-focus%3A-stock-surges-17.3-tale-of-the-tape-2014-09-24", "https://www.nasdaq.com/articles/galmeds-aramchol-gets-fast-track-designation-in-the-u.s.-analyst-blog-2014-09-24", "https://www.nasdaq.com/articles/emergent-biosolutions-initiates-pivotal-study-on-biothrax-analyst-blog-2014-09-24", "https://www.nasdaq.com/articles/zs-pharma-gains-on-positive-phase-iii-hyperkalemia-results-analyst-blog-2014-09-24", "https://www.nasdaq.com/articles/biomarin-bmrn-faces-threat-of-genericization-for-kuvan-analyst-blog-2014-09-25", "https://www.nasdaq.com/articles/auxilium-pharmaceuticals-favors-qlt-deal-over-endo-bid-analyst-blog-2014-09-23", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-friday-tale-of-the-tape-2014-09-19", "https://www.nasdaq.com/articles/weakness-seen-in-avanir-pharmaceuticals-avnr%3A-stock-falls-6.5-tale-of-the-tape-2014-09-19", "https://www.nasdaq.com/articles/salix-s-xifaxan-550-snda-under-review-response-feb-28-analyst-blog-2014-09-19", "https://www.nasdaq.com/articles/spectrum-pharmaceuticals-out-licenses-products-in-china-analyst-blog-2014-09-19", "https://www.nasdaq.com/articles/bayer-to-shed-materialscience-business-shares-rise-analyst-blog-2014-09-19", "https://www.nasdaq.com/articles/alcobra-adhd-worth-watching%3A-stock-moves-5.1-higher-tale-of-the-tape-2014-09-18", "https://www.nasdaq.com/articles/supernus-confirms-2014-outlook-epilepsy-products-in-focus-analyst-blog-2014-09-23", "https://www.nasdaq.com/articles/auxilium-pharmaceuticals-favors-qlt-deal-over-endo-bid-analyst-blog-2014-09-23", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-friday-tale-of-the-tape-2014-09-19", "https://www.nasdaq.com/articles/weakness-seen-in-avanir-pharmaceuticals-avnr%3A-stock-falls-6.5-tale-of-the-tape-2014-09-19", "https://www.nasdaq.com/articles/salix-s-xifaxan-550-snda-under-review-response-feb-28-analyst-blog-2014-09-19", "https://www.nasdaq.com/articles/spectrum-pharmaceuticals-out-licenses-products-in-china-analyst-blog-2014-09-19", "https://www.nasdaq.com/articles/bayer-to-shed-materialscience-business-shares-rise-analyst-blog-2014-09-19", "https://www.nasdaq.com/articles/alcobra-adhd-worth-watching%3A-stock-moves-5.1-higher-tale-of-the-tape-2014-09-18", "https://www.nasdaq.com/articles/supernus-confirms-2014-outlook-epilepsy-products-in-focus-analyst-blog-2014-09-23", "https://www.nasdaq.com/articles/auxilium-pharmaceuticals-favors-qlt-deal-over-endo-bid-analyst-blog-2014-09-23", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-friday-tale-of-the-tape-2014-09-19", "https://www.nasdaq.com/articles/weakness-seen-in-avanir-pharmaceuticals-avnr%3A-stock-falls-6.5-tale-of-the-tape-2014-09-19", "https://www.nasdaq.com/articles/salix-s-xifaxan-550-snda-under-review-response-feb-28-analyst-blog-2014-09-19", "https://www.nasdaq.com/articles/spectrum-pharmaceuticals-out-licenses-products-in-china-analyst-blog-2014-09-19", "https://www.nasdaq.com/articles/bayer-to-shed-materialscience-business-shares-rise-analyst-blog-2014-09-19", "https://www.nasdaq.com/articles/alcobra-adhd-worth-watching%3A-stock-moves-5.1-higher-tale-of-the-tape-2014-09-18", "https://www.nasdaq.com/articles/supernus-confirms-2014-outlook-epilepsy-products-in-focus-analyst-blog-2014-09-23", "https://www.nasdaq.com/articles/midday-update-stocks-mixed-subdued-upcoming-fomc-outcome-2014-09-17", "https://www.nasdaq.com/articles/lennar-gains-upbeat-earnings-adobe-shares-slide-2014-09-17", "https://www.nasdaq.com/articles/endo-international-endp-shares-cross-above-200-dma-2014-09-17", "https://www.nasdaq.com/articles/markets-gain-fedex-profit-beats-street-view-2014-09-17", "https://www.nasdaq.com/articles/futures-move-sideways-ahead-pivotal-fomc-outcome-2014-09-17", "https://www.nasdaq.com/articles/endo-looking-to-acquire-auxilium-pharmaceuticals-for-%242.2b-analyst-blog-2014-09-17", "https://www.nasdaq.com/articles/closing-update-stocks-positive-though-gains-compromised-fed-keeps-dovish-language", "https://www.nasdaq.com/articles/oncogenexs-phase-iii-prostate-cancer-study-fully-enrolled-analyst-blog-2014-09-18", "https://www.nasdaq.com/articles/catalyst-pharmaceutical-cprx-jumps%3A-stock-up-9-tale-of-the-tape-2014-09-05", "https://www.nasdaq.com/articles/merck-kgaas-kuvan-effective-in-under-4-year-olds-analyst-blog-2014-09-05", "https://www.nasdaq.com/articles/tetraphase-pharmaceuticals-ttph-in-focus%3A-stock-gains-14.8-tale-of-the-tape-2014-09-04", "https://www.nasdaq.com/articles/teva-wins-patent-litigation-vs.-astrazeneca-in-uk-analyst-blog-2014-09-04", "https://www.nasdaq.com/articles/rxi-pharmaceuticals-rxii-jumps%3A-stock-moves-11.4-higher-tale-of-the-tape-2014-09-03", "https://www.nasdaq.com/articles/merck-kgaa-in-deal-with-s-target-allergy-pipeline-in-focus-analyst-blog-2014-09-03", "https://www.nasdaq.com/articles/novo-nordisk-drops-anti-inflammatory-rd-activities-analyst-blog-2014-09-03", "https://www.nasdaq.com/articles/flexion-therapeutics-flxn-jumps%3A-stock-rises-9.4-tale-of-the-tape-2014-09-05", "https://www.nasdaq.com/articles/novo-nordisks-ryzodeg-now-in-mexico-for-type-ii-diabetes-analyst-blog-2014-09-02", "https://www.nasdaq.com/articles/glaxo-up-on-accelerated-ebola-vaccine-development-process-analyst-blog-2014-09-02", "https://www.nasdaq.com/articles/igi-laboratories-inc.-ig-in-focus%3A-stock-rises-5.8-tale-of-the-tape-2014-08-29", "https://www.nasdaq.com/articles/intellipharmaceutics-oxycodone-program-to-prevent-overdose-analyst-blog-2014-08-29", "https://www.nasdaq.com/articles/amicus-therapeutics-hits-52-week-high-on-migalastat-data-analyst-blog-2014-08-27", "https://www.nasdaq.com/articles/flamel-technologies-sa-flml-in-focus%3A-stock-rises-8-tale-of-the-tape-2014-08-22", "https://www.nasdaq.com/articles/oncogenexs-custirsen-passes-first-interim-futility-analysis-analyst-blog-2014-08-22", "https://www.nasdaq.com/articles/ucbs-epilepsy-drug-vimpats-label-expanded-in-the-u.s.-analyst-blog-2014-09-02", "https://www.nasdaq.com/articles/astrazeneca-updates-on-plato-study-investigation-on-brilinta-analyst-blog-2014-08-22", "https://www.nasdaq.com/articles/supernus-trokendi-xr-faces-generic-threat-from-actavis-analyst-blog-2014-08-22", "https://www.nasdaq.com/articles/lannett-updates-on-digoxin-safety-issues-expands-portfolio-analyst-blog-2014-08-22", "https://www.nasdaq.com/articles/gilead-gild-hits-52-week-high-thanks-to-sovaldi-analyst-blog-2014-08-21", "https://www.nasdaq.com/articles/astellas-basileas-isavuconazole-accepted-for-eu-review-analyst-blog-2014-08-21", "https://www.nasdaq.com/articles/salix-pharmaceuticals-slxp-jumps%3A-stock-moves-15.5-higher-tale-of-the-tape-2014-08-20", "https://www.nasdaq.com/articles/falling-earnings-estimates-signal-weakness-ahead-for-egalet-eglt-tale-of-the-tape-2014-08", "https://www.nasdaq.com/articles/auxilium-pharmaceuticals-up-on-mid-stage-data-on-xiaflex-analyst-blog-2014-08-22", "https://www.nasdaq.com/articles/salix-pharmaceuticals-jumps-on-takeover-rumours-by-allergan-analyst-blog-2014-08-20", "https://www.nasdaq.com/articles/apricus-biosciences-ed-treatment-vitaros-now-in-germany-analyst-blog-2014-08-19", "https://www.nasdaq.com/articles/astrazenecas-asthma-drug-in-focus-phase-iii-study-initiated-analyst-blog-2014-08-18", "https://www.nasdaq.com/articles/merck-kgaa-q2-earnings-slip-y-y-2014-sales-view-confirmed-analyst-blog-2014-08-15", "https://www.nasdaq.com/articles/astrazenecas-gout-drug-in-focus-with-phase-iii-data-readout-analyst-blog-2014-08-15", "https://www.nasdaq.com/articles/biodel-q3-loss-narrower-than-expected-gives-pipeline-update-analyst-blog-2014-08-14", "https://www.nasdaq.com/articles/jazz-pharmaceuticals-jazz-in-focus%3A-stock-surges-8.8-tale-of-the-tape-2014-08-14", "https://www.nasdaq.com/articles/alcobra-starts-patient-enrollment-for-mid-stage-study-on-mdx-analyst-blog-2014-08-20", "https://www.nasdaq.com/articles/salix-pharmaceuticals-jumps-on-takeover-rumours-by-allergan-analyst-blog-2014-08-20", "https://www.nasdaq.com/articles/athersys-loss-in-line-with-expectations-revenues-down-y-y-analyst-blog-2014-08-13", "https://www.nasdaq.com/articles/what-makes-durata-therapeutics-drtx-a-strong-sell-tale-of-the-tape-2014-08-13", "https://www.nasdaq.com/articles/biodelivery-sciences-q2-loss-narrows-up-on-solid-revenues-analyst-blog-2014-08-13", "https://www.nasdaq.com/articles/spectrum-pharmaceuticals-sppi-posts-strong-earnings-in-q2-analyst-blog-2014-08-12", "https://www.nasdaq.com/articles/repros-therapeutics-q2-loss-a-penny-wider-than-expected-analyst-blog-2014-08-12", "https://www.nasdaq.com/articles/anacors-q2-loss-narrower-than-expected-kerydin-in-focus-analyst-blog-2014-08-12", "https://www.nasdaq.com/articles/rigels-r348-fails-in-phase-ii-study-shares-down-13.6-analyst-blog-2014-08-14", "https://www.nasdaq.com/articles/salix-pharmaceuticals-beats-on-q2-earnings-cuts-guidance-analyst-blog-2014-08-12", "https://www.nasdaq.com/articles/tekmira-shares-continue-to-rise-in-the-search-for-ebola-cure-analyst-blog-2014-08-12", "https://www.nasdaq.com/articles/ariad-falls-on-wider-than-expected-loss-revenues-miss-analyst-blog-2014-08-11", "https://www.nasdaq.com/articles/osiris-falls-despite-narrower-q2-loss-and-higher-revenues-analyst-blog-2014-08-11", "https://www.nasdaq.com/articles/oncogenex-pharmaceuticals-ogxi-soars%3A-stock-up-8.2-tale-of-the-tape-2014-08-08", "https://www.nasdaq.com/articles/jazz-pharmaceuticals-jazz-jumps%3A-stock-moves-5.2-higher-tale-of-the-tape-2014-08-07", "https://www.nasdaq.com/articles/qlt-q2-loss-widens-focus-on-impending-merger-with-auxilium-analyst-blog-2014-08-06", "https://www.nasdaq.com/articles/cardiome-pharma-corp.-crme-jumps%3A-stock-rises-6.9-tale-of-the-tape-2014-08-12", "https://www.nasdaq.com/articles/valeant-pharmaceuticals-slumps%3A-vrx-falls-5.3-in-session-tale-of-the-tape-2014-08-06", "https://www.nasdaq.com/articles/avanirs-q3-loss-in-line-revenues-up-on-high-nuedexta-demand-analyst-blog-2014-08-06", "https://www.nasdaq.com/articles/ironwood-pharmaceuticals-narrows-q2-loss-revenues-down-analyst-blog-2014-08-05", "https://www.nasdaq.com/articles/durata-therapeutics-drtx-worth-watching%3A-stock-gains-18.5-tale-of-the-tape-2014-08-05", "https://www.nasdaq.com/articles/biocryst-pharmaceuticals-bcrx-jumps%3A-stock-adds-5.4-in-session-tale-of-the-tape-2014-08-05", "https://www.nasdaq.com/articles/flamel-technologies-sa-flml-soars%3A-stock-rises-10.9-tale-of-the-tape-2014-08-05", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-kalydeco-label-expanded-in-eu-analyst-blog-2014-08-05", "https://www.nasdaq.com/articles/earnings-up-at-jazz-pharmaceuticals-revenue-guidance-raised-analyst-blog-2014-08-06", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-endp-2014-08-04", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-acrx-soars%3A-stock-adds-6.8-in-session-tale-of-the-tape-2014-08-01", "https://www.nasdaq.com/articles/endo-international-beats-on-q2-earnings-sales-guidance-up-analyst-blog-2014-08-01", "https://www.nasdaq.com/articles/pharmacyclics-pcyc-jumps%3A-stock-rises-15-tale-of-the-tape-2014-07-30", "https://www.nasdaq.com/articles/qlt-inc.-qlti-soars%3A-stock-adds-7.9-in-session-tale-of-the-tape-2014-07-30", "https://www.nasdaq.com/articles/why-neptune-technologies-nept-could-be-positioned-for-a-slump-tale-of-the-tape-2014-07-30", "https://www.nasdaq.com/articles/zoetis-misses-marginally-on-q2-earnings-up-y-y-view-adjusted-analyst-blog-2014-08-05", "https://www.nasdaq.com/articles/tesaro-tsro-slips-on-wider-than-expected-q2-loss-analyst-blog-2014-07-30", "https://www.nasdaq.com/articles/will-merck-co.-mrk-surprise-this-earnings-season-analyst-blog-2014-07-28", "https://www.nasdaq.com/articles/is-pfizer-inc.-pfe-poised-to-beat-earnings-estimates-analyst-blog-2014-07-28", "https://www.nasdaq.com/articles/will-amgen-amgn-disappoint-this-earnings-season-analyst-blog-2014-07-28", "https://www.nasdaq.com/articles/will-express-scripts-miss-earnings-estimates-this-season-analyst-blog-2014-07-28", "https://www.nasdaq.com/articles/will-vertex-pharmaceuticals-vrtx-loss-be-below-estimates-analyst-blog-2014-07-28", "https://www.nasdaq.com/articles/can-hospira-hsp-keep-the-earnings-streak-alive-analyst-blog-2014-07-28", "https://www.nasdaq.com/articles/will-teva-pharmaceutical-teva-beat-q2-earnings-estimates-analyst-blog-2014-07-30", "https://www.nasdaq.com/articles/will-abbvie-abbv-surprise-this-earnings-season-analyst-blog-2014-07-24", "https://www.nasdaq.com/articles/will-alexion-pharmaceuticals-alxn-miss-this-earnings-season-analyst-blog-2014-07-23", "https://www.nasdaq.com/articles/will-generics-eat-into-eli-lillys-lly-q2-earnings-analyst-blog-2014-07-23", "https://www.nasdaq.com/articles/will-bristol-myers-squibb-bmy-disappoint-this-earnings-season-analyst-blog-2014-07-23", "https://www.nasdaq.com/articles/celgene-celg-set-to-beat-earnings-estimates-on-strong-revs-analyst-blog-2014-07-22", "https://www.nasdaq.com/articles/will-biogen-idec-inc.-biib-surprise-this-earnings-season-analyst-blog-2014-07-22", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-acrx-jumps%3A-stock-adds-11.7-in-session-tale-of-the-tape-2014-07-21", "https://www.nasdaq.com/articles/bayer-amgens-nexavar-does-not-show-resilience-in-study-analyst-blog-2014-07-25", "https://www.nasdaq.com/articles/zafgens-beloranib-gets-orphan-drug-status-in-the-eu-analyst-blog-2014-07-14", "https://www.nasdaq.com/articles/mediwound-mdwd-falls%3A-stock-goes-down-6.1-tale-of-the-tape-2014-07-14", "https://www.nasdaq.com/articles/astellas-seeks-fda-nod-for-fungal-infection-treatment-analyst-blog-2014-07-10", "https://www.nasdaq.com/articles/biodelivery-jumps-after-pain-drug-performs-well-in-study-analyst-blog-2014-07-08", "https://www.nasdaq.com/articles/us-futures-follow-european-asian-markets-down-record-highs-amid-lack-catalysts-2014-07-07", "https://www.nasdaq.com/articles/us-futures-edge-down-thursdays-record-highs-2014-07-07", "https://www.nasdaq.com/articles/karyopharm-therapeutics-kpti-in-focus%3A-stock-goes-down-5.2-tale-of-the-tape-2014-07-02", "https://www.nasdaq.com/articles/immunogen-imgn-soars%3A-stock-up-8.8-tale-of-the-tape-2014-07-21", "https://www.nasdaq.com/articles/endo-international-to-expand-generics-business-with-dava-buy-analyst-blog-2014-06-25", "https://www.nasdaq.com/articles/pipeline-update-from-biodelivery-sciences-analyst-blog-2014-05-14", "https://www.nasdaq.com/articles/earnings-beat-at-endo-shares-up-on-improved-outlook-analyst-blog-2014-05-02", "https://www.nasdaq.com/articles/endo-international-plc-endp-jumps%3A-stock-rises-5.4-tale-of-the-tape-2014-05-02", "https://www.nasdaq.com/articles/will-mylan-myl-miss-q1-earnings-analyst-blog-2014-04-30", "https://www.nasdaq.com/articles/can-hospira-hsp-keep-the-earnings-streak-alive-analyst-blog-2014-04-29", "https://www.nasdaq.com/articles/tuesdays-etf-unusual-volume-pph-2014-04-29", "https://www.nasdaq.com/articles/paciras-exparel-positive-in-phase-iv-studies-analyst-blog-2014-06-27", "https://www.nasdaq.com/articles/mylan-to-settle-with-endo-on-frova-analyst-blog-2014-04-14", "https://www.nasdaq.com/articles/biodelivery-sciences-clonidine-in-phase-iii-study-analyst-blog-2014-04-04", "https://www.nasdaq.com/articles/biodelivery-sciences-and-quintiles-sign-deal-for-bunavail-analyst-blog-2014-03-28", "https://www.nasdaq.com/articles/endo-international-moves-market-cap-rank-passing-l-3-communications-holdings-2014-03-26", "https://www.nasdaq.com/articles/ijh-hfc-endp-amg-etf-inflow-alert-2014-03-19", "https://www.nasdaq.com/articles/pipeline-update-from-biodelivery-sciences-analyst-blog-2014-03-18", "https://www.nasdaq.com/articles/update-on-endos-product-portfolio-analyst-blog-2014-03-10", "https://www.nasdaq.com/articles/pullback-brings-bulls-back-endo-2014-04-17", "https://www.nasdaq.com/articles/mylan-to-settle-with-endo-on-frova-analyst-blog-2014-04-14", "https://www.nasdaq.com/articles/biodelivery-sciences-clonidine-in-phase-iii-study-analyst-blog-2014-04-04", "https://www.nasdaq.com/articles/biodelivery-sciences-and-quintiles-sign-deal-for-bunavail-analyst-blog-2014-03-28", "https://www.nasdaq.com/articles/endo-international-moves-market-cap-rank-passing-l-3-communications-holdings-2014-03-26", "https://www.nasdaq.com/articles/ijh-hfc-endp-amg-etf-inflow-alert-2014-03-19", "https://www.nasdaq.com/articles/pipeline-update-from-biodelivery-sciences-analyst-blog-2014-03-18", "https://www.nasdaq.com/articles/update-on-endos-product-portfolio-analyst-blog-2014-03-10", "https://www.nasdaq.com/articles/q4-earnings-decline-y-y-at-endo-weak-outlook-analyst-blog-2014-03-03", "https://www.nasdaq.com/articles/earnings-reaction-history-endo-health-solutions-inc-250-follow-through-indicator-54", "https://www.nasdaq.com/articles/pre-market-earnings-report-february-28-2014-lmca-nrg-endp-ddd-isis-irm-pom-kbr-xls-erie", "https://www.nasdaq.com/articles/first-week-october-18th-options-trading-endo-health-solutions-endp-2014-02-26", "https://www.nasdaq.com/articles/will-mylan-myl-miss-this-earnings-season-analyst-blog-2014-02-26", "https://www.nasdaq.com/articles/interesting-endp-put-and-call-options-january-2016-2014-02-25", "https://www.nasdaq.com/articles/legal-settlement-at-endo-on-lidoderm-analyst-blog-2014-02-24", "https://www.nasdaq.com/articles/pre-market-most-active-mar-5-2014-fcel-blmn-bldp-vz-rate-vntv-endp-cpst-bac-fb-nok-nlsn", "https://www.nasdaq.com/articles/endo-closes-boca-pharmacal-acquisition-analyst-blog-2014-02-04", "https://www.nasdaq.com/articles/endo-health-scores-legal-victory-analyst-blog-2014-01-30", "https://www.nasdaq.com/articles/closing-update-blue-chips-pull-stocks-under-following-fed-minutes-sp-500-ends-little", "https://www.nasdaq.com/articles/update-on-endos-acquisition-strategy-analyst-blog-2013-12-23", "https://www.nasdaq.com/articles/endo-to-acquire-nupathe-analyst-blog-2013-12-17", "https://www.nasdaq.com/articles/update-on-endos-ams-unit-analyst-blog-2013-12-16", "https://www.nasdaq.com/articles/teva-to-acquire-nupathe-analyst-blog-2014-01-22", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-12-16-0", "https://www.nasdaq.com/articles/healthcare-stocks-building-smaller-gains-earlier-endo-health-deal-acquire-nupathe-2013-12", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-12-16-1", "https://www.nasdaq.com/articles/back-to-neutral-on-endo-health-analyst-blog-2013-11-29", "https://www.nasdaq.com/articles/new-magic-formula-stocks-joel-greenblatt-urs-nabors-industries-pilgrims-pride-neustar-2013", "https://www.nasdaq.com/articles/blue-ridge-capital-buys-charter-communications-american-homes-4-rent-tesla-motors-sells", "https://www.nasdaq.com/articles/endo-health-beats-on-earnings-eyes-paladin-analyst-blog-2013-11-06", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-higher-pre-market-endo-acquire-nupathe-2013-12-16", "https://www.nasdaq.com/articles/mid-afternoon-market-update-marvell-rises-kkr-stake-while-orbitz-gives-last-weeks-gains", "https://www.nasdaq.com/articles/mylan-beats-on-earnings-revs-down-analyst-blog-2013-10-31", "https://www.nasdaq.com/articles/will-amerisourcebergen-abc-disappoint-on-earnings-analyst-blog-2013-10-30", "https://www.nasdaq.com/articles/is-mylan-myl-poised-to-beat-earnings-estimates-analyst-blog-2013-10-29", "https://www.nasdaq.com/articles/will-pfizer-pfe-disappoint-this-earnings-analyst-blog-2013-10-28", "https://www.nasdaq.com/articles/will-gilead-gild-disappoint-in-q3-analyst-blog-2013-10-28", "https://www.nasdaq.com/articles/will-mercks-mrk-earnings-streak-end-analyst-blog-2013-10-25", "https://www.nasdaq.com/articles/pre-market-most-active-nov-5-2013-gtat-kors-endp-epd-alu-fb-nmr-bbry-wft-tsla-vale-qqq", "https://www.nasdaq.com/articles/will-celgenes-celg-earnings-streak-end-analyst-blog-2013-10-21", "https://www.nasdaq.com/articles/endo-health-upped-to-outperform-analyst-blog-2013-10-18", "https://www.nasdaq.com/articles/fda-not-in-favor-of-amarins-vascepa-analyst-blog-2013-10-17", "https://www.nasdaq.com/articles/nps-pharmas-gattex-looks-promising-analyst-blog-2013-10-16", "https://www.nasdaq.com/articles/pipeline-progress-at-alnylam-analyst-blog-2013-10-14", "https://www.nasdaq.com/articles/update-on-portolas-pipeline-analyst-blog-2013-10-14", "https://www.nasdaq.com/articles/update-on-biodelivery-sciences-bunavail-analyst-blog-2013-10-11", "https://www.nasdaq.com/articles/will-alexions-alxn-earnings-streak-end-analyst-blog-2013-10-22", "https://www.nasdaq.com/articles/good-news-for-biolinerx-analyst-blog-2013-10-08", "https://www.nasdaq.com/articles/generic-product-launches-at-actavis-analyst-blog-2013-09-20", "https://www.nasdaq.com/articles/drug-firm-actavis-eyes-growth-buyout-lidoderm-2013-09-19", "https://www.nasdaq.com/articles/target-date-for-endo-healths-aveed-analyst-blog-2013-09-09", "https://www.nasdaq.com/articles/update-on-bema-buprenorphine-analyst-blog-2013-09-05", "https://www.nasdaq.com/articles/endo-health-eyeing-generic-company-shares-up-analyst-blog-2013-08-29", "https://www.nasdaq.com/articles/biodelivery-sciences-posts-loss-y-y-analyst-blog-2013-08-14", "https://www.nasdaq.com/articles/pipeline-update-at-alnylam-analyst-blog-2013-10-08", "https://www.nasdaq.com/articles/endo-health-beats-on-earnings-revs.-in-q2-analyst-blog-2013-08-07", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-pre-market-endo-healths-q2-earnings-top-street", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-08-06-1", "https://www.nasdaq.com/articles/biodelivery-announces-%2420m-debt-financing-analyst-blog-2013-07-10", "https://www.nasdaq.com/articles/endo-health-to-shell-out-%2454.5-million-analyst-blog-2013-06-24", "https://www.nasdaq.com/articles/endo-to-trim-workforce-analyst-blog-2013-06-06", "https://www.nasdaq.com/articles/crl-for-endo-healths-aveed-analyst-blog-2013-06-03", "https://www.nasdaq.com/articles/endp-to-offload-anatomical-pathology-unit-analyst-blog-2013-08-14", "https://www.nasdaq.com/articles/merck-enters-into-strategic-deal-analyst-blog-2013-05-22", "https://www.nasdaq.com/articles/setback-for-endo-health-on-opana-er-analyst-blog-2013-05-13", "https://www.nasdaq.com/articles/company-news-for-may-8-2013-corporate-summary-2013-05-08", "https://www.nasdaq.com/articles/earnings-beat-at-endo-health-sales-slip-analyst-blog-2013-05-08", "https://www.nasdaq.com/articles/back-to-neutral-on-endo-health-analyst-blog-2013-03-06", "https://www.nasdaq.com/articles/actavis-files-anda-for-endo-product-analyst-blog-2013-03-05", "https://www.nasdaq.com/articles/earnings-beat-at-endo-health-analyst-blog-2013-03-04", "https://www.nasdaq.com/articles/two-top-endo-executives-depart-analyst-blog-2013-05-30", "https://www.nasdaq.com/articles/merck-enters-into-strategic-deal-analyst-blog-2013-05-22", "https://www.nasdaq.com/articles/setback-for-endo-health-on-opana-er-analyst-blog-2013-05-13", "https://www.nasdaq.com/articles/company-news-for-may-8-2013-corporate-summary-2013-05-08", "https://www.nasdaq.com/articles/earnings-beat-at-endo-health-sales-slip-analyst-blog-2013-05-08", "https://www.nasdaq.com/articles/back-to-neutral-on-endo-health-analyst-blog-2013-03-06", "https://www.nasdaq.com/articles/endo-inks-deal-with-indian-company-analyst-blog-2013-01-29", "https://www.nasdaq.com/articles/bearish-macd-for-endo-health-solutions-inc.-tale-of-the-tape-2013-01-22", "https://www.nasdaq.com/articles/endo-health-draws-big-call-spread-2013-02-28", "https://www.nasdaq.com/articles/tough-times-ahead-for-endo-health-analyst-blog-2013-01-04", "https://www.nasdaq.com/articles/patent-challenge-for-auxilium-pharma-analyst-blog-2013-01-04", "https://www.nasdaq.com/articles/setback-for-endo-health-analyst-blog-2012-12-21", "https://www.nasdaq.com/articles/endo-cuts-eps-view-ceo-to-retire-analyst-blog-2012-12-14", "https://www.nasdaq.com/articles/auxl-downgraded-to-underperform-analyst-blog-2012-11-19", "https://www.nasdaq.com/articles/stock-market-news-for-november-13-2012-market-news-2012-11-13", "https://www.nasdaq.com/articles/endp-beats-on-earnings-view-lowered-analyst-blog-2012-11-06", "https://www.nasdaq.com/articles/impax-launches-opana-er-generic-analyst-blog-2013-01-07", "https://www.nasdaq.com/articles/watson-a-step-closer-to-actavis-analyst-blog-2012-10-19", "https://www.nasdaq.com/articles/after-hours-most-active-oct-15-2012-cim-c-kmi-gov-gen-s-siri-cell-msft-qqq-endp-qcom-2012", "https://www.nasdaq.com/articles/endo-highlights-growth-strategy-analyst-blog-2012-10-10", "https://www.nasdaq.com/articles/update-on-repros-androxal-analyst-blog-2012-09-14", "https://www.nasdaq.com/articles/watsons-generic-lidoderm-approved-analyst-blog-2012-08-27", "https://www.nasdaq.com/articles/after-hours-most-active-aug-27-2012-bac-t-bsx-pbra-gfa-pssi-scs-qqq-csgs-vrsn-endp-dell", "https://www.nasdaq.com/articles/pipeline-progress-at-biodelivery-analyst-blog-2012-08-24", "https://www.nasdaq.com/articles/watson-pharma-starts-new-era-generic-drug-titan-2012-11-02", "https://www.nasdaq.com/articles/endo-health-walks-the-neutral-path-analyst-blog-2012-07-06", "https://www.nasdaq.com/articles/weekly-top-insider-buys-mdt-kmi-win-endp-oc-2012-06-25", "https://www.nasdaq.com/articles/weekly-ceo-buys-highlight-uthr-tat-pmc-brcd-endp-2012-06-16", "https://www.nasdaq.com/articles/good-news-for-endos-pain-portfolio-analyst-blog-2012-06-15", "https://www.nasdaq.com/articles/endo-watson-settle-patent-dispute-analyst-blog-2012-06-04", "https://www.nasdaq.com/articles/auxilium-pharma-sues-watson-analyst-blog-2012-05-29", "https://www.nasdaq.com/articles/auxilium-glaxo-to-drive-testim-sales-analyst-blog-2012-05-22", "https://www.nasdaq.com/articles/endo-health-beats-on-all-fronts-analyst-blog-2012-08-09", "https://www.nasdaq.com/articles/patent-challenge-for-auxilium-pharma-analyst-blog-2012-04-20", "https://www.nasdaq.com/articles/endo-pharma-to-shell-out-%2415m-analyst-blog-2012-04-18", "https://www.nasdaq.com/articles/endo-pullback-doesnt-scare-bulls-2012-04-11", "https://www.nasdaq.com/articles/management-change-at-endo-pharma-analyst-blog-2012-03-30", "https://www.nasdaq.com/articles/endo-pharma-treads-the-neutral-path-analyst-blog-2012-03-16", "https://www.nasdaq.com/articles/earnings-beat-at-endo-pharma-analyst-blog-2012-02-28", "https://www.nasdaq.com/articles/whats-driving-big-run-nasdaq-2012-02-20", "https://www.nasdaq.com/articles/endo-pharma-misses-backs-view-analyst-blog-2012-05-02", "https://www.nasdaq.com/articles/patent-challenge-for-auxilium-pharma-analyst-blog-2012-04-20", "https://www.nasdaq.com/articles/endo-pharma-to-shell-out-%2415m-analyst-blog-2012-04-18", "https://www.nasdaq.com/articles/risk-reward-balances-endo-pharma-analyst-blog-2012-02-01", "https://www.nasdaq.com/articles/risk-reward-balances-endo-pharma-analyst-blog-2012-02-01-0", "https://www.nasdaq.com/articles/increasing-volume-uncover-institutional-buying-screen-week-2012-01-24", "https://www.nasdaq.com/articles/zackscom-featured-expert-kevin-matras-highlights-akorn-inc-diana-shipping-inc-endo", "https://www.nasdaq.com/articles/pharma-biotech-stock-review-outlook-zacks-analyst-interviews-2011-12-28", "https://www.nasdaq.com/articles/upside-position-extended-endo-2012-02-14", "https://www.nasdaq.com/articles/mid-day-update-stocks-lower-europe-concern-weighs-moodys-evaluate-europe-ratings-2012-2011", "https://www.nasdaq.com/articles/largest-option-buying-equities-so-far-2011-11-22", "https://www.nasdaq.com/articles/mid-day-update-stocks-firm-greece-referendum-proceeds-jobs-gain-more-expected-2011-11-02", "https://www.nasdaq.com/articles/takeover-target-biosante-attracts-deal-talks-female-sex-drug-2011-07-19", "https://www.nasdaq.com/articles/stocks-early-lows-upbeat-service-sector-report-tempers-anemic-job-growth-2011-06-03", "https://www.nasdaq.com/articles/mid-day-update-weak-jobs-data-saps-stocks-signal-economic-slowdown-2011-06-03", "https://www.nasdaq.com/articles/giving-health-care-positive-prognosis-2011-04-20", "https://www.nasdaq.com/articles/company-news-for-december-13-2011-corporate-summary-2011-12-13", "https://www.nasdaq.com/articles/bear-bets-upside-limited-endo-2011-03-16", "https://www.nasdaq.com/articles/14-rallying-stocks-excellent-management-teams-2011-03-01", "https://www.nasdaq.com/articles/10-healthcare-stocks-excellent-growth-prospects-2011-02-25", "https://www.nasdaq.com/articles/25-undervalued-stocks-great-management-teams-2011-01-21", "https://www.nasdaq.com/articles/stocks-slide-despite-positive-employment-manufacturing-data-crude-stockpiles-fall-less", "https://www.nasdaq.com/articles/mid-day-update-stocks-moderately-lower-investors-shrug-positive-employment-data-2010-12-30", "https://www.nasdaq.com/articles/squeezing-pennies-penwest-2010-08-10", "https://www.nasdaq.com/articles/opening-view-stocks-could-retest-resistance-ahead-earnings-kick-aa-nyx-endp-lvlt-focus", "https://www.nasdaq.com/articles/endo-pharmaceuticals-has-some-upside-2010-04-22", "https://www.nasdaq.com/articles/high-conviction-stock-pick-won-cara-goldenberg-dinner-warren-buffett-2010-02-24", "https://www.nasdaq.com/articles/put-seller-sees-penwest-holding-2010-06-08"], "Content": []}